KR101557974B1 - Vectors for Preparing Serotype 6 Recombinant Adenovirus - Google Patents

Vectors for Preparing Serotype 6 Recombinant Adenovirus Download PDF

Info

Publication number
KR101557974B1
KR101557974B1 KR1020130034585A KR20130034585A KR101557974B1 KR 101557974 B1 KR101557974 B1 KR 101557974B1 KR 1020130034585 A KR1020130034585 A KR 1020130034585A KR 20130034585 A KR20130034585 A KR 20130034585A KR 101557974 B1 KR101557974 B1 KR 101557974B1
Authority
KR
South Korea
Prior art keywords
serotype
vector
adenovirus
recombinant
sequence
Prior art date
Application number
KR1020130034585A
Other languages
Korean (ko)
Other versions
KR20140118510A (en
Inventor
박기랑
최영국
조영화
Original Assignee
주식회사 에스씨티
충북보건과학대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 에스씨티, 충북보건과학대학교 산학협력단 filed Critical 주식회사 에스씨티
Priority to KR1020130034585A priority Critical patent/KR101557974B1/en
Priority to PCT/KR2013/006602 priority patent/WO2014157778A1/en
Publication of KR20140118510A publication Critical patent/KR20140118510A/en
Application granted granted Critical
Publication of KR101557974B1 publication Critical patent/KR101557974B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351Methods of production or purification of viral material
    • C12N2710/10352Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

본 발명은 혈청형 6 재조합 아데노바이러스를 생산하기 위한 벡터에 관한 것으로 구체적으로는, E1 영역은 포함하지 않는 혈청형 6 아데노바이러스 게놈 및 목적단백질을 코딩하는 유전자를 포함하는 혈청형 6 재조합 아데노바이러스 제조용 셔틀벡터 및 E1 영역이 제거된 혈청형 6 아데노바이러스 게놈을 포함하는 혈청형 6 재조합 아데노바이러스 제조용 레스큐벡터 (rescue vector) 및 상기 셔틀벡터와 상기 레스큐 벡터를 상동 재조합하는 것을 특징으로 하는 혈청형 6 아데노바이러스의 생산방법에 관한 것이다. The present invention relates to a vector for producing serotype 6 recombinant adenovirus, specifically, a serotype 6 adenovirus genome which does not contain the E1 region, and a serotype 6 recombinant adenovirus preparation comprising a gene encoding a target protein A rescue vector for preparing serotype 6 recombinant adenovirus comprising the serotype 6 adenovirus genome from which the shuttle vector and the El region have been removed, and a serotype 6 adenovirus which homologously recombines the shuttle vector and the rescue vector. The present invention relates to a method for producing a virus.

Description

혈청형6 재조합 아데노바이러스 제조용 벡터 {Vectors for Preparing Serotype 6 Recombinant Adenovirus}{Vectors for Preparing Serotype 6 Recombinant Adenovirus}

본 발명은 혈청형 6 재조합 아데노바이러스를 제조하기 위한 벡터에 관한 것으로, 구체적으로는, E1 영역을 포함하지 않는 혈청형 6 아데노바이러스 게놈 및 목적단백질을 코딩하는 유전자를 포함하는 혈청형 6 재조합 아데노바이러스 제조용 셔틀벡터; E1 영역이 제거된 혈청형 6 아데노바이러스 게놈을 포함하는 혈청형 6 재조합 아데노바이러스 제조용 레스큐벡터 (rescue vector); 및 상기 셔틀벡터와 상기 레스큐 벡터를 상동 재조합하는 것을 특징으로 하는 혈청형 6 아데노바이러스의 제조방법에 관한 것이다.
The present invention relates to a vector for producing serotype 6 recombinant adenovirus, and more specifically, to a serotype 6 recombinant adenovirus comprising a serotype 6 adenovirus genome which does not contain the E1 region and a gene encoding a target protein Shuttle vector for manufacturing; A rescue vector for the preparation of serotype 6 recombinant adenovirus comprising the serotype 6 adenovirus genome from which the El region has been removed; And a method for producing serotype 6 adenovirus, wherein the shuttle vector and the rescue vector are homologous recombined.

유전자 전달 기술은 크게 바이러스를 수송체로 사용하는 방법 (viral vector-based transfer method), 합성 인지질이나 합성 양이온성 고분자 등을 사용하는 비-바이러스성 방법 (non-viral delivery method) 및 세포막에 일시적인 전기자극을 가하여 유전자를 도입하는 전기 투과법 (electroporation) 등의 물리적 방법으로 구분할 수 있다. 그 중 바이러스 수송체를 사용하는 방법은 유전인자의 전달이 효율적으로 이루어질 수 있기 때문에 가장 선호되는 방법이다. 바이러스 수송체 또는 바이러스 벡터로 사용되는 바이러스로는 RNA 바이러스 벡터 (retroviral vector, lentiviral vector)와 DNA 바이러스 벡터 (adenoviral vector, adeno-associated viral vector)가 있으며, 이 외에도 단순포진 바이러스 벡터(herpes simplex viral vector), 알파 바이러스 벡터 (alpha viral vector) 등이 있다. The gene transfer technology is largely classified into a viral vector-based transfer method, a non-viral delivery method using a synthetic phospholipid or a synthetic cationic polymer, and a temporary electrical stimulation And electroporation in which a gene is introduced by adding the gene. Among them, the method using the viral transporter is the most preferred method because the transfer of the gene can be efficiently performed. Viruses used as viral vectors or viral vectors include retroviral vectors (lentiviral vectors) and adenoviral vectors (adeno-associated viral vectors), as well as herpes simplex viral vectors ), Alpha viral vector, and the like.

레트로바이러스 (retrovirus)는 증식이 쉽고 다양한 세포에 감염되며 인체에 해가 없지만 유사분열 이후의 세포에 감염되기 힘들며, 인 비보 (in vivo) 상태에서 유전자 전달이 어렵다. 또한 숙주세포의 게놈에 통합되기 때문에 정상세포의 기능을 억제하거나 괴사시킬 수 있으며 원형암유전자 (proto-oncogene)에 통합될 경우 돌연변이의 위험성이 있다는 단점을 지닌다. 반면, 아데노바이러스 (adenovirus)는 transduction효율이 높고 복제중이거나 분화된 세포에도 감염이 잘되며, 숙주세포에 integration (삽입)이 되지 않는 장점이 있다. Retroviruses are easy to proliferate, infect various cells and are harmless to the human body, but are difficult to infect cells after mitosis and are difficult to transfer in vivo. In addition, it integrates into the genome of the host cell, which can inhibit or necrotize the function of normal cells and have a disadvantage of being mutated when integrated into a proto-oncogene. Adenoviruses, on the other hand, have high transduction efficiency and are well infected even during replication or differentiation and are not integrated (inserted) into host cells.

재조합 아데노바이러스 생산방법은 크게 3가지로 1)아데노바이러스 유전체에 직접 클로닝, 2)셔틀벡터 (shuttle vector) 와 레스큐벡터 (rescue vector)를 사용하여 아데노바이러스 생산세포주에서 상동 재조합시키는 방법, 3)셔틀벡터 와 레스큐벡터를 사용하여 재조합효소 (recombinase) 활성을 가진 대장균 (예로, BJ5183)에서 상동 재조합 시키는 방법이 있다. 현재로는 위 3)의 방법이 혈청형2 또는 혈청형5 재조합 아데노바이러스 생산으로 사용되고 있다. 이러한 아데노바이러스에 의해 매개된 목적 유전자의 형질도입 효율 (transduction efficiency: TE)은 생체 내에 존재하는 중화항체 (neutralizing antbody: NAb)에 의하여 방해받는다. 따라서 대상으로 하는 개체 또는 종의 혈청에 최소한으로 존재하는 중화항체 종류에 대응하는 혈청형 아데노바이러스에 목적 유전자를 전달하는 것이 중요하다. Methods for producing recombinant adenovirus are as follows. 1) direct cloning into adenovirus genome, 2) homologous recombination in adenovirus producing cell line using shuttle vector and rescue vector, 3) There is a method of homologous recombination in Escherichia coli (for example, BJ5183) having a recombinase activity using a vector and a rescue vector. Currently, method 3) has been used to produce serotype 2 or serotype 5 recombinant adenoviruses. The transduction efficiency (TE) of the target gene mediated by the adenovirus is blocked by a neutralizing antibody (NAb) present in vivo. Therefore, it is important to deliver the target gene to the serotype adenovirus corresponding to the type of neutralizing antibody that exists at least in the serum of the subject or species.

현재까지 알려진 사람 아데노바이러스의 혈청형은 약 55가지이며, subgroup C에 속하는 혈청형 2 또는 5 아데노바이러스 (Ad5)가 유전자전달체, 유전자치료, 세포치료와 백신개발에 가장 많이 사용이 되었다. 혈청형 2 아데노바이러스는 면역 반응을 일으킬 확률이 높다. 한편 대부분의 사람은 (예로, sub-Saharan African) 이미 Ad5에 노출되어 생성된 중화항체 (neutralizing antibody, NAb)에 의해 예상된 임상적 치료효능을 얻기가 어렵다 (Abbink P et al., J Virol. 2007, 81(9): 4654-4663). 낭포성 섬유증 (Cystic fibrosis)를 가진 유아에서 중화항체의 존재를 연구한 결과에 의하면, 혈청형 3 (91.1%), 혈청 형2 (37.5%), 혈청형 1 (27.1%), 혈청형 7 (26.1%), 혈청형 5 (16.7%), 혈청형 4 (8.5%), 혈청형 6 (2.0%)가 중화항체를 가지고 있다고 보고 되었다 (Piedra PA et al., Pediatrics. 1998, 101(6): 1013-1019). There are about 55 serotypes of known human adenoviruses, and serotype 2 or 5 adenovirus (Ad5) belonging to subgroup C has been most widely used for gene transfer, gene therapy, cell therapy and vaccine development. Serotype 2 adenoviruses are highly likely to cause an immune response. On the other hand, most people (eg sub-Saharan African) have difficulty in obtaining the clinical therapeutic efficacy anticipated by neutralizing antibodies (NAbs) that have already been exposed to Ad5 (Abbink P et al ., J Virol. 2007, 81 (9): 4654-4663). Serologic type 3 (91.1%), serotype 2 (37.5%), serotype 1 (27.1%), serotype 7 (7%) and serotype 2 were found to be serotypes 1 and 2 in children with cystic fibrosis Piedra PA et al ., Pediatrics 1998, 101 (6)), serotype 5 (16.7%), serotype 4 (8.5%) and serotype 6 : 1013-1019).

이에, 본 발명자들은 혈청형 6 재조합 아데노바이러스 제조용 벡터를 개발하고자 예의 노력한 결과, 혈청형 6 재조합 아데노 바이러스의 유전정보를 함유하는 셔틀벡터와 레스큐벡터를 제작하고, 이를 대장균에서 상동성 재조합 시키는 경우, 혈청형 6 재조합 아데노바이러스를 생산할 수 있는 것을 확인하고 본 발명을 완성하게 되었다.
Thus, the present inventors have made intensive efforts to develop a vector for the production of serotype 6 recombinant adenovirus. As a result, when a shuttle vector and a rescue vector containing genetic information of serotype 6 recombinant adenovirus are prepared and homologous recombination is performed in E. coli, 6 recombinant adenovirus can be produced, and the present invention has been completed.

본 발명의 목적은 혈청형 6 재조합 아데노바이러스의 제조용 벡터를 제작하기 위한 셔틀벡터 및 레스큐벡터를 제공하는데 있다.It is an object of the present invention to provide a shuttle vector and a rescue vector for producing a vector for the production of serotype 6 recombinant adenovirus.

본 발명의 다른 목적은 셔틀벡터와 레스큐벡터를 상동 재조합하여 재조합 혈청형 6 아데노바이러스 벡터를 제조하는 방법 및 상기 방법으로 제조된 재조합 혈청형 6 아데노바이러스 벡터를 제공하는데 있다.Another object of the present invention is to provide a recombinant serotype 6 adenovirus vector by homologous recombination of a shuttle vector and a rescue vector, and a recombinant serotype 6 adenovirus vector produced by the method.

본 발명의 또 다른 목적은 상기 혈청형 6 재조합 아데노바이러스 벡터에 목적 단백질을 코딩하는 유전자가 도입되어 있는 목적단백질 발현용 혈청형 재조합 아데노바이러스 벡터를 제공하는데 있다.
It is still another object of the present invention to provide a serotype recombinant adenovirus vector for expressing a target protein in which a gene encoding a target protein is introduced into the serotype 6 recombinant adenovirus vector.

상기 목적을 달성하기 위하여, 본 발명은 혈청형 6 아데노바이러스 게놈의 LITR(left Ad6 inverted terminal repeat), 핵산외각생성신호 (encapsidation signal), RITR(right Ad6 inverted terminal repeat), right arm homology 및 상기 right arm homology와 인접하는 left arm homology를 포함하고, 혈청형 6 아데노바이러스 게놈의 E1 영역은 포함하지 않으며, 복제기점 및 항생제 저항성 유전자를 포함하는 혈청형 6 재조합 아데노바이러스 제조용 셔틀벡터를 제공한다.In order to accomplish the above object, the present invention provides a recombinant vector comprising a left ad 6 inverted terminal repeat (LITR), an encapsidation signal of a serotype 6 adenovirus genome, a right ad 6 inverted terminal repeat (RITR) The present invention provides a shuttle vector for serotype 6 recombinant adenovirus, which contains the arm homology and adjacent left arm homology, does not include the E1 region of the serotype 6 adenovirus genome, and contains a replication origin and an antibiotic resistance gene.

본 발명은 또한, E1 영역이 제거된 혈청형 6 아데노바이러스 게놈, right arm homology 및 상기 right arm homology와 인접하는 left arm homology, 복제기점, 항생제 저항성 유전자를 포함하는 혈청형 6 재조합 아데노바이러스 제조용 레스큐벡터 (rescue vector)를 제공한다.The present invention also provides a recombinant adenoviral vector for producing serotype 6 recombinant adenovirus comprising the serotype 6 adenovirus genome from which the E1 region has been deleted, the right arm homology, and the left arm homology, the origin of replication and the antibiotic resistance gene adjacent to the right arm homology and a rescue vector.

본 발명은 또한, (a) 상기 셔틀벡터와 상기 레스큐벡터를 리콤비네이즈 기능을 가지는 미생물에 동시에 형질전환시키는 단계; (b) 상기 형질전환된 미생물을 배양하는 단계; 및 (c) 상기 배양된 미생물에서 재조합 혈청형 6 아데노바이러스 벡터를 수득하는 단계 단계를 포함하는 재조합 혈청형 6 아데노바이러스 벡터의 제조방법을 제공한다. (A) simultaneously transforming the shuttle vector and the rescue vector into a microorganism having a recombinase function; (b) culturing the transformed microorganism; And (c) obtaining a recombinant serotype 6 adenovirus vector from the cultured microorganism.

본 발명은 또한, 상기 방법으로 제조되고, E1 유전자를 포함하지 않는 혈청형 6 아데노바이러스 유전체, 프로모터, 복제기점 및 항생제 저항성 유전자를 함유하는 것을 특징으로 하는 재조합 혈청형 6 아데노바이러스 벡터를 제공한다.The present invention also provides a recombinant serotype 6 adenovirus vector which comprises the serotype 6 adenovirus genome, the promoter, the origin of replication and the antibiotic resistance gene, which is produced by the above method and does not contain the E1 gene.

본 발명은 또한, 상기 재조합 혈청형 6 아데노바이러스 벡터를 E1 단백질을 발현하는 세포주에 감염시키고, 상기 감염된 세포주로부터 재조합 혈청형 6 아데노바이러스를 수득하는 것을 특징으로 하는 재조합 혈청형 6 아데노바이러스 벡터의 생산방법을 제공한다.The present invention also provides a method of producing a recombinant serotype 6 adenovirus vector, characterized in that the recombinant serotype 6 adenovirus vector is infected into a cell line expressing the E1 protein and the recombinant serotype 6 adenovirus is obtained from the infected cell line ≪ / RTI >

본 발명은 또한, 상기 재조합 세포주를 배양하여 목적단백질을 발현시킨 다음, 상기 발현된 목적단백질을 수득하는 것을 특징으로 하는 목적단백질의 제조방법을 제공한다.The present invention also provides a method for producing a target protein, wherein the recombinant cell line is cultured to express a target protein, and then the expressed target protein is obtained.

본 발명은 또한, 상기 혈청형 6 재조합 아데노바이러스 벡터를 함유하는 유전자 치료제, 세포유전자치료제 및 백신을 제공한다.
The present invention also provides a gene therapy agent, a cell gene therapy agent and a vaccine containing the serotype 6 recombinant adenovirus vector.

본 발명에 따르면, 면역반응 확률이 낮은 혈청형 6 아데노바이러스를 쉽고 효율적으로 생산할 수 있으므로, 유전자 치료제, 세포유전자치료제 및 백신을 생산하는데 유용하다.
According to the present invention, it is possible to easily and efficiently produce serotype 6 adenovirus having a low probability of an immune response, which is useful for producing gene therapy agents, cell gene therapy agents and vaccines.

도 1은 야생형 혈청형 6 아데노바이러스의 유전체 지도이다.
도 2는 pAd6-Transfer와 pAd6-Simple 제작에 사용된 벡터를 나타낸 것이다(A:rAd6 제작에 사용된 pGEM-11Zf(+) 벡터; B:pGEM-11Zf(+)-YC1; C:클로닝부위의 염기서열분석 결과).
도 3은 pGEM-11Zf(+)-YC2의 제작과정을 나타낸 것이다(A: Wild type Ad6의 PCR 증폭부위는 1~558 부위로, forward primer와 reverse primer에는 PacI과 AflII flanking sequence를 가진다. B:Gradient PCR로 annealing 온도를 55℃로 설정하였다. C:pGEM-11Zf(+)-YC1의 PacI, AflII 절단한 전기영동 확인결과; D:pGEM-11Zf(+)-YC2의 플라스미드 지도).
도 4는 pGEM-11Zf(+)-YC3의 제작과정을 나타낸 것이다(A: 야생형 타입 Ad6 지도의 일부로 E1영역 이후의 AflII~XhoI 절단부위. B와 C:여러 클론을 AflII와 BamHI (B), XhoI (C)으로 절단하여 확인하였다. D:pGEM-11Zf(+)-YC3의 플라스미드 지도).
도 5는 pGEM-11Zf(+)-YC3-AsisSI의 제작과정을 나타낸 것이다(A:pGEM-11Zf(+)-YC3에 AsiSI을 추가하기 위한 PCR 프라이머; B: 5개의 클론중 5번이 원하는 크기의 insert를 가지고 있다. C: pGEM-11Zf(+)-YC3에 AsiSI의 염기서열D:pGEM-11Zf(+)-YC3-AsiSI의 플라스미드 유전자지도. M: 100 bp DNA ladder)
도 6은 pGEM-11Zf(+)-YC3-AsisSI-AsisSI의 제작과정을 나타낸 것이다(A: RITR flanking 부위에 AsiSI을 추가하기 위한 PCR 방법도; B:Annealing온도 설정을 위한 gradient PCR. C:3개의 클론을 확보 (4-2. 4-7, 5-9) 후 염기서열분석 결과; D: pGEM-11Zf(+)-YC3-AsisSI-AsisSI의 플라스미드 지도).
도 7은 pGEM-11Zf(+)-YC4-MCS1의 제작과정을 나타낸 것이다(A:pGEM-11Zf(+)-YC4-MCS1의 스크리닝 결과; B:클론 1번을 XbaI, XhoI, SalI, AflII로 절단하여 단일절단을 확인한 결과;C:pGEM-11Zf(+)-YC4-MCS1의 플라스미드 지도).
도 8은 pAd6-Transfer vector의 제작과정을 나타낸 것이다(A: pGEM-11Zf(+)-YC4-MCS1벡터 B. PacI 절단부위를 가진 pShuttle-Ad5의 backbone (Kana, Ori)을 pGEM-11Zf(+)-YC4-MCS1에 클로닝; C:pAd6-Transfer 벡터의 지도).
도 9는 pGEM-11Zf(+)-YC2-R1의 제작과정을 나타낸 것이다(A:pGEM-11Zf(+)-YC2의 플라스미드 지도; B:pGEM-11Zf(+)-YC2-R1의 플라스미드 지도; C: 염기서열 분석결과)
도 10은 YC2-R1-1의 제작 과정을 나타낸 것이다 (A. pGEM-11Zf(+)-YC2-R1에 존재하는 두 곳의 PacI 절단부위와 PCR 프라이머 위치; B:YC2-R1-1의 스크리닝 결과; C: 1번 클론에 대한 염기서열분석결과의 일부; D:YC2-R1-1의 플라스미드 지도).
도 11은 YC2-R2의 제작과정을 나타낸 것이다(A. 혈청형 6 Ad6의 유전체지도. AflII (3,530 nt)와 BstBI 부위를 YC2-R1-1의 AflII, BstBI에 클로닝함 B: EcoRV 절단 결과; C:YC2-R2의 플라스미드 지도).
도 12는 YC2-R3의 제작과정을 나타낸 것이다 (A. YC2-R3의 스크리닝;B: YC2-R3, 클론 21번을 EcoRV 또는 HindIII로 절단하여 추가 분석한 결과; C:YC2-R3의 플라스미드 지도).
도 13은 YC2-R3에서 아데노바이러스 1~558 nt의 제거하는 과정을 나타낸 것이다 (A: YC2-R3 플라스미드 지도, B: YC2-R3를 주형으로 하는 PCR 프라이머 위치).
도 14는 YC2-R3-2의 제작과정을 나타낸 것이다(A:클론 스크리닝 (ClaI & AflII digestion); B:클론 확인 (EcoRI digestion); C: YC2-R3-2의 플라스미드 지도).
도 15는 YC2-R4-2의 제작과정을 나타낸 것이다(A: YC2-R4-2 클로닝 전략; B:Gradient PCR (위: 11.8 Kb PCR 산물, 아래: 3.5 Kb PCR 산물), C:YC2-R4-2 클론의 스크리닝 (HindIII 절단), D: YC2-R4-2 플라스미드 지도).
도 16은 pAd6-Simple2의 제작을 위한 PCR 과정을 나타낸 것이다(A: 야생형 혈청형 6 아데노바이러스의 유전자지도와 PCR 증폭영역; B: gradient PCR 결과).
도 17은 pAd6-Simple2의 플라스미드 지도(A)와 제한효소 처리결과(B)를 나타낸 것이다.
도 18은 pAd6-Transfer-M3-GFP 벡터의 제작과정을 나타낸 것이다(A. pAd6-Transfer 벡터의 플라스미드 지도; B:pAAV-M3-GFP의 플라스미드 지도; C:pAd6-Transfer-M3-GFP 벡터의 플라스미드 지도; D:BglII로 처리된 pAd6-Transfer-M3-GFP (예상크기: 7,117 bp & 1,348 bp)).
도 19는 Ad6-Transfer 벡터와 Ad6-Simple2 벡터를 대장균 (BJ5183)에서 상동 재조합하는 과정을 나타내는 모식도이다.
도 20은 상동 재조합으로 생성된 재조합 pAd6-M3-GFP 벡터의 지도이다.
도 21은 재조합 pAd6-M3-GFP 벡터를 선별하기 위하여 제한효소로 절편한 후, 전기영동으로 확인한 사진이다. A는 분리한 DNA를 Pac1 제한효소로 처리한 것이다. 예상된 결과에 부합하는 클론은 레인 1, 레인 4, 레인 6, 레인 10의 클론이다. B는 재확인을 위하여 레인 6의 클론을 TOP-10 세포에 다시 형질전환한 후 제한효소로 절편하여 전기영동으로 확인한 그림이다. 좌측은 PacI, BstBI, HindIII 제한효소로 절단한 것이고 우측은 AsiSI 제한효소로 절단한 사진이다.
Figure 1 is a genomic map of wild-type serotype 6 adenovirus.
Figure 2 shows the vectors used in the construction of pAd6-Transfer and pAd6-Simple (A: pGEM-11Zf (+) vector used in the production of rAd6; B: pGEM-11Zf Results of base sequence analysis).
FIG. 3 shows the production process of pGEM-11Zf (+) - YC2. (A: Wild type Ad6 has 1 to 558 PCR amplified regions, and forward primer and reverse primer have Pac I and Afl II flanking sequences. . B: the annealing temperature to Gradient PCR was set at 55 ℃ C: pGEM-11Zf ( +) - Pac I, Afl II cut electrophoresis confirmed the results of YC1; D: pGEM-11Zf ( +) - plasmid YC2 map ).
Figure 4 shows the production process of pGEM-11Zf (+) - YC3 (A: Afl II to Xho I cleavage sites after the E1 region as part of the wild type Ad6 map.) B and C: Multiple clones were amplified with Afl II and Bam HI (B) and Xho I (C). D: Plasmid map of pGEM-11Zf (+) - YC3).
Figure 5 shows the procedure for the construction of pGEM-11Zf (+) - YC3-AsisSI (A: PCR primer to add Asi SI to pGEM-11Zf (+) - YC3; B: 5 out of 5 clones has an insert size of the C:. - pGEM-11Zf ( +) sequences of the D Asi SI to YC3:. pGEM-11Zf (+ ) - map of the plasmid genes YC3-AsiSI M: 100 bp DNA ladder)
Figure 6 shows the production process of pGEM-11Zf (+) - YC3-AsisSI-AsisSI (A: PCR method for adding Asi SI to the RITR flanking region, B: gradient PCR for annealing temperature setting, Plasmid map of D: pGEM-11Zf (+) - YC3-AsisSI-AsisSI), obtained by sequencing three clones (4-2. 4-7, 5-9).
7: Screening results of pGEM-11Zf (+) - YC4-MCS1 (A: Screening results of pGEM-11Zf (+) - YC4-MCS1; B: Clone No. 1 as Xba I, Xho I, Sal I , the result is cut by Afl II, make a single cut; C: pGEM-11Zf (+ ) - a plasmid map of YC4-MCS1).
(A) pGEM-11Zf (+) - YC4-MCS1 vector B. The backbone of pShuttle-Ad5 with the Pac I cleavage site (Kana, Ori) was substituted with pGEM-11Zf +) - YC4-MCS1; C: map of pAd6-Transfer vector.
FIG. 9 shows the production process of pGEM-11Zf (+) - YC2-R1 (A: Plasmid map of pGEM-11Zf (+) - YC2; B: Plasmid map of pGEM-11Zf (+) - YC2-R1; C: Result of nucleotide sequence analysis)
FIG. 10 shows the production process of YC2-R1-1 (A. pGEM-11Zf (+) - YC2-R1 in which two Pac I cleavage sites and PCR primers are located; Screening results: C: part of the result of nucleotide sequence analysis for clone 1; D: plasmid map of YC2-R1-1).
Figure 11 shows the production process of YC2-R2 (A. Genomic map of serotype 6 Ad6. Afl II (3,530 nt) and Bst BI site were cloned into Afl II, Bst BI of YC2-R1-1. B: EcoRV cleavage result; C: plasmid map of YC2-R2).
Figure 12 shows the production process of YC2-R3 (screening of A. YC2-R3; B: YC2-R3, clone 21 was further digested with Eco RV or Hind III; Plasmid map).
Fig. 13 shows a process of removing 1 to 558 nt of adenovirus from YC2-R3 (A: YC2-R3 plasmid map, B: PCR primer position using YC2-R3 as a template).
Figure 14 illustrates a manufacturing process of YC2-R3-2 (A: clone screening (Cla I & Afl II digestion) ; B: clone confirmed (Eco RI digestion); C: Plasmid map of YC2-R3-2).
B: Gradient PCR (stomach: 11.8 Kb PCR product, below: 3.5 Kb PCR product), C: YC2-R4 (SEQ ID NO: -2 clone ( Hind III cut), D: YC2-R4-2 plasmid map).
FIG. 16 shows the PCR process for the production of pAd6-Simple2 (A: gene map and PCR amplification region of wild-type serotype 6 adenovirus;
FIG. 17 shows the plasmid map (A) and the restriction enzyme treatment result (B) of pAd6-Simple2.
Figure 18 shows the production process of the pAd6-Transfer-M3-GFP vector (A. pAd6-Transfer vector plasmid map B: pAAV-M3-GFP plasmid map C: pAd6-Transfer-M3-GFP vector Plasmid map; D: pAd6-Transfer-M3-GFP treated with Bgl II (expected size: 7,117 bp & 1,348 bp)).
19 is a schematic diagram showing a process of homologous recombination of Ad6-Transfer vector and Ad6-Simple2 vector in Escherichia coli (BJ5183).
Figure 20 is a map of the recombinant pAd6-M3-GFP vector generated by homologous recombination.
FIG. 21 is a photograph of the recombinant pAd6-M3-GFP vector fragmented with restriction enzymes to select it, followed by electrophoresis. A is the treated DNA with Pac1 restriction enzyme. The clones that meet the expected results are clones of lane 1, lane 4, lane 6, lane 10. B is a picture obtained by re-transforming clone of lane 6 into TOP-10 cells and then digesting with restriction enzyme by electrophoresis. The left side shows the digestion with PacI, BstBI and HindIII restriction enzymes, and the right side shows the digest with AsiSI restriction enzyme.

일 관점에서, 본 발명은 혈청형 6 아데노바이러스 게놈에서 LITR(left Ad6 inverted terminal repeat), 핵산외각생성신호 (encapsidation signal), RITR(right Ad6 inverted terminal repeat),right arm homology 및 상기 right arm homology와 인접하는 left arm homology를 포함하고, 혈청형 6 아데노바이러스 게놈의 E1 영역은 포함하지 않으며, 복제기점 및 항생제 저항성 유전자를 포함하는 혈청형 6 재조합 아데노바이러스 제조용 셔틀벡터에 관한 것이다.In one aspect, the present invention is directed to a method for the detection and / or identification of a human adenoviral genome comprising the steps of: (a) constructing a human adenoviral vector comprising a left ad 6 inverted terminal repeat (LITR), an encapsidation signal, a right Ad6 inverted terminal repeat (RITR) A shuttle vector for serotype 6 recombinant adenovirus comprising contiguous left arm homology, which does not include the E1 region of the serotype 6 adenovirus genome, and contains a replication origin and an antibiotic resistance gene.

본 발명의 셔틀벡터는, 변형된 야생형 혈청형 6 아데노바이러스의 염기서열, 원하는 유전자의 클로닝을 위한 다중클로닝부위 (multiple cloning sites), 클론선별을 위한 항생제 저항성 유전자, 복제기점 및 항생제 저항성 유전자를 제거할 수 있는 제한효소절단부위를 가진다. The shuttle vector of the present invention can be used to remove the nucleotide sequence of the modified wild-type serotype 6 adenovirus, multiple cloning sites for cloning of the desired gene, antibiotic resistance gene for clone selection, replication origin and antibiotic resistance gene And has a restriction enzyme cleavage site that can be made.

상기 변형된 야생형 혈청형 6 아데노바이러스의 염기서열은, 야생형 염기서열로부터 자체복제를 위한 E1 영역은 제거하되 바이러스 패키징 (virus packaging)에 관여하는 encapsidation signal 영역은 포함하도록 한다. 또한 RITR을 포함한 right arm homology와 LITR을 포함한 left arm homology를 포함하며 그 사이에 고유한 제한효소절단부위를 가진다. The nucleotide sequence of the modified wild-type serotype 6 adenovirus includes an encapsidation signal region that is involved in virus packaging while removing the E1 region for self-replication from the wild type sequence. It also contains a right arm homology with RITR and a left arm homology with LITR, with a unique restriction site between them.

본 발명의 일 양태에서는 상기의 특징을 모두 가지는 7022 bp의 크기의 pAd-transfer 벡터를 제작하였고, 제한효소 분석을 통하여 검증하였다.In one embodiment of the present invention, a 702 bp pAd-transfer vector having all of the above characteristics was prepared and verified by restriction enzyme analysis.

본 발명의 셔틀벡터는 목적 단백질을 코딩하는 유전자를 추가로 함유할 수 있으며, 바람직하게는 상기 목적 단백질은 치료용 단백질일 수 있다. The shuttle vector of the present invention may further contain a gene encoding a target protein, and preferably the target protein may be a therapeutic protein.

본 발명의 셔틀벡터는 상기 복제기점과 상기 항생제 저항성 유전자가 제한효소에 의해 제거될 수 있는 구조를 가지는 것을 특징으로 할 수 있다. The shuttle vector of the present invention may be characterized in that the replication origin and the antibiotic resistance gene have a structure capable of being removed by a restriction enzyme.

본 발명에 있어서, 상기 LITR(left Ad6 inverted terminal repeat)은 서열번호 1의 염기서열 중 2,939 ~ 2,998의 서열을 가지는 것을 특징으로 할 수 있고, 상기 RITR(right Ad6 inverted terminal repeat)은 서열번호 1의 염기서열 중 6,946 ~ 7,005의 서열을 가지는 것을 특징으로 할 수 있다. In the present invention, the LITR (left Ad6 inverted terminal repeat) may have a sequence of 2,939 to 2,998 of the nucleotide sequence of SEQ ID NO: 1, and the right AD6 inverted terminal repeat may have the sequence of SEQ ID NO: It may be characterized by having a sequence of 6,946 to 7,005 in the nucleotide sequence.

본 발명에 있어서, 상기 핵산외각생성신호 (encapsidation signal)는 서열번호 1의 염기서열 중 3,120 ~ 3,269의 서열을 가지는 것을 특징으로 할 수 있고, 상기 right arm homology는 서열번호 1의 염기서열 중 3,604 ~ 5,848의 서열을 가지는 것을 특징으로 할 수 있으며, 상기 left arm homology는 서열번호 1의 염기서열 중 5,855 ~ 7,006의 서열을 가지는 것을 특징으로 할 수 있다. In the present invention, the encapsidation signal of the nucleic acid may have a sequence of 3,120 to 3,269 of the nucleotide sequence of SEQ ID NO: 1, and the right arm homology may include 3,604 to 3,604 of the nucleotide sequence of SEQ ID NO: 5,848, and the left arm homology may have a sequence of 5,855 to 7,006 in the nucleotide sequence of SEQ ID NO: 1.

본 발명에서 상기 left arm homology와 right arm homology 서열은 셔틀벡터와 이와함께 사용되는 레스큐 벡터에 모두 포함되며, 상기 left arm homology와 right arm homology에서 상동성 재조합이 발생하게 된다. In the present invention, the left arm homology and the right arm homology sequences are included both in the shuttle vector and the rescue vector used together, and homologous recombination occurs in the left arm homology and the right arm homology.

다른 관점에서, 본 발명은 E1 영역이 제거된 혈청형 6 아데노바이러스 게놈, right arm homology 및 상기 right arm homology와 인접하는 left arm homology, 복제기점, 항생제 저항성 유전자를 포함하는 혈청형 6 재조합 아데노바이러스 생산용 레스큐 벡터 (rescue vector)에 관한 것이다.In another aspect, the present invention provides a method of producing serotype 6 recombinant adenovirus comprising the serotype 6 adenovirus genome from which the E1 region has been deleted, the right arm homology and the right arm homology and the adjacent arm homology, origin of replication and antibiotic resistance gene Gt; rescue < / RTI >

본 발명의 일 양태에서, 레스큐 벡터는 E1 영역이 제거된 혈청형 6 아데노바이러스의 염기서열을 모두 가지며, 혈청형 6 아데노바이러스의 LITR~AflII (1~3,530 nt) 영역을 제거하였으며, 그 결과 야생형 혈청형 6 아데노바이러스의 AflII (3,530 nt)부터 right ITR (35,759 nt)까지를 포함하는 pAd-Simple2 벡터를 제작하였다.In one embodiment of the present invention, the rescue vector has all of the nucleotide sequences of the serotype 6 adenovirus from which the E1 region has been removed, and removes the LITR to AflII (1 to 3,530 nt) region of the serotype 6 adenovirus, A pAd-Simple2 vector containing the serotype 6 adenovirus AflII (3,530 nt) to the right ITR (35,759 nt) was constructed.

본 발명의 레스큐 벡터는 혈청형 6 아데노바이러스 게놈에서 제거된 E1 영역은 LITR~AFlll 영역(GenBank no. HQ413315.1의 1~3,530nt)을 포함하는 것을 특징으로 할 수 있다. .The rescue vector of the present invention may be characterized in that the E1 region deleted from the serotype 6 adenovirus genome includes the LITR to AFIII region (GenBank No. HQ413315.1, 1 to 3,530 nt). .

본 발명에 있어서, 상기 E1 영역이 제거된 혈청형 6 아데노바이러스 게놈은 서열번호 2의 염기서열 중 10~32,251의 염기서열을 가지는 것을 특징으로 할 수 있고, 상기 right arm homology는 서열번호 1의 염기서열 중 3,604 ~ 5,848의 서열을 가지는 것을 특징으로 할 수 있으며, 상기 left arm homology는 서열번호 1의 염기서열 중 5,855 ~ 7,006의 서열을 가지는 것을 특징으로 할 수 있다. In the present invention, the serotype 6 adenovirus genome from which the E1 region has been deleted may have a nucleotide sequence of 10 to 32,251 of the nucleotide sequence of SEQ ID NO: 2, and the right arm homology may include a nucleotide sequence of SEQ ID NO: And 3,604 to 5,848 of the sequence, and the left arm homology may have a sequence of 5,855 to 7,006 of the nucleotide sequence of SEQ ID NO: 1.

또 다른 관점에서, 본 발명은 (a) 상기 셔틀벡터와 상기 레스큐벡터를 리콤비네이즈 기능을 가지는 미생물에 동시에 형질전환시키는 단계; (b) 상기 형질전환된 미생물을 배양하는 단계; 및 (c) 상기 배양된 미생물에서 재조합 혈청형 6 아데노바이러스 벡터를 수득하는 단계 단계를 포함하는 재조합 혈청형 6 아데노바이러스 벡터의 제조방법 및 상기 방법으로 제조되고, E1 유전자를 포함하지 않는 혈청형 6 아데노바이러스 유전체, 프로모터, 복제기점 및 항생제 저항성 유전자를 함유하는 것을 특징으로 하는 재조합 혈청형 6 아데노바이러스 벡터에 관한 것이다.According to another aspect of the present invention, there is provided a method for regenerating a shuttle vector comprising: (a) simultaneously transforming the shuttle vector and the rescue vector into microorganisms having a recombinase function; (b) culturing the transformed microorganism; And (c) obtaining a recombinant serotype 6 adenovirus vector from the cultured microorganism. Also provided is a method for producing a recombinant serotype 6 adenovirus vector comprising the serotype 6 An adenovirus genome, a promoter, a replication origin, and an antibiotic resistance gene. The present invention also relates to a recombinant serotype 6 adenovirus vector.

본 발명에 따른 혈청형 6 재조합 아데노바이러스 제조용 벡터는 다양한 제한효소자리, 항생제 저항성 유전자, 다중클로닝부위를 포함하고 있어 편리하게 혈청형 6 재조합 아데노바이러스를 생산할 수 있다.The vector for preparing serotype 6 recombinant adenovirus according to the present invention can conveniently produce serotype 6 recombinant adenovirus because it contains various restriction enzyme sites, an antibiotic resistance gene and a multiple cloning site.

본 발명의 혈청형 6 재조합 아데노바이러스 제조용 벡터를 사용하여 만들어진 혈청형 6 재조합 아데노바이러스는 유전자전달체, 유전자치료제, 세포치료제, 백신개발 등에 적용할 수 있으며, 킷트의 형태나 혈청형 6 재조합 아데노바이러스 생산 서비스의 형태로 연구용 또는 치료제용으로 제공이 가능하다.The serotype 6 recombinant adenovirus produced by using the vector for the production of the serotype 6 recombinant adenovirus of the present invention can be applied to the development of a gene carrier, a gene therapy agent, a cell therapeutic agent, a vaccine and the like, and the kit type, serotype 6 recombinant adenovirus production It can be provided for research or therapeutic purposes in the form of services.

본 발명에서 셔틀벡터는 right arm homology와 left arm homology 연결부위를 제한효소로 절단하여 선형화시킨 것을 상기 미생물에 도입시키는 것이 바람직하다. In the present invention, the shuttle vector is preferably introduced into the microorganism by linearizing the right arm homology and the left arm homology linkage sites with restriction enzymes.

본 발명의 일 양태에서, 혈청형 6 재조합 아데노바이러스 생산용 재조합 바이러스 벡터는, pAd6-Transfer (셔틀벡터)와 pAd6-Simple2 (rescue vector) 두 종류의 플라스미드 벡터로 이루어져 있다. In one embodiment of the present invention, the recombinant viral vector for serotype 6 recombinant adenovirus production comprises two types of plasmid vectors, pAd6-Transfer (shuttle vector) and pAd6-Simple2 (rescue vector).

본 발명의 셔틀벡터와 rescue vector는 재조합효소 기능을 가지는 박테리아에 형질전환시켜 상동재조합에 의하여, 혈청형 6 재조합 아데노바이러스를 생산할 수 있다. The shuttle vector and the rescue vector of the present invention can be transformed into bacteria having a recombinant enzyme function to produce serotype 6 recombinant adenovirus by homologous recombination.

본 발명의 일양태에서는 pAd6-Transfer 셔틀벡터에 GFP를 목적단백질로 사용하여, GFP를 코딩하는 유전자를 삽입하여 pAd6-Transfer-M3-GFP를 제작한 후, pAd6-Simple2와 대장균 (BJ5183)에 형질전환시켜, 상동재조합을 유도하고, GFP를 발현하는 세포주를 성공적으로 스크리닝하여, 본 발명의 혈청형 6 재조합 아데노바이러스 제조용 벡터가 성공적으로 혈청형 6 재조합 아데노 바이러스를 생산할 수 있다는 것을 확인하였다. In one embodiment of the present invention, pAd6-Transfer-M3-GFP is prepared by inserting a gene coding for GFP using GFP as a target protein in the pAd6-Transfer shuttle vector, and then pAd6-Simple2 and Escherichia coli (BJ5183) The homologous recombination was induced, and the cell line expressing GFP was successfully screened to confirm that the vector for serotype 6 recombinant adenovirus production of the present invention was able to successfully produce serotype 6 recombinant adenovirus.

본 발명에 있어서, 상기 리콤비네이즈 활성을 가지는 미생물은 대장균, EL250 cells, EL350 cells 및 아데노바이러스 생산세포주 구성된 군에서 선택되는 것을 특징으로 할 수 있다.In the present invention, the microorganism having recombinase activity may be selected from the group consisting of E. coli, EL250 cells, EL350 cells and adenovirus-producing cell lines.

본 발명의 재조합 혈청형 6 아데노바이러스 벡터는 E1 유전자를 포함하지 않는 혈청형 6 아데노바이러스 유전체, 프로모터, 복제기점 및 항생제 저항성 유전자를 함유하는 것을 특징으로 할 수 있다. The recombinant serotype 6 adenovirus vector of the present invention may include a serotype 6 adenovirus genome that does not contain the E1 gene, a promoter, a replication origin, and an antibiotic resistance gene.

본 발명의 재조합 혈청형 6 아데노바이러스 벡터는 목적단백질을 코딩하는 유전자를 추가로 함유하는 것이 바람직하며, 상기 목적단백질은 치료용 단백질일 수 있다. The recombinant serotype 6 adenovirus vector of the present invention preferably further comprises a gene encoding a target protein, and the target protein may be a therapeutic protein.

본 발명에서 용어 “벡터 (vector)”는 적합한 숙주 내에서 DNA를 발현시킬 수 있는 적합한 조절 서열에 작동가능하게 연결된 DNA 서열을 함유하는 DNA 제조물을 의미한다. 벡터는 플라스미드, 파지 입자, 또는 간단하게 잠재적 게놈 삽입물일 수 있다. 적당한 숙주로 형질전환되면, 벡터는 숙주 게놈과 무관하게 복제하고 기능할 수 있거나, 또는 일부 경우에 게놈 그 자체에 통합될 수 있다. 플라스미드가 현재 벡터의 가장 통상적으로 사용되는 형태이므로, 본 발명의 명세서에서 “플라스미드 (plasmid)” 및 “벡터 (vector)”는 때로 상호 교환적으로 사용된다. 그러나, 본 발명은 당업계에 알려진 또는 알려지게 되는 바와 동등한 기능을 갖는 벡터의 다른 형태를 포함한다. 포유동물 세포 배양물 발현을 위한 전형적인 발현 벡터는 예를 들면 pRK5 (EP 307,247호), pSV16B (WO 91/08291호) 및 pVL1392 (Pharmingen)을 기초로 한다. As used herein, the term " vector " means a DNA product containing a DNA sequence operably linked to an appropriate regulatory sequence capable of expressing the DNA in the appropriate host. The vector may be a plasmid, phage particle, or simply a potential genome insert. Once transformed into the appropriate host, the vector may replicate and function independently of the host genome, or, in some cases, integrate into the genome itself. Because the plasmid is the most commonly used form of the current vector, the terms " plasmid " and " vector " are sometimes used interchangeably in the context of the present invention. However, the present invention includes other forms of vectors having functions equivalent to those known or known in the art. Typical expression vectors for mammalian cell culture expression are based on, for example, pRK5 (EP 307,247), pSV16B (WO 91/08291) and pVL1392 (Pharmingen).

“발현 조절 서열 (expression control sequence)”이라는 표현은 특정한 숙주 생물에서 작동가능하게 연결된 코딩 서열의 발현에 필수적인 DNA 서열을 의미한다. 그러한 조절 서열은 전사를 실시하기 위한 프로모터, 그러한 전사를 조절하기 위한 임의의 오퍼레이터 서열, 적합한 mRNA 리보좀 결합 부위를 코딩하는 서열 및 전사 및 해독의 종결을 조절하는 서열을 포함한다. 예를 들면, 원핵생물에 적합한 조절 서열은 프로모터, 임의로 오퍼레이터 서열 및 리보좀 결합 부위를 포함한다. The expression " expression control sequence " means a DNA sequence that is essential for the expression of a coding sequence operably linked to a particular host organism. Such regulatory sequences include promoters for carrying out transcription, any operator sequences for regulating such transcription, sequences encoding suitable mRNA ribosome binding sites, and sequences controlling the termination of transcription and translation. For example, regulatory sequences suitable for prokaryotes include promoters, optionally operator sequences, and ribosome binding sites.

핵산은 다른 핵산 서열과 기능적 관계로 배치될 때 “작동가능하게 연결 (operably linked)”된다. 이것은 적절한 분자 (예를 들면, 전사 활성화 단백질)은 조절 서열(들)에 결합될 때 유전자 발현을 가능하게 하는 방식으로 연결된 유전자 및 조절 서열(들)일 수 있다. 예를 들면, 전서열(pre-sequence) 또는 분비 리더 (leader)에 대한 DNA는 폴리펩타이드의 분비에 참여하는 전단백질로서 발현되는 경우 폴리펩타이드에 대한 DNA에 작동가능하게 연결되고; 프로모터 또는 인핸서는 서열의 전사에 영향을 끼치는 경우 코딩서열에 작동가능하게 연결되거나; 또는 리보좀 결합 부위는 서열의 전사에 영향을 끼치는 경우 코딩 서열에 작동가능하게 연결되거나; 또는 리보좀 결합 부위는 번역을 용이하게 하도록 배치되는 경우 코딩 서열에 작동가능하게 연결된다. 일반적으로, “작동가능하게 연결된”은 연결된 DNA 서열이 접촉하고, 또한 분비 리더의 경우 접촉하고 리딩 프레임 내에 존재하는것을 의미한다. 그러나, 인핸서 (enhancer)는 접촉할 필요가 없다. 이들 서열의 연결은 편리한 제한 효소 부위에서 라이게이션(연결)에 의해 수행된다. 그러한 부위가 존재하지 않는 경우, 통상의 방법에 따른 합성 올리고뉴클레오티드 어댑터 (oligonucleotide adaptor) 또는 링커(linker)를 사용한다. A nucleic acid is " operably linked " when placed in a functional relationship with another nucleic acid sequence. This may be the gene and regulatory sequence (s) linked in such a way that the appropriate molecule (e. G., Transcriptional activator protein) is capable of gene expression when bound to the regulatory sequence (s). For example, DNA for a pre-sequence or secretory leader is operably linked to DNA for a polypeptide when expressed as a whole protein participating in the secretion of the polypeptide; A promoter or enhancer is operably linked to a coding sequence if it affects the transcription of the sequence; Or the ribosome binding site is operably linked to a coding sequence if it affects the transcription of the sequence; Or a ribosome binding site is operably linked to a coding sequence if positioned to facilitate translation. Generally, " operably linked " means that the linked DNA sequences are in contact and, in the case of a secretory leader, are in contact and present in the reading frame. However, the enhancer need not be in contact. The linkage of these sequences is carried out by ligation (linkage) at convenient restriction sites. If such a site does not exist, a synthetic oligonucleotide adapter or a linker according to a conventional method is used.

당업계에 주지된 바와 같이, 숙주세포에서 형질감염 유전자의 발현 수준을 높이기 위해서는, 해당 유전자가, 선택된 발현 숙주 내에서 기능을 발휘하는 전사 및 해독 발현 조절 서열에 작동가능하도록 연결되어야만 한다. 바람직하게는 발현 조절서열 및 해당 유전자는 세균 선택 마커 및 복제 개시점 (replication origin)을 같이 포함하고 있는 하나의 발현 벡터 내에 포함되게 된다. 발현 숙주가 진핵세포인 경우에는, 발현 벡터는 진핵 발현 숙주 내에서 유용한 발현 마커를 더 포함하여야만 한다.As is well known in the art, to increase the level of expression of a transfected gene in a host cell, the gene must be operably linked to a transcriptional and detoxification regulatory sequence that functions in the selected expression host. Preferably the expression control sequence and the gene are contained within an expression vector containing a bacterial selection marker and a replication origin. If the expression host is a eukaryotic cell, the expression vector should further comprise a useful expression marker in the eukaryotic expression host.

본원 명세서에 사용된 용어 “형질전환”은 DNA를 숙주로 도입하여 DNA가 염색체외 인자로서 또는 염색체 통합완성에 의해 복제가능하게 되는 것을 의미한다. 본원 명세서에 사용된 용어 “형질감염”은 임의의 코딩 서열이 실제로 발현되든 아니든 발현 벡터가 숙주 세포에 의해 수용되는 것을 의미한다. As used herein, the term " transformation " means introducing DNA into a host and allowing the DNA to replicate as an extrachromosomal factor or by chromosomal integration. As used herein, the term " transfection " means that an expression vector, whether or not any coding sequence is actually expressed, is accepted by the host cell.

발명의 숙주 세포는 원핵 또는 진핵생물 세포일 수 있다. 또한, DNA의 도입효율이 높고, 도입된 DNA의 발현효율이 높은 숙주가 통상 사용된다. 이. 콜라이, 슈도모나스, 바실러스, 스트렙토마이세스, 진균, 효모와 같은 주지의 진핵 및 원핵 숙주들, 스포도프테라 프루기페르다(SF9)와 같은 곤충 세포, CHO 및 생쥐 세포같은 동물 세포, COS 1, COS 7, BSC 1, BSC 40 및 BMT 10과 같은 아프리카 그린 원숭이 세포, 및 조직배양된 인간 세포는 사용될 수 있는 숙주 세포의 예이다.The host cell of the invention may be a prokaryotic or eukaryotic cell. In addition, a host having high efficiency of introduction of DNA and high efficiency of expression of the introduced DNA is usually used. this. Known eukaryotic and prokaryotic hosts such as E. coli, Pseudomonas, Bacillus, Streptomyces, fungi, and yeast, insect cells such as Spodoptera prougiperata (SF9), animal cells such as CHO and mouse cells, COS 1, COS 7, BSC 1, BSC 40 and BMT 10, and tissue cultured human cells are examples of host cells that can be used.

본 발명의 셔틀벡터와 레스큐벡터를 상동성 재조합 시키기 위하여서는, 리콤비네이즈(recombinase)를 함유하는 숙주세포에 상기 두 벡터를 형질전환시키는 것이 바람직하다. In order to homologously recombine the shuttle vector and the rescue vector of the present invention, it is preferable to transform the two vectors into a host cell containing recombinase.

또다른 관점에서, 본 발명은 E1 단백질을 발현는 세포주에 상기 재조합 혈청형 6 아데노바이러스 벡터가 도입되어 있는 목적단백질 발현능을 가지는 재조합 세포주 및 상기 재조합 세포주를 배양하고, 상기 배양된 재조합 세포주로부터 재조합 혈청형 6 아데노바이러스를 수득하는 것을 특징으로 하는 재조합 혈청형 6 아데노바이러스 백터의 생산방법에 관한 것이다.In another aspect, the present invention provides a recombinant cell line having the ability to express a target protein, wherein the recombinant serotype 6 adenovirus vector is introduced into a cell line expressing the E1 protein, and the recombinant cell line, and the recombinant cell line is cultured from the cultured recombinant cell line Type 6 adenovirus vector, wherein the recombinant serotype 6 adenovirus vector is obtained by cultivating the recombinant serotype 6 adenovirus vector.

또다른 관점에서, 본 발명은 상기 재조합 세포주를 배양하여 목적단백질을 발현시킨 다음, 상기 발현된 목적단백질을 수득하는 것을 특징으로 하는 목적단백질의 제조방법에 관한 것이다. In another aspect, the present invention relates to a method for producing a target protein, which comprises culturing the recombinant cell line to express a target protein, and then obtaining the expressed target protein.

또다른 관점에서, 본 발명은 상기 혈청형 6 재조합 아데노바이러스 벡터를 함유하는 유전자 치료제에 관한 것이다.In another aspect, the present invention relates to a gene therapy agent containing the serotype 6 recombinant adenovirus vector.

또한, 본 발명의 벡터는, 당 유전공학 분야에서 통상적으로 이루어지고 있는 수정, 변형, 응용이 가능하다.In addition, the vector of the present invention can be modified, modified, and applied in the field of genetic engineering.

본 발명에서 상기 유전자치료제는 혈청형 6 재조합 아데노바이러스 벡터에 감염된 세포를 사용하는 세포유전자치료제 및 혈청형 6 재조합 아데노바이러스 벡터 또는 혈청형 6 재조합 아데노바이러스 벡터에 감염된 세포를 함유하는 백신을 포함한다.In the present invention, the gene therapy agent includes a cell gene therapy agent using cells infected with the serotype 6 recombinant adenovirus vector, and a vaccine containing the cells infected with the serotype 6 recombinant adenovirus vector or the serotype 6 recombinant adenovirus vector.

본 발명의 벡터는, 세포, 조직 및 기관으로 전달 및 발현하고자 하는 하나 이상의 유전자를 코딩하는 핵산을 벡터에 삽입하여 의학적, 수의학적 분야에서 다양한 질병의 예방 및 치료의 목적으로 사용될 수 있다.The vector of the present invention can be used for the purpose of prevention and treatment of various diseases in the medical and veterinary fields by inserting a nucleic acid encoding one or more genes to be transferred and expressed into cells, tissues and organs into a vector.

본 발명의 벡터에 삽입될 수 있는 유전자는 호르몬, 사이토카인, 효소, 항체, 성장인자, 전사조절인자, 혈액인자, 백신, 구조단백질, 약제감수성 유전자, 약제 내성 유전자, 리간드 단백질 및 수용체, 세포표면항원, 수용체 길항물질과 같은 다양한 생리활성 펩타이드, 이들의 유도체 등을 코딩하는 유전자를 예로 들 수 있으나, 이로 제한되지 않는다. 또한, 표적 세포에서 유전자 발현을 조절하는 안티센스 핵산 또는 siRNA를 발현하는 핵산을 포함할 수 있다.The gene that may be inserted into the vector of the present invention may be a hormone, a cytokine, an enzyme, an antibody, a growth factor, a transcription regulator, a blood factor, a vaccine, a structural protein, a drug susceptibility gene, a drug resistance gene, a ligand protein and a receptor, But are not limited to, genes encoding various physiologically active peptides such as antigens and receptor antagonists, derivatives thereof, and the like. In addition, antisense nucleic acids that regulate gene expression in target cells or nucleic acids that express siRNA can be included.

상기 혈청형 6 재조합 아데노바이러스는, 개체에서 분리한 세포에 이입한 후 개체에게 세포를 재이식하는 방법의 엑스 비보 (ex vivo)적 방법과 개체에게 직접 주사하는 인 비보 (in vivo)적 방법으로 인간뿐만 아니라 바이러스에 의해 감염능을 가지는 동물에게도 유전자 전달체로 사용가능하다. The serotype 6 recombinant adenovirus may be produced by ex vivo method of transferring cells to a subject isolated from the subject, and in vivo method of directly injecting the subject into a subject It can be used not only as a human but also as an animal carrier for an animal having an ability to infect by a virus.

본 발명의 혈청형 6 재조합 아데노바이러스는, 혈우병, 경상적혈구빈혈 등의 혈액이상 질환, 알츠하이머, 파킨스씨병, 다발성경화증, 헌팅턴병 및 유전자결함 등의 중추신경계 질환, 당뇨병, 성장호르몬결핍증 및 골다공증 등의 대사이상 질환, 다발성경화증, 건선 및 류마티스성 질환 등의 자가면역 질환, HIV감염, 인플루엔자, 유두종바이러스 및 마이코박테리아 등의 감염증과 종양 등의 다양한 질환의 치료에 사용될 수 있다. The serotype 6 recombinant adenovirus of the present invention is useful for the treatment and prevention of diseases such as hematological diseases such as hemophilia and orthopedic anemia, diseases of the central nervous system such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, Huntington's disease and genetic defects, diabetes, growth hormone deficiency and osteoporosis Autoimmune diseases such as hyperlipidemia, multiple sclerosis, psoriasis and rheumatic diseases, HIV infection, infectious diseases such as influenza, papillomavirus and mycobacteria, and tumors.

본 발명의 혈청형 6 재조합 아데노바이러스는 허용 가능한 약제학적 담체와 함께 적절한 제제로 제형화되어 다양한 경로, 예를 들어, 경구 투여, 복강내 투여, 정맥내 투여, 근육내 투여, 피하 투여, 피내 투여, 국소 투여, 비내 투여, 폐내 투여, 직장내 투여 될 수 있다. 
The serotype 6 recombinant adenovirus of the present invention may be formulated into an appropriate formulation together with an acceptable pharmaceutical carrier and administered in a variety of routes, for example, oral administration, intraperitoneal administration, intravenous administration, intramuscular administration, subcutaneous administration, , Topical administration, intranasal administration, intrapulmonary administration, rectal administration.

이하, 본 발명을 하기 실시예에 의하여 더욱 상세하게 한다. 이들 실시예는 단지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 범위가 이들 실시예에 국한되지 않는다는 것은 당업계에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.
Hereinafter, the present invention will be described in more detail with reference to the following examples. It will be apparent to those skilled in the art that these embodiments are merely illustrative of the present invention and that the scope of the present invention is not limited to these embodiments.

실시예 1: 혈청형 6 아데노바이러스 (Ad6)의 게놈 유전자 분리Example 1 Genomic Gene Isolation of Serotype 6 Adenovirus (Ad6)

야생형 혈청형 6 아데노바이러스 (Tonsil 99; ATCC VR-6, USA)를 A549(ATCC CLL 185) 세포에서 다음과 같이 증식시켰다. A549세포는 10% FBS, 1% Penicillin (100 U/ml), streptomycin (100 mg/ml)이 함유된 Dulbecco's Modified Eagle Medium (DMEM) 배지에서 37℃, 5% CO2 incubator에서 배양하였다. Wild-type serotype 6 adenovirus (Tonsil 99; ATCC VR-6, USA) was propagated in A549 (ATCC CLL 185) cells as follows. A549 cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) medium containing 10% FBS, 1% Penicillin (100 U / ml) and streptomycin (100 mg / ml) at 37 ° C in a 5% CO2 incubator.

야생형 Ad6는 약 70% confluency로 시딩된 100개의 10-cm dish A549 세포에 약 1 TCID50/cell로 감염시킨 후, 3일째 수확하였다. 세포는 3회의 freeze/thaw 과정 후, cell debris가 제거된 상층액을 CsCl-gradient ultra-centrifugation 방법으로 분리하여 야생형 Ad6의 게놈 DNA 분리에 사용하였다. CsCl-gradient ultra-centrifugation 방법으로 분리한 야생형 Ad6 게놈을 포함하는 분획 350μl를 benzonase (30 Units, Novagen)으로 37℃에서 1시간 동안 반응시킨 후, 10μl의 0.5 M EDTA (pH 8.0), 5μl의 proteinase K (10 mg/ml), 20μl의 10% SDS를 첨가하여 55℃에서 밤새 반응하였다. Wild-type Ad6 was infected with about 1 TCID 50 / cell into 100 10-cm dish A549 cells seeded at about 70% confluency and harvested at 3 days. After three freeze / thaw cycles, the cell debris-free supernatant was separated by CsCl-gradient ultra-centrifugation and used for genomic DNA isolation of wild-type Ad6. 350 μl of the fraction containing the wild-type Ad6 genome separated by CsCl-gradient ultra-centrifugation method was reacted with benzonase (30 Units, Novagen) at 37 ° C for 1 hour and then 10 μl of 0.5 M EDTA (pH 8.0) K (10 mg / ml), 20 μl of 10% SDS, and reacted overnight at 55 ° C.

페놀/클로로포름 추출 후, 에탄올 침전을 통해 Ad6 DNA를 분리하였다. 야생형 혈청형 6 아데노바이러스는 고유한 ClaI (918 nt), BstBI (10,674 nt), PmeI (13,251 nt), PacI (28,602 nt), SwaI (28,887 nt) 제한효소부위를 가지고 있다 (도 1).
After phenol / chloroform extraction, Ad6 DNA was isolated by ethanol precipitation. The wild-type serotype 6 adenovirus has a unique restriction site of ClaI (918 nt), BstBI (10,674 nt), PmeI (13,251 nt), PacI (28,602 nt) and SwaI (28,887 nt).

실시예 2: 셔틀벡터 (pAd6-Transfer)의 제작Example 2: Construction of a shuttle vector (pAd6-Transfer)

혈청형 6 재조합 아데노바이러스 제작에 필요한 pAd6-Transfer는 E1영역이 없이 혈청형 6 아데노바이러스의 right arm homology (RITR포함)과 left arm homology (LITR포함)을 가지며, right arm homology와 right arm homology사이에 unique한 제한효소절단부위가 있어야 하며, 원하는 유전자의 클로닝을 위해 multiple cloning sites가 있어야 하며, 클론선별을 쉽게 하기 위해 Kanamycin저항성 유전자를 가지며, transfection을 통해 재조합 아데노바이러스 생산을 위해 한 종류의 제한효소를 이용하여 Kanamycine저항성 유전자를 제거할 수 있어야 한다. PAd6-Transfer, which is required for serotype 6 recombinant adenovirus, has right arm homology (including RITR) and left arm homology (including LITR) of serotype 6 adenoviruses without the E1 region and between right arm homology and right arm homology There should be unique restriction enzyme cleavage sites, multiple cloning sites for the cloning of desired genes, kanamycin resistance gene for easy clone selection, and a restriction enzyme for recombinant adenovirus production through transfection Should be able to remove the kanamycin resistance gene.

총 7단계의 과정을 통해 위의 조건에 맞는 pAd6-Transfer를 제작하였다. Ad6-Transfer는 7,022 bp의 크기로 야생형 혈청형 6 아데노바이러스의 E1영역 (559~3,505 nt)이 제거되어 자체적으로 복제능이 결여된 재조합 아데노바이러스를 생산할 수 있다. 다양한 DNA를 클로닝할 수 있게 multiple cloning site를 가진다. pAd-Simple2와의 상동 재조합에 필요한 left arm homology와 right arm homology를 가지며, 그 사이이 unique한 XhoI 제한효소 절단부위를 가지고 있다. pAd6-Transfer 내에 존재하는 특정 염기서열의 특징과 위치는 표 1에 나타내었다.The pAd6-Transfer was prepared in seven steps. Ad6-Transfer can produce a recombinant adenovirus lacking its own replication ability by removing the E1 region (559-3,505 nt) of the wild-type serotype 6 adenovirus to a size of 7,022 bp. It has multiple cloning sites to clone a variety of DNA. It has a left arm homology and a right arm homology required for homologous recombination with pAd-Simple2, and has a unique XhoI restriction site between the two. The characteristics and positions of the specific base sequences present in the pAd6-Transfer are shown in Table 1.

pAd6-Transfer 벡터의 특징과 nucleotide positionCharacteristics and nucleotide position of pAd6-Transfer vector FeatureFeature Nucleotide Position in pAd6-TransferNucleotide Position in pAd6-Transfer Genebank No.Genebank No. Nucleotide Position in adenovirus 6Nucleotide Position in adenovirus 6 Left Ad6 inverted terminal repeat (LITR)Left Ad6 inverted terminal repeat (LITR) 2,939 ~ 2,9982,939-2,998 HQ413315.1HQ413315.1 1~1021 to 102 Encapsidation signalEncapsidation signal 3,120 ~ 3,2693,120 ~ 3,269 HQ413315.1HQ413315.1 182~331182 to 331 Multiple cloning siteMultiple cloning site 3,498 ~ 3,6003,498 to 3,600 N/AN / A N/AN / A Right Ad6 inverted terminal repeat (RITR)Right Ad6 inverted terminal repeat (RITR) 6,946 ~ 7,0056,946 to 7,005 HQ413315.1HQ413315.1 35,657~35,75935,657 to 35,759 pBR322 origin of replicationpBR322 origin of replication 128 ~ 906128 ~ 906 N/AN / A N/AN / A Kanamycin resistance ORFKanamycin resistance ORF 1,664 ~ 2,4661,664 ~ 2,466 N/AN / A N/AN / A Left arm homologyLeft arm homology 5,855 ~ 7,0065,855-7,006 HQ413315.1HQ413315.1 34,608~35,75934,608 to 35,759 Right arm homologyRight arm homology 3,604 ~ 5,8483,604 to 5,848 HQ413315.1HQ413315.1 3,535~5,7793,535 ~ 5,779

벡터 pAd6-Transfer는 하기 총 7단계의 과정을 통하여 제작하였다(표 2). The vector pAd6-Transfer was constructed through the following seven steps (Table 2).

pAd6-Transfer의 제작 단계Production steps of pAd6-Transfer 제작과정Production process 내 용Contents 단계 1Step 1 클로닝에 필요한 제한효소절단부위를 가지는 pGEM-11Zf(+)-YC1의 제작Construction of pGEM-11Zf (+) - YC1 with restriction enzyme cleavage site for cloning 단계 2Step 2 pGEM-11Zf(+)-YC1에 혈청형 6 아데노바이러스의 LITR을 포함하는 영역 (1~558 nt)을 클로닝하여 pGEM-11Zf(+)-YC2의 제작Construction of pGEM-11Zf (+) - YC2 by cloning region (1 ~ 558 nt) containing LITR of serotype 6 adenovirus into pGEM-11Zf 단계 3Step 3 pGEM-11Zf(+)-YC2에 혈청형 6 아데노바이러스의 AflII (3530 nt)~XhoI (5,781 nt)을 포함하는 영역을 클로닝하여 pGEM-11Zf(+)-YC3의 제작Construction of pGEM-11Zf (+) - YC3 by cloning regions containing AflII (3530 nt) to XhoI (5,781 nt) of serotype 6 adenovirus into pGEM-11Zf 단계 4Step 4 pGEM-11Zf(+)-YC3에 하나의 AsiSI 절단부위를 삽입하여 pGEM-11Zf(+)-YC3-AsiSI의 제작Construction of pGEM-11Zf (+) - YC3-AsiSI by inserting one AsiSI cleavage site into pGEM-11Zf (+) - YC3 단계 5Step 5 pGEM-11Zf(+)-YC3-AsiSI에 AsiSI 절단부위를 삽입하여 pGEM-11Zf(+)-YC3-AsiSI-AsiSI의 제작Construction of pGEM-11Zf (+) - YC3-AsiSI-AsiSI by inserting AsiSI cleavage site into pGEM-11Zf (+) - YC3-AsiSI 단계 6Step 6 pGEM-11Zf(+)-YC3-AsiSI-AsiSI에 multiple cloning sites를 삽입하여
pGEM-11Zf(+)-YC4-MCS1의 제작
Multiple cloning sites were inserted into pGEM-11Zf (+) - YC3-AsiSI-AsiSI
Production of pGEM-11Zf (+) - YC4-MCS1
단계 7Step 7 pGEM-11Zf(+)-YC4-MCS1의 Ampicillin저항성 유전자를 Kanamycine 저항성 유전자로 교체하여 pAd6-Transfer벡터제작The pAd6-Transfer vector was constructed by replacing the ampicillin resistance gene of pGEM-11Zf (+) - YC4-MCS1 with the Kanamycine resistance gene

혈청형 재조합아데노바이러스 (rAd6) 생산을 위해서 두 종류의 벡터, pAd6-Transfer와 pAd6-Simple2가 사용된다. pAd6-Simple2의 제작을 위해서는 약 37 Kb이상이 클로닝 될 수 있어야 한다. 100 Kb까지 클로닝 될 수 있다고 보고되어 있는 pGEM-11Zf(+) 벡터를 pAd6-Transfer와 pAd6-Simple2 제작에 사용하였다.
Two types of vectors, pAd6-Transfer and pAd6-Simple2, are used for the production of serotype recombinant adenovirus (rAd6). For the construction of pAd6-Simple2, about 37 Kb or more should be cloned. The pGEM-11Zf (+) vector, which has been reported to be cloned up to 100 Kb, was used in the construction of pAd6-Transfer and pAd6-Simple2.

(1) pGEM-11Zf(+)-YC1의 제작(1) Production of pGEM-11Zf (+) - YCl

혈청형 6 재조합 아데노바이러스의 클로닝에 필요한 제한효소 절단부위를 가지는 pGEM-11Zf(+)-YC1를 제작하기 위하여 pGEM-11Zf(+) 벡터 (Promega, USA)를 구매하여 사용하였다. pGEM-11Zf(+) 벡터의 플라스미드 지도를 도 2A 에 나타내었다. 각종효소는 Roche (Germany), Fermentas (Thermo, USA) 또는 NEB (USA)에서 구매하여 사용하였다. 야생형 혈청형 6 재조합아데노바이러스는 ClaI, BstBI, PacI, PmeI, SwaI 제한부위가 고유하며, E1부위 (E1a, E1b 19K, E1b 55K)를 제거하고 클로닝하기 위해서는 AflII (3,530 nt)절단부위를 활용하여야 한다. SfiI과 HindIII로 절단된 pGEM-11Zf(+)에 합성유전자 SfiI - PacI - AflII - PmeI - EcoRV - SwaI - SnaBI - XhoI - BamHI - HindIII (5'-GGC CAA GTC GGC CTT AAT TAA CTT AAG GTT TAA ACG ATA TCA TTT AAA TTA CGT ACT CGA GGG ATC CAA GCT T-3': 서열번호 3)을 클로닝하여 (Bioneer, Korea), 제작한 벡터를 pGEM-11Zf(+)-YC1로 명명하였다 (도 2B). pGEM-11Zf(+)-YC1에 클로닝된 부위는 염기서열분석으로 확인하였다 (도 2C).
The pGEM-11Zf (+) vector (Promega, USA) was purchased and used to construct pGEM-11Zf (+) - YC1 with restriction enzyme cleavage sites necessary for cloning of serotype 6 recombinant adenovirus. A plasmid map of the pGEM-11Zf (+) vector is shown in Fig. 2A. Various enzymes were purchased from Roche (Germany), Fermentas (Thermo, USA) or NEB (USA). The wild-type serotype 6 recombinant adenovirus is unique in ClaI, BstBI, PacI, PmeI, SwaI restriction sites and should be used to remove the E1 region (E1a, E1b 19K, E1b 55K) do. The pGEM-11Zf (+) digested with Sfi I and Hind III synthetic gene Sfi I - Pac I - Afl II - Pme I - Eco RV - Swa I - Sna BI - Xho I - Bam HI - Hind III (5'- GGC CAA GTC GGC CTT AAT TAA CTT AAG GTT TAA ACG ATA TCA TTT AAA TTA CGT ACT CGA GGG ATC CAA GCT T-3 '(SEQ ID NO: 3) was cloned (Bioneer, Korea) +) - YC1 (Fig. 2B). The cloned region in pGEM-11Zf (+) - YCl was confirmed by sequencing (FIG. 2C).

(2) pGEM-11Zf(+)-YC2의 제작(2) Production of pGEM-11Zf (+) - YC2

pGEM-11Zf(+)-YC1에 혈청형 6 아데노바이러스의 LITR을 포함하는 영역 (1~558 nt)을 클로닝하여 pGEM-11Zf(+)-YC2를 제작하였다.pGEM-11Zf (+) - YC2 was prepared by cloning a region (1 to 558 nt) containing LITR of serotype 6 adenovirus into pGEM-11Zf (+) - YC1.

야생형 Ad6 유전체에서 약 559~3505 nucleotides (nt)는 E1영역 (E1a, E1b 19K, E1b 55K)을 암호화하고 있다. E1영역은 아데노바이러스 자체복제의 기능에 필요하고, 복제능력이 결여된 재조합 아데노바이러스에서는 E1영역이 제거되어야 한다. 대신, E1 단백질은 HEK293 세포나 PER.C6같은 rAd 생산세포주에서 제공된다. E1영역만을 제거하기 위하여 야생형 혈청형 6 아데노바이러스의 1~558 nucleotides 영역까지를 우선적으로 PCR 하여 상기 단계에서 제작된 pGEM-11Zf(+)-YC1에 클로닝하여 제작된 벡터를 pGEM-11Zf(+)-YC2로 명명하였다. Ad6의 1~558 nucleotides 영역의 클로닝을 쉽게 하기 위하여 forward primer에는 PacI 절단부위와 reverse primer에는 AflII 절단부위를 flanking 하였다 (도 3A).
Approximately 559 to 3505 nucleotides (nt) in the wild-type Ad6 genome encode the E1 region (E1a, E1b 19K, E1b 55K). The E1 region is required for the function of the adenovirus self-replication, and the recombinant adenovirus lacking the replication ability must remove the E1 region. Instead, the E1 protein is provided in HEK293 cells or rAd producing cell lines such as PER.C6. 11Zf (+) - YC1 prepared in the above step was firstly PCR amplified from 1 to 558 nucleotides of the wild-type serotype 6 adenovirus in order to remove only the E1 region, and the vector was cloned into pGEM-11Zf -YC2. To facilitate the cloning of the 1 to 558 nucleotides region of Ad6, the Pac I cleavage site and the Afl II cleavage site were flanked on the forward primer (FIG. 3A).

Forward primer:5‘-ATG CTT AAT TAA ATC ATC AAT AAT ATA CCT TAT TTT GGA TTG-3'(서열번호 4)Forward primer: 5'-ATG CTT AAT TAA ATC ATC AAT AAT ATA CCT TAT TTT GGA TTG-3 '(SEQ ID NO: 4)

Reverse primer: 5’-ATG CCT TAA GTT TCA GTC CCG GTG TCG GAG CGG CTC GGA G -3(서열번호 5)
Reverse primer: 5'-ATG CCT TAA GTT TCA GTC CCG GTG TCG GAG CGG CTC GGA G-3 (SEQ ID NO: 5)

혈청형 6 아데노바이러스를 주형으로 gradient PCR 결과, 최적의 온도가 55℃ 임을 확인(도 3B)한 후 annealing 온도 조건을 55℃로 하여 DNA 중합반응을 Taq polymerase (Bioprince, China)로 35 사이클 수행하였다. 증폭된 DNA산물은 분리하여 PacI과 AflII로 절단된 pGEM-11Zf(+)-YC2에 클로닝 하였다. 여러 개의 클론 중 558bp를 가지는 4개의 클론을 선별하였다 (도 3C). 제작된 pGEM-11Zf(+)-YC2의 플라스미드 지도는 도 3D에 나타내었다.
As a result of gradient PCR with serotype 6 adenovirus as a template, it was confirmed that the optimum temperature was 55 ° C (FIG. 3B), and the DNA polymerization reaction was carried out with Taq polymerase (Bioprince, China) . The amplified DNA product was isolated and cloned into pGEM-11Zf (+) - YC2 digested with Pac I and Afl II. Four clones having 558 bp among several clones were selected (Fig. 3C). A plasmid map of the prepared pGEM-11Zf (+) - YC2 is shown in FIG. 3D.

(3) pGEM-11Zf(+)-YC3의 제작(3) Production of pGEM-11Zf (+) - YC3

pGEM-11Zf(+)-YC2에 야생형 혈청형 6 아데노바이러스의 3,530 (AflII)~5,781 (XhoI) 영역 (도 4A)을 클로닝하여 pGEM-11Zf(+)-YC3을 제작하였다. CsCl-gradient ultra-centrifugation으로 분리된 Ad6 DNA를 제한효소 AflII와 XhoI으로 처리하였으며, AflII와 XhoI으로 절단된 pGEM-11Zf(+)-YC2에 클로닝 하였다. 제작된 10개의 클론을 제한효소 분석을 하여 7개의 클론을 1차 선별 (도 4B) 하고, 다른 제한효소로 재확인 하였다 (도 4C). 7개의 클론 중 1번 클론을 pGEM-11Zf(+)-YC3 제작에 이용하였다. 제작된 pGEM-11Zf(+)-YC3의 플라스미드 지도를 도 4D 에 나타내었다.
pGEM-11Zf (+) - YC3 was prepared by cloning 3,530 ( Afl II) to 5,781 ( Xho I) regions (FIG. 4A) of wild type serotype 6 adenovirus into pGEM-11Zf (+) - YC2. Ad6 DNA isolated by CsCl-gradient ultra-centrifugation was treated with restriction enzymes Afl II and Xho I and cloned into pGEM-11Zf (+) - YC2 cut with Afl II and Xho I. Seven clones were firstly screened (Fig. 4B) by restriction enzyme analysis and confirmed with other restriction enzymes (Fig. 4C). One clone of seven clones was used for the construction of pGEM-11Zf (+) - YC3. A plasmid map of the prepared pGEM-11Zf (+) - YC3 is shown in Fig. 4D.

(4) pGEM-11Zf(+)-YC3-AsiSI의 제작(4) Preparation of pGEM-11Zf (+) - YC3-AsiSI

pGEM-11Zf(+)-YC3에 하나의 AsiSI 절단부위를 삽입하여 pGEM-11Zf(+)-YC3-AsiSI의 제작를 제작하였다(도 5). One AsiSI cleavage site was inserted into pGEM-11Zf (+) - YC3 to construct pGEM-11Zf (+) - YC3-AsiSI (FIG.

두 종류의 플라스미드벡터를 이용하여 재조합 아데노바이러스를 생산하기 위해서는 리콤비네이즈(recombinase)를 가진 competent cells에 형질전환시켜야 한다. 이때 만들어진 재조합 플라스미드는 카나마이신 저항성 유전자를 가지는 데, 아데노바이러스 생산 세포주에 형질감염하기 전에 카나마이신 저항성 유전자를 포함하는 backbone을 제거할 수 있는 제한효소 절단부위가 두 군데 있어야 한다. In order to produce recombinant adenovirus using two kinds of plasmid vectors, competent cells having recombinase should be transformed. The recombinant plasmid thus constructed has a kanamycin resistance gene, and two restriction enzyme cleavage sites capable of removing the backbone containing the kanamycin resistance gene before transfection into the adenovirus producing cell line should be provided.

먼저, Ad6 아데노바이러스 1~558 nt flanking부위에 AsisSI 절단부위를 삽입하였다. PacI이 처리된 pGEM-11Zf(+)-YC3를 주형으로 PacI과 AsiSI flanking 염기서열을 forward primer와 pGEM-11Zf(+)-YC3의 667~690 nt부위에 해당하는 reverse primer를 사용하였다. First, the AsisSI cleavage site was inserted into the flanking region of Ad5 adenovirus 1 to 558 nt. Pac I and Asi SI flanking sequences were used as forward primer and reverse primer corresponding to 667 to 690 nt sites of pGEM-11Zf (+) - YC3 with Pac I treated pGEM-11Zf (+) - .

forward primer: 5'-ATT TAA TTA AGC GAT CGC ATC ATC AAT AAT ATA CCT TAT TTT GGA TTG-3'(서열번호 6)forward primer: 5'-ATT TAA TTA AGC GAT CGC ATC ATC AAT AAT ATA CCT TAT TTT GGA TTG-3 '(SEQ ID NO: 6)

reverse primer: 5'-ATG CTT CCA TCA AAC GAG TTG GCG-3'(서열번호 7)
reverse primer: 5'-ATG CTT CCA TCA AAC GAG TTG GCG-3 '(SEQ ID NO: 7)

PCR 산물과 pGEM-11Zf(+)-YC3는 PacI과 AflII로 절단 후, 서로 라이게이션 하여 1개의 클론 (pGEM-11Zf(+)-YC3-AsiSI)을 얻었으며, 염기서열분석 후 pGEM-11Zf(+)-YC3-AsiSI-AsiSI의 제작에 사용하였다.
PCR products and pGEM-11Zf (+) - YC3 are Pac I and Afl II and then digested with, each other ligated to a single clone (pGEM-11Zf (+) - YC3-AsiSI) have gained, after sequencing pGEM- 11Zf (+) - YC3-AsiSI-AsiSI.

(5) pGEM-11Zf(+)-YC3-AsiSI-AsiSI의 제작(5) Construction of pGEM-11Zf (+) - YC3-AsiSI-AsiSI

pGEM-11Zf(+)-YC3-AsiSI에 AsiSI 절단부위를 삽입하여 pGEM-11Zf(+)-YC3-AsiSI-AsiSI를 제작하였다 (도 6). AsiSI cleavage site was inserted into pGEM-11Zf (+) - YC3-AsiSI to construct pGEM-11Zf (+) - YC3-AsiSI-AsiSI (FIG.

클론된 혈청형 6 아데노바이러스의 RITR부위는 PacI과 AsiSI 절단부위를 가지는 forward primer와 벡터 sequence에 해당하는 reverse primer를 이용하여 증폭하였다.
The RITR region of the cloned serotype 6 adenovirus was amplified using a forward primer with Pac I and Asi SI cleavage sites and a reverse primer corresponding to the vector sequence.

forward primer :5'-TCT TAC CTC TGG TTT CCA TGA GCC-3'(서열번호 8)forward primer: 5'-TCT TAC CTC TGG TTT CCA TGA GCC-3 '(SEQ ID NO: 8)

reverse primer :5'-att taa tta agc gat cgc CAT CAT CAA TAA TAT ACC TTA TTT TGG-3'(서열번호 9)reverse primer: 5'-att taa tta agc gat cgc CAT CAT CAA TAA TAT ACC TTA TTT TGG-3 '(SEQ ID NO: 9)

Annealing온도는 53℃이며, 세 개의 클론 (4-2, 4-7, 5-9)중 염기서열이 일치하는 클론 5-9를 이용하여 다음 과정을 진행하였다.
The annealing temperature was 53 ° C and the following procedure was carried out using clones 5-9 whose nucleotide sequences corresponded to those of the three clones (4-2, 4-7, 5-9).

(6) pGEM-11Zf(+)-YC4-MCS1의 제작(6) Production of pGEM-11Zf (+) - YC4-MCS1

pGEM-11Zf(+)-YC3-AsiSI-AsiSI에 multiple cloning sites를 삽입하여 pGEM-11Zf(+)-YC4-MCS1를 제작하였다 (도 7). Multiple cloning sites were inserted into pGEM-11Zf (+) - YC3-AsiSI-AsiSI to construct pGEM-11Zf (+) - YC4-MCS1 (FIG.

원하는 유전자를 삽입할 수 있는 다중클로닝 사이트를 pGEM-11Zf(+)-YC3-AsiSI-AsiSI에 삽입하기 위하여, pGEM-T vector에 AflII-SalI-ClaI-PmeI-NotI-EcoRV-EcoRI-SwaI-NheI-BstBI-BglII-SnaBI-AflII를 합성 후 클로닝 하였으며 (Bioneer, Korea), AflII로 절단 후 multiple cloning sites를 AflII로 절단된 pGEM-11Zf(+)-YC3-AsiSI-AsiSI에 클로닝 하였다. 클론들은 AsiSI과 PmeI으로 절단하여 스크리닝 하였으며, multiple cloning sites를 가진 1번 클론을 이용하여 다음 단계를 진행하였다.
A multiple cloning site for inserting the desired gene pGEM-11Zf (+) - to insert a YC3-AsiSI-AsiSI, pGEM- T vector to Afl II- Sal I- Cla I- Pme I- Not I- Eco RV - Eco RI- Swa I- Nhe I- Bgl II- Bst BI- Sna BI- was cloned into the Afl II after synthesis (Bioneer, Korea), and then digested with Afl II-cut the multiple cloning sites into Afl II pGEM-11Zf ( +) - YC3-AsiSI-AsiSI. ≪ / RTI > Clones were screened for Asi SI and Pme I, and the next step was performed using clone No. 1 with multiple cloning sites.

(7) pAd6-Transfer벡터제작(7) Construction of pAd6-Transfer vector

pGEM-11Zf(+)-YC4-MCS1의 Ampicillin저항성 유전자를 Kanamycine 저항성 유전자로 교체하여 pAd6-Transfer벡터를 제작하였다 (도 8).The pAd6-Transfer vector was prepared by replacing the ampicillin resistance gene of pGEM-11Zf (+) - YC4-MCS1 with the Kanamycine resistance gene (Fig. 8).

Ampicillin 저항성 유전자를 가진 pGEM-11Zf(+)-YC4-MCS1에서 ampicillin 저항성유전자를 포함하는 backbone을 제거하고 kanamycin 저항성 유전자를 삽입하였다. pGEM-11Zf(+)-YC4-MCS1에서 ampicillin은 PacI으로 절단하여 ampicillin 저항성유전자를 포함하는 backbone을 제거하고, pShuttle-Ad5 (Qbiogen, USA)의 backbone에 존재하는 kanamycin 저항성 유전자를 PacI으로 절단하여 확보한 후, ligation하여 pAd6-Transfer vector를 제작하였다.
The backbone containing the ampicillin resistance gene was removed from pGEM-11Zf (+) - YC4-MCS1 with the ampicillin resistance gene and a kanamycin resistance gene was inserted. pGEM-11Zf (+) - in YC4-MCS1 ampicillin is cutting the kanamycin resistance gene of removing the backbone, including the ampicillin resistance gene cleaved with Pac I, and present in the backbone of the pShuttle-Ad5 (Qbiogen, USA) with Pac I After ligation, pAd6-Transfer vector was constructed.

실시예 3: 레스큐 벡터(pAD5-Simple2)의 제작Example 3: Construction of rescue vector (pAD5-Simple2)

혈청형 6 재조합 아데노바이러스 제작에 필요한 pAd6-Simple2는 E1영역만이 제거되고, 플라스미드 형태로 혈청형 6 아데노바이러스(Ad6)를 모두 가져야 한다. 혈청형 6 아데노바이러스는 크기가 35,759 bp로 한 번에 모든 유전자를 플라스미드에 클로닝하기에는 어려움이 따른다. 즉, 혈청형 6 아데노바이러스에서 unique한 제한효소부위를 가지는 벡터에 순차적으로 클로닝하는 방법으로 진행하여, pAd6-Simple2를 제작하였다. pAd6-Simple2는 혈청형 6 아데노바이러스의 E1영역을 포함하는 LITR~AflII (1~3,530 nt)까지 제거하여 제작되었다. 재조합 pAd6-Simple2는 야생형 혈청형 6 아데노바이러스의 AflII (3,530 nt)부터 right ITR (7,158 nt)까지 포함하고 있으며, E1영역이 결여되어 있다. pAd6-Transfer 내에 존재하는 특정 염기서열의 특징과 위치는 표 3에 나타내었다.PAd6-Simple2, which is required for serotype 6 recombinant adenovirus production, should have only the E1 region removed and all plasmid 6 adenovirus (Ad6) in plasmid form. Serotype 6 adenoviruses are 35,759 bp in size, making it difficult to clone all of the genes into plasmids at once. Namely, pAd6-Simple2 was prepared by sequential cloning into a vector having a unique restriction enzyme site in serotype 6 adenovirus. pAd6-Simple2 was constructed by removing LITR to AflII (1 to 3,530 nt) containing the E1 region of the serotype 6 adenovirus. Recombinant pAd6-Simple2 contains the wild-type serotype 6 adenovirus AflII (3,530 nt) to the right ITR (7,158 nt), lacking the E1 region. The characteristics and positions of the specific nucleotide sequences present in the pAd6-Transfer are shown in Table 3.

pAd6-Simple2 벡터의 특징과 nucleotide positionCharacteristics and nucleotide position of pAd6-Simple2 vector FeatureFeature Nucleotide Position in pAd6-Simple2Nucleotide Position in pAd6-Simple2 Genebank No.Genebank No. Nucleotide Position in adenovirus 6Nucleotide Position in adenovirus 6 f1 origin of replicationf1 origin of replication 34,764 ~ 35,21934,764 ~ 35,219 N/AN / A N/AN / A ampicillin resistance ORFampicillin resistance ORF 33,467 ~ 34,32733,467 to 34,327 N/AN / A N/AN / A Serotype 6 Adenovirus without E1 Serotype 6 Adenovirus without E1 10~32,25110 to 32,251 HQ413315.1HQ413315.1 3,529~35,7593,529 to 35,759 Right arm homologyRight arm homology 16 ~ 2,26016-2260 HQ413315.1HQ413315.1 3,535~5,7793,535 ~ 5,779 Left arm homologyLeft arm homology 31,089 ~32,24031,089 to 32,240 HQ413315.1HQ413315.1 34,608~35,75934,608 to 35,759 Origin of replicationOrigin of replication 32,666~33,22132,666 to 33,221 N/AN / A N/AN / A

레스큐 벡터(pAD5-Simple2)는 하기 총 7단계의 과정을 통하여 제작하였다(표 4). The rescue vector (pAD5-Simple2) was constructed through the following seven steps (Table 4).

pAD5-Simple2의 제작 단계Production steps of pAD5-Simple2 단계 1Step 1 pGEM-11Zf(+)-YC2에 AflII, BstBI, PmeI, PacI, ClaI등의 제한효소를 포함하는
pGEM-11Zf(+)-YC2-R1의 제작
pGEM-11Zf (+) - YC2 containing restriction enzymes Afl II, Bst BI, Pme I, Pac I and Cla I
Construction of pGEM-11Zf (+) - YC2-R1
단계 2Step 2 pGEM-11Zf(+)-YC2-R1에 존재하는 두 곳의 PacI sites중 하나를 제거하여 YC2-R1-1의 제작One of the two Pac I sites present in pGEM-11Zf (+) - YC2-R1 was removed to produce YC2-R1-1 단계 3Step 3 YC2-R1-1에 혈청형 6 아데노바이러스의 AflII (3,530 nt)~BstBI (10,674 nt)부위 삽입하여 YC2-R2의 제작Production of YC2-R2 by inserting Afl II (3,530 nt) to Bst BI (10,674 nt) of serotype 6 adenovirus into YC2-R1-1 단계 4Step 4 YC2-R2에 혈청형 6 아데노바이러스의 BstBI (10,674 nt)~PmeI (13,251 nt)부위를 삽입하여 YC2-R3의 제작The production of YC2-R3 by inserting Bst BI (10,674 nt) to Pme I (13,251 nt) of serotype 6 adenovirus into YC2-R2 단계 5Step 5 YC2-R3에서 혈청형 6 아데노바이러스의 1~558 nt 부위를 제거하여 YC2-R3-2의 제작In YC2-R3, 1 ~ 558 nt of serotype 6 adenovirus was removed to produce YC2-R3-2 단계 6Step 6 YC2-R3-2에 PmeI (9,736 nt)~PacI (25,077 nt)부위를 삽입하여 YC2-R4-2의 제작Production of YC2-R4-2 by inserting Pme I (9,736 nt) to Pac I (25,077 nt) in YC2-R3-2 단계 7Step 7 YC2-R4-2에 혈청형 6 아데노바이러스의 PacI (25,086 nt)~RITR end (32,251 nt)부위를 삽입하여 pAd6-Simple2의 제작The production of pAd6-Simple2 by inserting Pac I (25,086 nt) to RITR end (32,251 nt) of serotype 6 adenovirus into YC2-R4-2

(1)pGEM-11Zf(+)-YC2-R1의 제작(1) Production of pGEM-11Zf (+) - YC2-R1

pGEM-11Zf(+)-YC2에 AflII, BstBI, PmeI, PacI, ClaI등의 제한효소를 포함하는 pGEM-11Zf(+)-YC2-R1을 제작하였다 (도 9).pGEM-11Zf (+) - YC2-R1 containing restriction enzymes Afl II, Bst BI, Pme I, Pac I and Cla I was prepared in pGEM-11Zf (+) - YC2 (FIG.

혈청형 6 아데노바이러스에서 unique한 제한효소부위를 포함하는 multiple cloning sites (AflII-SacI-BstBI-XhoI-PmeI-EcoRV-PacI-BamHI-SwaI-XbaI-ClaI-HindIII; 5'-CTT AAG GAG CTC TTC GAA CTC GAG GTT TAA ACG ATA TCT TAA TTA AGG ATC CAT TTA AAT TCT AGA ATC GAT AAG CTT-3': 서열번호 10)를 pGEM-11Zf(+)-YC2에 클로닝하여 pGEM-11Zf(+)-YC2-R1을 제작하였으며 (Bioneer, Korea), 다중 클로닝사이트(MCS)는 염기서열분석으로 확인하였다.
Multiple cloning sites ( Afl II- Sac I- Bst BI- Xho I- Pme I- Eco RV- Pac I- Bam HI- Swa I- Xba I- Cla I - HindIII ; 5'-CTT AAG GAG CTC TTC GAA CTC GAG GTT TAA ACG ATA TCT TAA TTA AGG ATC CAT TTA AAT TCT AGA ATC GAT AAG CTT-3 ': SEQ ID NO: 10) (Bioneer, Korea), and the multiple cloning site (MCS) was confirmed by sequencing. The pGEM-11Zf (+) - YC2-

(2) YC2-R1-1의 제작(2) Production of YC2-R1-1

pGEM-11Zf(+)-YC2-R1에 존재하는 두 곳의 PacI 사이트 중 하나를 제거하여 YC2-R1-1를 제작하였다 (도 10).One of the two PacI sites existing in pGEM-11Zf (+) - YC2-R1 was removed to prepare YC2-R1-1 (FIG. 10).

pAd6-Simple2 제작의 마지막 단계 (7단계)에서 PacI을 사용하게 되는 데, pGEM-11Zf(+)-YC2-R1에는 두 개의 PacI 절단부위가 존재한다. pAd6-Simple2 클로닝을 쉽게하기 위해 pGEM-11Zf(+)-YC2-R1의 5'쪽에 존재하는 PacI (1) 절단부위를 제거하였다. 벡터인 pGEM-11Zf(+)-YC2-R1을 PacI 절단 후 klenow를 평활말단 (blunt)를 만든 후, HindIII로 절단하였다. Insert는 pGEM-11Zf(+)-YC2-R1의 31~56 bp에 해당하는 forward primer (5'-ATC ATC AAT AAT ATA CCT TAT TTT GG-3': 서열번호 11)와 747~772 bp에 해당하는 reverse primer (5'-TCC GGC TCG TAT GTT GTG TGG AAT TG-3':서열번호 12)로 PCR 증폭하여 준비하였다. PCR 증폭산물은 klenow로 blunting 후, HindIII로 절단하였다. 5' 평활말단과 3'이 HindIII 절단된 벡터와 insert를 ligation하여 10개의 클론중 1개를 선별하여 염기서열 확인 후, YC2-R2제작에 사용하였다.
In the final step (Step 7) of pAd6-Simple2 production, Pac I is used, and there are two Pac I cleavage sites in pGEM-11Zf (+) - YC2-R1. To facilitate pAd6-Simple2 cloning, the Pac I (1) cleavage site on the 5 'side of pGEM-11Zf (+) - YC2-R1 was removed. The vector pGEM-11Zf (+) - YC2-R1 was cleaved by Pac I, blunt-ended with klenow, and then digested with Hind III. Insert corresponds to 747 to 772 bp with forward primer (5'-ATC ATC AAT AAT ATA CCT TAT TTT GG-3 ': SEQ ID NO: 11) corresponding to 31-56 bp of pGEM-11Zf (5'-TCC GGC TCG TAT GTT GTG TGG AAT TG-3 ': SEQ ID NO: 12). The PCR products were blunted with klenow and then digested with Hind III. The 5 'smooth end and 3' HindIII truncated vector and insert were ligated and one of the 10 clones was selected and sequenced and used for YC2-R2 construction.

(3) YC2-R2의 제작(3) Production of YC2-R2

YC2-R1-1에 혈청형 6 아데노바이러스의 AflII (3,530 nt)~BstBI (10,674 nt)부위 삽입하여 YC2-R2를 제작하였다 (도 11).YC2-R2 was prepared by inserting Afl II (3,530 nt) to Bst BI (10,674 nt) of serotype 6 adenovirus into YC2-R1-1 (FIG. 11).

혈청형 6 아데노바이러스에는 4부위의 AflII 절단부위와 한 부위의 BstBI 절단부위가 있어, 이중 일부인 AflII (3,530 nt) 와 BstBI (10,674 nt) DNA절편을 YC2-R1에 먼저 클로닝하였다. YC2-R1-1과 혈청형 6 아데노바이러스 DNA를 AflII와 BstBI으로 절단한 후, 10개의 클론을 스크리닝하여 9개의 클론을 얻었다. EcoRV로 절단하였을 때 9426 bp, 1238 bp와 267 bp를 확인할 수 있었다.
In serotype 6 adenovirus, four Afl II cleavage sites and one Bst BI cleavage site were found, and a part of Afl II (3,530 nt) and Bst BI (10,674 nt) DNA fragments were first cloned into YC2-R1. YC2-R1-1 and serotype 6 adenovirus DNA were cut into Afl II and Bst BI, and 10 clones were screened to obtain 9 clones. When digested with EcoRV, 9426 bp, 1238 bp and 267 bp were found.

(4) YC2-R3의 제작(4) Production of YC2-R3

YC2-R2에 혈청형 6 아데노바이러스의 BstBI (10,674 nt)~PmeI (13,251 nt)부위를 삽입하여 YC2-R3를 제작하였다 (도 12).YC2-R3 was prepared by inserting Bst BI (10,674 nt) to Pme I (13,251 nt) of serotype 6 adenovirus into YC2-R2 (FIG. 12).

YC2-R2의 BstBI와 PmeI 절단부위에 혈청형 6 아데노바이러스 유전체의 BstBI (10,674 nt)에서 PmeI (13,251 nt)부위를 삽입하였다. 총 30개의 클론을 스크리닝하여 BamHI으로 절단하였을 때, 원하는 크기의 DNA절편 (10,905 bp, 2,587 bp)을 가진 10개의 클론을 얻을 수 있었다. 클론번호 21번을 선택하여 EcoRV와 HindIII로 절단하였을 때, 원하는 크기의 DNA절편을 확인할 수 있었으며, YC2-R3로 명명하고 YC2-R4 제작에 사용하였다.
Pst I (13,251 nt) region was inserted from Bst BI (10,674 nt) of the serotype 6 adenovirus genome at the BstB I and PmeI cleavage sites of YC2-R2. A total of 30 clones were screened and cleaved with Bam HI to yield 10 clones with the desired size fragments (10,905 bp, 2,587 bp). When clone # 21 was selected and digested with Eco RV and HindIII , a DNA fragment of the desired size was identified and named YC2-R3 and used in the construction of YC2-R4.

(5) YC2-R3-2의 제작(5) Production of YC2-R3-2

YC2-R3에서 혈청형 6 아데노바이러스의 1~558 nt 부위를 제거하여 YC2-R3-2를 제작하였다.YC2-R3-2 was prepared by removing 1 to 558 nt of serotype 6 adenovirus from YC2-R3.

YC2-R3는 혈청형 6 아데노바이러스의 1~558 nt부위를 가지고 있다. 이 영역이 BJ5183에서 상동재조합 시 원하지 않는 recombinant가 생기거나, 상동재조합을 방해할 수도 있기 때문에 pYC2-R3에서 혈청형 6 아데노바이러스의 1~558 nt부위를 제거하였다 (도 13).YC2-R3 has 1 to 558 nt of serotype 6 adenovirus. Since this region has an unwanted recombination in homologous recombination in BJ5183 or may interfere with homologous recombination, the 1 to 558 nt region of serotype 6 adenovirus was removed from pYC2-R3 (Figure 13).

YC2-R3를 AflII와 ClaI으로 절단하여 클로닝벡터로 사용하였고, AmpR유전자를 포함하는 backbone은 YC2-R3를 PCR로 증폭한 후 AflII와 ClaI으로 절단하여 insert로 사용하였다. PCR에 사용한 프라이머의 염기서열은 YC2-R3-ClaI (5'- tag aat cga taa gct tga gta ttc t-3': 서열번호 13)이며, YC2-R3-AflII (5'-atg cct taa gaa ttc gcc cta tag tga gtc gta t-3': 서열번호 14) 이다.YC2-R3 was cut into Afl II and Cla I and used as a cloning vector. The backbone containing the Amp R gene was amplified by PCR with YC2-R3 and then cut into Afl II and Cla I and used as an insert. The base sequence of the primer used in the PCR was YC2-R3-ClaI (5'-atg cct taa gaa ttc (SEQ ID NO: 13) gcc cta tag tga gtc gta t-3 ': SEQ ID NO: 14).

YC2-R3 (AflII & ClaI digested)과 PCR product (AflII & ClaI digested)를 라이게이션하여 10개의 콜로니를 AflII & ClaI 또는 EcoRI으로 절단하고 스크리닝 한 결과, 3개의 클론이 원하는 크기의 DNA 절편을 가지고 있었다 (clone #1, #3, #6)(도 14).
10 clones were cut into Afl II & Cla I or Eco RI by ligation of YC2-R3 ( Afl II and Cla I digested) and PCR product ( Afl II and Cla I digested). As a result, three clones (Clone # 1, # 3, # 6) (FIG. 14).

(6) YC2-R4-2의 제작(6) Production of YC2-R4-2

YC2-R3-2에 PmeI (13,251 nt)~PacI (28,602 nt)부위를 삽입하여 YC2-R4-2를 제작하였다 (도 15).YC2-R4-2 was prepared by inserting Pme I (13,251 nt) to Pac I (28,602 nt) in YC2-R3-2 (FIG. 15).

YC2-R4-2를 제작하기 위하여 YC2-R3-2를 PmeI과 PacI으로 절단하여 클로닝 벡터로 사용하였고, 혈청형 6을 주형으로 약 15 Kb에 해당하는 부위를 두 절편으로 PCR하여 inserts (11.8 Kb, 3.5 Kb)로 사용하였으며, YC2-R4-2는 in-fusion 반응으로 클론을 확보하였다.
To prepare YC2-R4-2, YC2-R3-2 was digested with Pme I and Pac I and used as a cloning vector. The region corresponding to about 15 Kb of the serotype 6 was PCR amplified by insertions ( 11.8 Kb, 3.5 Kb), and YC2-R4-2 was cloned by in-fusion reaction.

(7) pAd6-Simple2의 제작(7) Production of pAd6-Simple2

YC2-R4-2에 혈청형 6 아데노바이러스의 PacI (25,086 nt)~RITR end (32,251 nt)부위를 삽입하여 pAd6-Simple2를 제작하였다. PAd6-Simple2 was constructed by inserting Pac I (25,086 nt) to RITR end (32,251 nt) of serotype 6 adenovirus into YC2-R4-2.

YC2-R4-2를 PacI과 ClaI으로 절단하여 클로닝벡터로 사용하였으며, 혈청형 6 아데노바이러스 유전체를 주형으로 증폭된 PacI 에서 RITR 부위 (25,086 nt ~ 32,251 nt)를 in-fusion system으로 클로닝 하였다. 사용된 primers의 염기서열은 Infu-F5 (5'-ctg gga ttt ttt aat taa gta tat gag-3': 서열번호 15), Infu-R7 (5'-TAC TCA AGC TTA TCG CAT CAT CAA TAA TAT ACC TTA TTT TG-3': 서열번호 16) 이다. 도 16은 혈청형 6에서 증폭된 영역을 나타내고 있으며, 도 16 B는 primers, Infu-F5와 Infu-R7을 사용하여 gradient PCR을 수행하였을 때 결과이다. 확보된 클론은 XhoI 또는 ClaI으로 절단하여 원하는 크기 (XhoI cuts; 14.2 kb, 11.4 kb, 5.8 kb, 2.5 kb, 1.4 kb, ClaI cuts; 35 kb)를 확인하였으며, pAd6-Simple2의 플라스미드 지도는 도 17에 나타내었다.
YC2-R4-2 was digested with Pac I and Cla I and used as a cloning vector. The RITR region (25,086 nt to 32,251 nt) was cloned in the Pac I amplified with the serotype 6 adenovirus genome as a template by in-fusion system Respectively. The nucleotide sequence of the primers used was Infu-F5 (5'-ctg gga ttt ttt aat ta gta tat gag-3 ': SEQ ID NO: 15), Infu-R7 (5'-TAC TCA AGC TTA TCG CAT CAT CAA TAA TAT ACC TTA TTT TG-3 ': SEQ ID NO: 16). FIG. 16 shows amplified regions in serotype 6, and FIG. 16B shows the results when gradient PCR was performed using primers, Infu-F5 and Infu-R7. The obtained clone was digested with Xho I or Cla I to confirm the desired size ( Xho I cuts: 14.2 kb, 11.4 kb, 5.8 kb, 2.5 kb, 1.4 kb, Cla I cuts: 35 kb) and the plasmid of pAd6- The map is shown in Fig.

실시예 4: 재조합 플라스미드 벡터 제작Example 4 Production of Recombinant Plasmid Vector

(1) pAd6-Transfer-M3-eGFP 벡터 제작(1) Construction of pAd6-Transfer-M3-eGFP vector

개발된 두 종류의 벡터를 이용하여 재조합 플라스미드 벡터가 만들어지는지 증명하였다. 유전자발현분석을 용이하게 하기위해 먼저, pAd6-Transfer 벡터의 multiple cloning site에 eGFP를 발현할 수 있는 카세트를 클로닝하여 pAd6-Transfer-M3-eGFP를 제작하였다.Two types of vectors were used to demonstrate that recombinant plasmid vectors were produced. In order to facilitate gene expression analysis, a cassette capable of expressing eGFP was cloned into multiple cloning sites of pAd6-Transfer vector to prepare pAd6-Transfer-M3-eGFP.

M3 promoter는 암특이적으로 작동되는 프로모터로 알려져 있다. M3 프로모터의 조절하에 리포터유전자인 GFP를 발현하기 위해 pAd6-Transfer-M3-GFP vector를 제작하였다. pAd6-Transfer vector를 PmeI, NotI 제한효소로 처리하고, pAAV-M3-GFP vector(대한민국 등록특허 1,204,895호)는 SmaI, NotI 제한효소를 처리하여 M3 promoter와 GFP DNA 단편을 분리하였다 (PmeI과 SmaI은 blunt end). 벡터와 insert는 서로 라이게이션하여 pAd6-Transfer-M3-GFP vector를 제작하였다(도 18).
The M3 promoter is known to be a cancer-specific promoter. A pAd6-Transfer-M3-GFP vector was constructed to express the reporter gene GFP under the control of the M3 promoter. The pAd6-Transfer vector was treated with Pme I and Not I restriction enzymes, and the pAAV-M3-GFP vector (Korean Patent No. 1,204,895) was treated with restriction enzymes Sma I and Not I to separate the M3 promoter and the GFP DNA fragment Pme I and Sma I are blunt end). The vector and the insert were ligated with each other to construct a pAd6-Transfer-M3-GFP vector (Fig. 18).

(2) 벡터의 상동 재조합 (2) homologous recombination of vectors

상기의 pAd6-Transfer-M3-eGFP 벡터는 하나의 XhoI 제한효소자리를 가진다. pAd6-Simple2 와의 상동 재조합을 위하여 pAd6-Transfer-M3-eGFP에 XhoI을 처리하여 구조를 선형화하였다. 상동 재조합을 유도하기 위하여 대장균(BJ5183)에 선형화된 pAd6-Transfer-M3-eGFP와 환형의 pAd6-Simple2를 동시 형질전환 (co-transformation) 하였다. 재조합 pAd6-Transfer-M3-eGFP를 제작하기 위한 상동 재조합 과정의 모식도를 도 19에 나타내었다. 성공적으로 상동 재조합이 이루어진 경우 얻어지는 벡터는 복제기점, 항생제 저항성 유전자, M3 promoter, GFP 유전자와 PacI, BstBI, HindIII, AsiSi에 대한 제한효소 자리를 가진다 (도 20).
The above pAd6-Transfer-M3-eGFP vector has one XhoI restriction enzyme site. For homologous recombination with pAd6-Simple2, pAd6-Transfer-M3-eGFP was treated with XhoI to linearize the structure. To induce homologous recombination, pAd6-Transfer-M3-eGFP linearized in E. coli (BJ5183) and cyclic pAd6-Simple2 were co-transformed. A schematic diagram of a homologous recombination process for producing recombinant pAd6-Transfer-M3-eGFP is shown in Fig. The vector obtained when successful homologous recombination has restriction sites for the replication origin, antibiotic resistance gene, M3 promoter, GFP gene and PacI, BstBI, HindIII and AsiSi (Fig. 20).

(3) 재조합 벡터의 스크리닝(3) Screening of recombinant vector

성공적으로 재조합이 일어난 균주를 선별하기 위하여 BJ5183에 co-transformation한 후, 항생제 내성을 가지는 12개의 클론을 분석하였다. BJ5183으로부터 분리한 DNA를 PacI으로 처리하였을 때, 예상되는 DNA 절편의 크기는 27,192 bp, 7,171 bp, 2930 bp이다. 12개의 클론으로부터 얻은 재조합 pAd6-Transfer-M3-GFP을 PacI 제한효소로 절단한 후, 전기영동 한 결과 예상된 절편크기를 가지는 클론 4개(레인1, 레인 4, 레인 6, 레인 10)를 선별하였다 (도 21A). BJ5183에서 분리한 DNA는 양이 적고, 해상도가 낮아 일반적으로 사용되는 competent cell인 TOP-10 (Invitrogen, USA)에 다시 형질전환 하였다. 하나의 예시로서, 6번 클론의 DNA를 증폭하였다. 재조합 벡터는 PacI, BstBI, HindIII 제한효소자리를 가지므로 이들 효소를 처리한 후, 전기영동하여 절편의 크기를 확인하였다. BstBI를 처리하였을 때 예상되는 DNA 절편의 크기는 28,924 bp, 7,178 bp, 1,191 bp이고, HindIII를 처리하였을 때 예상되는 크기는 8,777, 5,324, 4,966, 3,420,3,292, 3,074, 2,388, 2,276, 2,081, 1,311, 309, 75 bp 이다. 전기영동으로 분석한 결과, 예상한 크기의 DNA 절편이 관찰되어, 본 발명에서 제작한 pAd6-Transfer 벡터와 pAd6-Simple2 가 성공적으로 재조합된 클론을 선별하였다 (도 21B). 선별된 재조합 pAd6-M3-GFP는 AsiSI으로 절단하여 아데노바이러스 packaging에 불필요한 origin of replication과 Kanamycine 저항성 유전자를 제거하고, 아데노바이러스 생산세포주 (예로, HEK293 cells)에 transfection하여 복제능력이 결여된 혈청형 6 재조합 아데노바이러스를 생산할 수 있다.
Twelve clones with antibiotic resistance were analyzed after co-transformation with BJ5183 to select strains that were successfully recombinant. When DNA isolated from BJ5183 is treated with PacI, the expected size of the DNA fragment is 27,192 bp, 7,171 bp, and 2930 bp. Recombinant pAd6-Transfer-M3-GFP obtained from 12 clones was digested with PacI restriction enzyme and then electrophoresed to select four clones having the expected fragment size (lane 1, lane 4, lane 6, lane 10) (Fig. 21A). DNA isolated from BJ5183 was reduced in volume and resolved into TOP-10 (Invitrogen, USA), a commonly used competent cell with low resolution. As an example, DNA of clone 6 was amplified. Since the recombinant vector had restriction sites of PacI, BstBI, and HindIII, these enzymes were treated and electrophoresed to confirm the size of the sections. The expected size of DNA fragments when treated with BstBI was 28,924 bp, 7,178 bp and 1,191 bp, and the predicted sizes when treated with HindIII were 8,777, 5,324, 4,966, 3,420,3,292, 3,074, 2,388, 2,276, 2,081, 1,311 , 309, 75 bp. As a result of analysis by electrophoresis, a DNA fragment of a predicted size was observed, and a clone in which the pAd6-Transfer vector prepared in the present invention and pAd6-Simple2 were successfully recombined was selected (Fig. 21B). The selected recombinant pAd6-M3-GFP was digested with AsiSI to remove unnecessary origin of replication and kanamycin resistance genes in adenovirus packaging, and transfected into adenovirus-producing cell lines (eg, HEK293 cells) To produce recombinant adenovirus.

이상으로 본 발명 내용의 특정한 부분을 상세히 기술하였는바, 당업계의 통상의 지식을 가진 자에게 있어서, 이러한 구체적 기술은 단지 바람직한 실시양태일분이며, 이에 의한 본 발명의 범위가 제한되는 것이 아닌 점은 명백할 것이다. 따라서 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의하여 정의 된다고 할 것이다.Having described specific portions of the present invention in detail, those skilled in the art will appreciate that these specific descriptions are only for a preferred embodiment and that the scope of the present invention is not limited thereby. It will be obvious. It is therefore intended that the scope of the invention be defined by the claims appended hereto and their equivalents.

<110> SCT Industry Academy Coopteration Groop of Chungbuk Health & Science University <120> Vectors for Prepaing Serotype 6 Recombinant Adenovirus <130> P13-B078 <160> 16 <170> KopatentIn 2.0 <210> 1 <211> 7022 <212> DNA <213> Artificial Sequence <220> <223> Total sequence of pAd6-Transfer <400> 1 catgcatgga tccatatgcg gtgtgaaata ccgcacagat gcgtaaggag aaaataccgc 60 atcaggcgct cttccgcttc ctcgctcact gactcgctgc gctcggtcgt tcggctgcgg 120 cgagcggtat cagctcactc aaaggcggta atacggttat ccacagaatc aggggataac 180 gcaggaaaga acatgtgagc aaaaggccag caaaaggcca ggaaccgtaa aaaggccgcg 240 ttgctggcgt ttttccatag gctccgcccc cctgacgagc atcacaaaaa tcgacgctca 300 agtcagaggt ggcgaaaccc gacaggacta taaagatacc aggcgtttcc ccctggaagc 360 tccctcgtgc gctctcctgt tccgaccctg ccgcttaccg gatacctgtc cgcctttctc 420 ccttcgggaa gcgtggcgct ttctcatagc tcacgctgta ggtatctcag ttcggtgtag 480 gtcgttcgct ccaagctggg ctgtgtgcac gaaccccccg ttcagcccga ccgctgcgcc 540 ttatccggta actatcgtct tgagtccaac ccggtaagac acgacttatc gccactggca 600 gcagccactg gtaacaggat tagcagagcg aggtatgtag gcggtgctac agagttcttg 660 aagtggtggc ctaactacgg ctacactaga aggacagtat ttggtatctg cgctctgctg 720 aagccagtta ccttcggaaa aagagttggt agctcttgat ccggcaaaca aaccaccgct 780 ggtagcggtg gtttttttgt ttgcaagcag cagattacgc gcagaaaaaa aggatctcaa 840 gaagatcctt tgatcttttc tacggggtct gacgctcagt ggaacgaaaa ctcacgttaa 900 gggattttgg tcatgagatt atcaaaaagg atcttcacct agatcctttt aaattaaaaa 960 tgaagtttta aatcaatcta aagtatatat gagtaaactt ggtctgacag ttaccaatgc 1020 ttaatcagtg aggcacctat ctcagcgatc tgtctatttc gttcatccat agttgcctga 1080 ctccccgtcg tgtagataac tacgatacgg gagggcttac catctggccc cagtgctgca 1140 atgataccgc gagacccacg ctcaccggct ccagatttat cagcaataaa ccagccagcc 1200 ggaagggccg agcgcagaag tggtcctgca actttatccg cctccatcca gtctattaat 1260 tgttgccggg aagctagagt aagtagttcg ccagttaata gtttgcgcaa cgttgttgcc 1320 attgctgcag ccatgagatt atcaaaaagg atcttcacct agatcctttt cacgtagaaa 1380 gccagtccgc agaaacggtg ctgaccccgg atgaatgtca gctactgggc tatctggaca 1440 agggaaaacg caagcgcaaa gagaaagcag gtagcttgca gtgggcttac atggcgatag 1500 ctagactggg cggttttatg gacagcaagc gaaccggaat tgccagctgg ggcgccctct 1560 ggtaaggttg ggaagccctg caaagtaaac tggatggctt tctcgccgcc aaggatctga 1620 tggcgcaggg gatcaagctc tgatcaagag acaggatgag gatcgtttcg catgattgaa 1680 caagatggat tgcacgcagg ttctccggcc gcttgggtgg agaggctatt cggctatgac 1740 tgggcacaac agacaatcgg ctgctctgat gccgccgtgt tccggctgtc agcgcagggg 1800 cgcccggttc tttttgtcaa gaccgacctg tccggtgccc tgaatgaact gcaagacgag 1860 gcagcgcggc tatcgtggct ggccacgacg ggcgttcctt gcgcagctgt gctcgacgtt 1920 gtcactgaag cgggaaggga ctggctgcta ttgggcgaag tgccggggca ggatctcctg 1980 tcatctcacc ttgctcctgc cgagaaagta tccatcatgg ctgatgcaat gcggcggctg 2040 catacgcttg atccggctac ctgcccattc gaccaccaag cgaaacatcg catcgagcga 2100 gcacgtactc ggatggaagc cggtcttgtc gatcaggatg atctggacga agagcatcag 2160 gggctcgcgc cagccgaact gttcgccagg ctcaaggcga gcatgcccga cggcgaggat 2220 ctcgtcgtga cccatggcga tgcctgcttg ccgaatatca tggtggaaaa tggccgcttt 2280 tctggattca tcgactgtgg ccggctgggt gtggcggacc gctatcagga catagcgttg 2340 gctacccgtg atattgctga agagcttggc ggcgaatggg ctgaccgctt cctcgtgctt 2400 tacggtatcg ccgctcccga ttcgcagcgc atcgccttct atcgccttct tgacgagttc 2460 ttctgaattt tgttaaaatt tttgttaaat cagctcattt tttaaccaat aggccgaaat 2520 cggcaacatc ccttataaat caaaagaata gaccgcgata gggttgagtg ttgttccagt 2580 ttggaacaag agtccactat taaagaacgt ggactccaac gtcaaagggc gaaaaaccgt 2640 ctatcagggc gatggcccac tacgtgaacc atcacccaaa tcaagttttt tgcggtcgag 2700 gtgccgtaaa gctctaaatc ggaaccctaa agggagcccc cgatttagag cttgacgggg 2760 aaagccggcg aacgtggcga gaaaggaagg gaagaaagcg aaaggagcgg gcgctagggc 2820 gctggcaagt gtagcggtca cgctgcgcgt aaccaccaca cccgcgcgct taatgcgccg 2880 ctacagggcg cgtccattcg ccattcagga tcgaattaat tcttaattaa gcgatcgcat 2940 catcaataat ataccttatt ttggattgaa gccaatatga taatgagggg gtggagtttg 3000 tgacgtggcg cggggcgtgg gaacggggcg ggtgacgtag tagtgtggcg gaagtgtgat 3060 gttgtaagtg tggcggaaca catgtaagcg ccggatgtgg taaaagtgac gtttttggtg 3120 tgcgccggtg tacacgggaa gtgacaattt tcgcgcggtt ttaggcggat gttgtagtaa 3180 atttgggcgt aaccaagtaa tatttggcca ttttcgcggg aaaactgaat aagaggaagt 3240 gaaatctgaa taattctgtg ttactcatag cgcgtaatat ttgtctaggg ccgcggggac 3300 tttgaccgtt tacgtggaga ctcgcccagg tgtttttctc aggtgttttc cgcgttccgg 3360 gtcaaagttg gcgttttatt attatagtca gctgacgcgc agtgtattta tacccggtga 3420 gttcctcaag aggccactct tgagtgccag cgagtagagt tttctcctcc gagccgctcc 3480 gacaccggga ctgaaactta aggtcgacat cgattctaga gtttaaacgc ggccgcgata 3540 tcgaattcag tactatttaa atgctagctt cgaaagatct tacgtaacta gtacgcgtct 3600 taaggtggga aagaatatat aaggtggggg tctcatgtag ttttgtatct gttttgcagc 3660 agccgccgcc atgagcgcca actcgtttga tggaagcatt gtgagctcat atttgacaac 3720 gcgcatgccc ccatgggccg gggtgcgtca gaatgtgatg ggctccagca ttgatggtcg 3780 ccccgtcctg cccgcaaact ctactacctt gacctacgag accgtgtctg gaacgccgtt 3840 ggagactgca gcctccgccg ccgcttcagc cgctgcagcc accgcccgcg ggattgtgac 3900 tgactttgct ttcctgagcc cgcttgcaag cagtgcagct tcccgttcat ccgcccgcga 3960 tgacaagttg acggctcttt tggcacaatt ggattctttg acccgggaac ttaatgtcgt 4020 ttctcagcag ctgttggatc tgcgccagca ggtttctgcc ctgaaggctt cctcccctcc 4080 caatgcggtt taaaacataa ataaaaacca gactctgttt ggatttggat caagcaagtg 4140 tcttgctgtc tttatttagg ggttttgcgc gcgcggtagg cccgggacca gcggtctcgg 4200 tcgttgaggg tcctgtgtat tttttccagg acgtggtaaa ggtgactctg gatgttcaga 4260 tacatgggca taagcccgtc tctggggtgg aggtagcacc actgcagagc ttcatgctgc 4320 ggggtggtgt tgtagatgat ccagtcgtag caggagcgct gggcgtggtg cctaaaaatg 4380 tctttcagta gcaagctgat tgccaggggc aggcccttgg tgtaagtgtt tacaaagcgg 4440 ttaagctggg atgggtgcat acgtggggat atgagatgca tcttggactg tatttttagg 4500 ttggctatgt tcccagccat atccctccgg ggattcatgt tgtgcagaac caccagcaca 4560 gtgtatccgg tgcacttggg aaatttgtca tgtagcttag aaggaaatgc gtggaagaac 4620 ttggagacgc ccttgtgacc tccaagattt tccatgcatt cgtccataat gatggcaatg 4680 ggcccacggg cggcggcctg ggcgaagata tttctgggat cactaacgtc atagttgtgt 4740 tccaggatga gatcgtcata ggccattttt acaaagcgcg ggcggagggt gccagactgc 4800 ggtataatgg ttccatccgg cccaggggcg tagttaccct cacagatttg catttcccac 4860 gctttgagtt cagatggggg gatcatgtct acctgcgggg cgatgaagaa aaccgtttcc 4920 ggggtagggg agatcagctg ggaagaaagc aggttcctaa gcagctgcga cttaccgcag 4980 ccggtgggcc cgtaaatcac acctattacc ggctgcaact ggtagttaag agagctgcag 5040 ctgccgtcat ccctgagcag gggggccact tcgttaagca tgtccctgac ttgcatgttt 5100 tccctgacca aatccgccag aaggcgctcg ccgcccagcg atagcagttc ttgcaaggaa 5160 gcaaagtttt tcaacggttt gaggccgtcc gccgtaggca tgcttttgag cgtttgacca 5220 agcagttcca ggcggtccca cagctcggtc acgtgctcta cggcatctcg atccagcata 5280 tctcctcgtt tcgcgggttg gggcggcttt cgctgtacgg cagtagtcgg tgctcgtcca 5340 gacgggccag ggtcatgtct ttccacgggc gcagggtcct cgtcagcgta gtctgggtca 5400 cggtgaaggg gtgcgctccg ggttgcgcgc tggccagggt gcgcttgagg ctggtcctgc 5460 tggtgctgaa gcgctgccgg tcttcgccct gcgcgtcggc caggtagcat ttgaccatgg 5520 tgtcatagtc cagcccctcc gcggcgtggc ccttggcgcg cagcttgccc ttggaggagg 5580 cgccgcacga ggggcagtgc agacttttaa gggcgtagag cttgggcgcg agaaataccg 5640 attccgggga gtaggcatcc gcgccgcagg ccccgcagac ggtctcgcat tccacgagcc 5700 aggtgagctc tggccgttcg gggtcaaaaa ccaggtttcc cccatgcttt ttgatgcgtt 5760 tcttacctct ggtttccatg agccggtgtc cacgctcggt gacgaaaagg ctgtccgtgt 5820 ccccgtatac agacttgaga ggcctgtcct cgagttcgca gggccagctg aacataatcg 5880 tgcaggtctg cacggaccag cgcggccact tccccgccag gaaccatgac aaaagaaccc 5940 acactgatta tgacacgcat actcggagct atgctaacca gcgtagcccc gatgtaagct 6000 tgttgcatgg gcggcgatat aaaatgcaag gtactgctca aaaaatcagg caaagcctcg 6060 cgcaaaaaag caagcacatc gtagtcatgc tcatgcagat aaaggcaggt aagttccgga 6120 accaccacag aaaaagacac catttttctc tcaaacatgt ctgcgggttc ctgcataaac 6180 acaaaataaa ataacaaaaa aaaaaaaaca tttaaacatt agaagcctgt cttacaacag 6240 gaaaaacaac ccttataagc ataagacgga ctacggccat gccggcgtga ccgtaaaaaa 6300 actggtcacc gtgattaaaa agcaccaccg acagttcctc ggtcatgtcc ggagtcataa 6360 tgtaagactc ggtaaacaca tcaggttggt taacatcggt cagtgctaaa aagcgaccga 6420 aatagcccgg gggaatacat acccgcaggc gtagagacaa cattacagcc cccataggag 6480 gtataacaaa attaatagga gagaaaaaca cataaacccc tgaaaaaccc tcctgcctag 6540 gcaaaatagc accctcccgc tccagaacaa catacagcgc ttccacagcg gcagccataa 6600 cagtcagcct taccagtaaa aaaacctatt aaaaaacacc actcgacacg gcaccagctc 6660 aatcagtcac agtgtaaaaa gggccaagta cagagcgagt atatatagga ctaaaaaatg 6720 acgtaacggt taaagtccac aaaaaccacc cagaaaaccg cacgcgaacc tacgcccaga 6780 aacgaaagcc aaaaaaccca caacttcctc aaatcttcac ttccgttttc ccacgatacg 6840 tcacttccca ttttaaaaaa aaactacaat tcccaataca tgcaagttac tccgccctaa 6900 aacctacgtc acccgccccg ttcccacgcc ccgcgccacg tcacaaactc caccccctca 6960 ttatcatatt ggcttcaatc caaaataagg tatattattg atgatggcga tcgcttaatt 7020 aa 7022 <210> 2 <211> 35399 <212> DNA <213> Artificial Sequence <220> <223> Total sequence of pAd6-Simple2 <400> 2 gggcgaattc ttaagggtgg gaaagaatat ataaggtggg ggtctcatgt agttttgtat 60 ctgttttgca gcagccgccg ccatgagcgc caactcgttt gatggaagca ttgtgagctc 120 atatttgaca acgcgcatgc ccccatgggc cggggtgcgt cagaatgtga tgggctccag 180 cattgatggt cgccccgtcc tgcccgcaaa ctctactacc ttgacctacg agaccgtgtc 240 tggaacgccg ttggagactg cagcctccgc cgccgcttca gccgctgcag ccaccgcccg 300 cgggattgtg actgactttg ctttcctgag cccgcttgca agcagtgcag cttcccgttc 360 atccgcccgc gatgacaagt tgacggctct tttggcacaa ttggattctt tgacccggga 420 acttaatgtc gtttctcagc agctgttgga tctgcgccag caggtttctg ccctgaaggc 480 ttcctcccct cccaatgcgg tttaaaacat aaataaaaac cagactctgt ttggatttgg 540 atcaagcaag tgtcttgctg tctttattta ggggttttgc gcgcgcggta ggcccgggac 600 cagcggtctc ggtcgttgag ggtcctgtgt attttttcca ggacgtggta aaggtgactc 660 tggatgttca gatacatggg cataagcccg tctctggggt ggaggtagca ccactgcaga 720 gcttcatgct gcggggtggt gttgtagatg atccagtcgt agcaggagcg ctgggcgtgg 780 tgcctaaaaa tgtctttcag tagcaagctg attgccaggg gcaggccctt ggtgtaagtg 840 tttacaaagc ggttaagctg ggatgggtgc atacgtgggg atatgagatg catcttggac 900 tgtattttta ggttggctat gttcccagcc atatccctcc ggggattcat gttgtgcaga 960 accaccagca cagtgtatcc ggtgcacttg ggaaatttgt catgtagctt agaaggaaat 1020 gcgtggaaga acttggagac gcccttgtga cctccaagat tttccatgca ttcgtccata 1080 atgatggcaa tgggcccacg ggcggcggcc tgggcgaaga tatttctggg atcactaacg 1140 tcatagttgt gttccaggat gagatcgtca taggccattt ttacaaagcg cgggcggagg 1200 gtgccagact gcggtataat ggttccatcc ggcccagggg cgtagttacc ctcacagatt 1260 tgcatttccc acgctttgag ttcagatggg gggatcatgt ctacctgcgg ggcgatgaag 1320 aaaaccgttt ccggggtagg ggagatcagc tgggaagaaa gcaggttcct aagcagctgc 1380 gacttaccgc agccggtggg cccgtaaatc acacctatta ccggctgcaa ctggtagtta 1440 agagagctgc agctgccgtc atccctgagc aggggggcca cttcgttaag catgtccctg 1500 acttgcatgt tttccctgac caaatccgcc agaaggcgct cgccgcccag cgatagcagt 1560 tcttgcaagg aagcaaagtt tttcaacggt ttgaggccgt ccgccgtagg catgcttttg 1620 agcgtttgac caagcagttc caggcggtcc cacagctcgg tcacgtgctc tacggcatct 1680 cgatccagca tatctcctcg tttcgcgggt tggggcggct ttcgctgtac ggcagtagtc 1740 ggtgctcgtc cagacgggcc agggtcatgt ctttccacgg gcgcagggtc ctcgtcagcg 1800 tagtctgggt cacggtgaag gggtgcgctc cgggttgcgc gctggccagg gtgcgcttga 1860 ggctggtcct gctggtgctg aagcgctgcc ggtcttcgcc ctgcgcgtcg gccaggtagc 1920 atttgaccat ggtgtcatag tccagcccct ccgcggcgtg gcccttggcg cgcagcttgc 1980 ccttggagga ggcgccgcac gaggggcagt gcagactttt aagggcgtag agcttgggcg 2040 cgagaaatac cgattccggg gagtaggcat ccgcgccgca ggccccgcag acggtctcgc 2100 attccacgag ccaggtgagc tctggccgtt cggggtcaaa aaccaggttt cccccatgct 2160 ttttgatgcg tttcttacct ctggtttcca tgagccggtg tccacgctcg gtgacgaaaa 2220 ggctgtccgt gtccccgtat acagacttga gaggcctgtc ctcgagcggt gttccgcggt 2280 cctcctcgta tagaaactcg gaccactctg agacgaaggc tcgcgtccag gccagcacga 2340 aggaggctaa gtgggagggg tagcggtcgt tgtccactag ggggtccact cgctccaggg 2400 tgtgaagaca catgtcgccc tcttcggcat caaggaaggt gattggttta taggtgtagg 2460 ccacgtgacc gggtgttcct gaaggggggc tataaaaggg ggtgggggcg cgttcgtcct 2520 cactctcttc cgcatcgctg tctgcgaggg ccagctgttg gggtgagtac tccctctcaa 2580 aagcgggcat gacttctgcg ctaagattgt cagtttccaa aaacgaggag gatttgatat 2640 tcacctggcc cgcggtgatg cctttgaggg tggccgcgtc catctggtca gaaaagacaa 2700 tctttttgtt gtcaagcttg gtggcaaacg acccgtagag ggcgttggac agcaacttgg 2760 cgatggagcg cagggtttgg tttttgtcgc gatcggcgcg ctccttggcc gcgatgttta 2820 gctgcacgta ttcgcgcgca acgcaccgcc attcgggaaa gacggtggtg cgctcgtcgg 2880 gcactaggtg cacgcgccaa ccgcggttgt gcagggtgac aaggtcaacg ctggtggcta 2940 cctctccgcg taggcgctcg ttggtccagc agaggcggcc gcccttgcgc gagcagaatg 3000 gcggtagtgg gtctagctgc gtctcgtccg gggggtctgc gtccacggta aagaccccgg 3060 gcagcaggcg cgcgtcgaag tagtctatct tgcatccttg caagtctagc gcctgctgcc 3120 atgcgcgggc ggcaagcgcg cgctcgtatg ggttgagtgg gggaccccat ggcatggggt 3180 gggtgagcgc ggaggcgtac atgccgcaaa tgtcgtaaac gtagaggggc tctctgagta 3240 ttccaagata tgtagggtag catcttccac cgcggatgct ggcgcgcacg taatcgtata 3300 gttcgtgcga gggagcgagg aggtcgggac cgaggttgct acgggcgggc tgctctgctc 3360 ggaagactat ctgcctgaag atggcatgtg agttggatga tatggttgga cgctggaaga 3420 cgttgaagct ggcgtctgtg agacctaccg cgtcacgcac gaaggaggcg taggagtcgc 3480 gcagcttgtt gaccagctcg gcggtgacct gcacgtctag ggcgcagtag tccagggttt 3540 ccttgatgat gtcatactta tcctgtccct tttttttcca cagctcgcgg ttgaggacaa 3600 actcttcgcg gtctttccag tactcttgga tcggaaaccc gtcggcctcc gaacggtaag 3660 agcctagcat gtagaactgg ttgacggcct ggtaggcgca gcatcccttt tctacgggta 3720 gcgcgtatgc ctgcgcggcc ttccggagcg aggtgtgggt gagcgcaaag gtgtccctaa 3780 ccatgacttt gaggtactgg tatttgaagt cagtgtcgtc gcatccgccc tgctcccaga 3840 gcaaaaagtc cgtgcgcttt ttggaacgcg ggtttggcag ggcgaaggtg acatcgttga 3900 agagtatctt tcccgcgcga ggcataaagt tgcgtgtgat gcggaagggt cccggcacct 3960 cggaacggtt gttaattacc tgggcggcga gcacgatctc gtcaaagccg ttgatgttgt 4020 ggcccacaat gtaaagttcc aagaagcgcg ggatgccctt gatggaaggc aattttttaa 4080 gttcctcgta ggtgagctct tcaggggagc tgagcccgtg ctctgaaagg gcccagtctg 4140 caagatgagg gttggaagcg acgaatgagc tccacaggtc acgggccatt agcatttgca 4200 ggtggtcgcg aaaggtccta aactggcgac ctatggccat tttttctggg gtgatgcagt 4260 agaaggtaag cgggtcttgt tcccagcggt cccatccaag gtccgcggct aggtctcgcg 4320 cggcggtcac tagaggctca tctccgccga acttcatgac cagcatgaag ggcacgagct 4380 gcttcccaaa ggcccccatc caagtatagg tctctacatc gtaggtgaca aagagacgct 4440 cggtgcgagg atgcgagccg atcgggaaga actggatctc ccgccaccag ttggaggagt 4500 ggctgttgat gtggtgaaag tagaagtccc tgcgacgggc cgaacactcg tgctggcttt 4560 tgtaaaaacg tgcgcagtac tggcagcggt gcacgggctg tacatcctgc acgaggttga 4620 cctgacgacc gcgcacaagg aagcagagtg ggaatttgag cccctcgcct ggcgggtttg 4680 gctggtggtc ttctacttcg gctgcttgtc cttgaccgtc tggctgctcg aggggagtta 4740 cggtggatcg gaccaccacg ccgcgcgagc ccaaagtcca gatgtccgcg cgcggcggtc 4800 ggagcttgat gacaacatcg cgcagatggg agctgtccat ggtctggagc tcccgcggcg 4860 tcaggtcagg cgggagctcc tgcaggttta cctcgcatag ccgggtcagg gcgcgggcta 4920 ggtccaggtg atacctgatt tccaggggct ggttggtggc ggcgtcgatg gcttgcaaga 4980 ggccgcatcc ccgcggcgcg actacggtac cgcgcggcgg gcggtgggcc gcgggggtgt 5040 ccttggatga tgcatctaaa agcggtgacg cgggcgggcc cccggaggta gggggggctc 5100 gggacccgcc gggagagggg gcaggggcac gtcggcgccg cgcgcgggca ggagctggtg 5160 ctgcgcgcgg aggttgctgg cgaacgcgac gacgcggcgg ttgatctcct gaatctggcg 5220 cctctgcgtg aagacgacgg gcccggtgag cttgaacctg aaagagagtt cgacagaatc 5280 aatttcggtg tcgttgacgg cggcctggcg caaaatctcc tgcacgtctc ctgagttgtc 5340 ttgataggcg atctcggcca tgaactgctc gatctcttcc tcctggagat ctccgcgtcc 5400 ggctcgctcc acggtggcgg cgaggtcgtt ggagatgcgg gccatgagct gcgagaaggc 5460 gttgaggcct ccctcgttcc agacgcggct gtagaccacg cccccttcgg catcgcgggc 5520 gcgcatgacc acctgcgcga gattgagctc cacgtgccgg gcgaagacgg cgtagtttcg 5580 caggcgctga aagaggtagt tgagggtggt ggcggtgtgt tctgccacga agaagtacat 5640 aacccagcgc cgcaacgtgg attcgttgat atcccccaag gcctcaaggc gctccatggc 5700 ctcgtagaag tccacggcga agttgaaaaa ctgggagttg cgcgccgaca cggttaactc 5760 ctcctccaga agacggatga gctcggcgac agtgtcgcgc acctcgcgct caaaggctac 5820 aggggcctct tcttcttctt caatctcctc ttccataagg gcctcccctt cttcttcttc 5880 tggcggcggt gggggagggg ggacacggcg gcgacgacgg cgcaccggga ggcggtcgac 5940 aaagcgctcg atcatctccc cgcggcgacg gcgcatggtc tcggtgacgg cgcggccgtt 6000 ctcgcggggg cgcagttgga agacgccgcc cgtcatgtcc cggttatggg ttggcggggg 6060 gctgccgtgc ggcagggata cggcgctaac gatgcatctc aacaattgtt gtgtaggtac 6120 tccgccaccg agggacctga gcgagtccgc atcgaccgga tcggaaaacc tctcgagaaa 6180 ggcgtctaac cagtcacagt cgcaaggtag gctgagcacc gtggcgggcg gcagcgggcg 6240 gcggtcgggg ttgtttctgg cggaggtgct gctgatgatg taattaaagt aggcggtctt 6300 gagacggcgg atggtcgaca gaagcaccat gtccttgggt ccggcctgct gaatgcgcag 6360 gcggtcggcc atgccccagg cttcgttttg acatcggcgc aggtctttgt agtagtcttg 6420 catgagcctt tctaccggca cttcttcttc tccttcctct tgtcctgcat ctcttgcatc 6480 tatcgctgcg gcggcggcgg agtttggccg taggtggcgc cctcttcctc ccatgcgtgt 6540 gaccccgaag cccctcatcg gctgaagcag ggccaggtcg gcgacaacgc gctcggctaa 6600 tatggcctgc tgcacctgcg tgagggtaga ctggaagtcg tccatgtcca caaagcggtg 6660 gtatgcgccc gtgttgatgg tgtaagtgca gttggccata acggaccagt taacggtctg 6720 gtgacccggc tgcgagagct cggtgtacct gagacgcgag taagcccttg agtcaaagac 6780 gtagtcgttg caagtccgca ccaggtactg gtatcccacc aaaaagtgcg gcggcggctg 6840 gcggtagagg ggccagcgta gggtggccgg ggctccgggg gcgaggtctt ccaacataag 6900 gcgatgatat ccgtagatgt acctggacat ccaggtgatg ccggcggcgg tggtggaggc 6960 gcgcggaaag tcacggacgc ggttccagat gttgcgcagc ggcaaaaagt gctccatggt 7020 cgggacgctc tggccggtca ggcgcgcgca gtcgttgacg ctctagaccg tgcaaaagga 7080 gagcctgtaa gcgggcactc ttccgtggtc tggtggataa attcgcaagg gtatcatggc 7140 ggacgaccgg ggttcgaacc ccggatccgg ccgtccgccg tgatccatgc ggttaccgcc 7200 cgcgtgtcga acccaggtgt gcgacgtcag acaacggggg agcgctcctt ttggcttcct 7260 tccaggcgcg gcggatgctg cgctagcttt tttggccact ggccgcgcgc ggcgtaagcg 7320 gttaggctgg aaagcgaaag cattaagtgg ctcgctccct gtagccggag ggttattttc 7380 caagggttga gtcgcgggac ccccggttcg agtctcgggc cggccggact gcggcgaacg 7440 ggggtttgcc tccccgtcat gcaagacccc gcttgcaaat tcctccggaa acagggacga 7500 gccccttttt tgcttttccc agatgcatcc ggtgctgcgg cagatgcgcc cccctcctca 7560 gcagcggcaa gagcaagagc agcggcagac atgcagggca ccctcccctt ctcctaccgc 7620 gtcaggaggg gcaacatccg cggctgacgc ggcggcagat ggtgattacg aacccccgcg 7680 gcgccggacc cggcactact tggacttgga ggagggcgag ggcctggcgc ggctaggagc 7740 gccctctcct gagcgacacc caagggtgca gctgaagcgt gacacgcgcg aggcgtacgt 7800 gccgcggcag aacctgtttc gcgaccgcga gggagaggag cccgaggaga tgcgggatcg 7860 aaagttccat gcagggcgcg agttgcggca tggcctgaac cgcgagcggt tgctgcgcga 7920 ggaggacttt gagcccgacg cgcggaccgg gattagtccc gcgcgcgcac acgtggcggc 7980 cgccgacctg gtaaccgcgt acgagcagac ggtgaaccag gagattaact ttcaaaaaag 8040 ctttaacaac cacgtgcgca cgcttgtggc gcgcgaggag gtggctatag gactgatgca 8100 tctgtgggac tttgtaagcg cgctggagca aaacccaaat agcaagccgc tcatggcgca 8160 gctgttcctt atagtgcagc acagcaggga caacgaggca ttcagggatg cgctgctaaa 8220 catagtagag cccgagggcc gctggctgct cgatttgata aacattctgc agagcatagt 8280 ggtgcaggag cgcagcttga gcctggctga caaggtggcc gccattaact attccatgct 8340 cagtctgggc aagttttacg cccgcaagat ataccatacc ccttacgttc ccatagacaa 8400 ggaggtaaag atcgaggggt tctacatgcg catggcgctg aaggtgctta ccttgagcga 8460 cgacctgggc gtttatcgca acgagcgcat ccacaaggcc gtgagcgtga gccggcggcg 8520 cgagctcagc gaccgcgagc tgatgcacag cctgcaaagg gccctggctg gcacgggcag 8580 cggcgataga gaggccgagt cctactttga cgcgggcgct gacctgcgct gggccccaag 8640 ccgacgcgcc ctggaggcag ctggggccgg acctgggctg gcggtggcac ccgcgcgcgc 8700 tggcaacgtc ggcggcgtgg aggaatatga cgaggacgat gagtacgagc cagaggacgg 8760 cgagtactaa gcggtgatgt ttctgatcag atgatgcaag acgcaacgga cccggcggtg 8820 cgggcggcgc tgcagagcca gccgtccggc cttaactcca cggacgactg gcgccaggtc 8880 atggaccgca tcatgtcgct gactgcgcgc aaccctgacg cgttccggca gcagccgcag 8940 gccaaccggc tctccgcaat tctggaagcg gtggtcccgg cgcgcgcaaa ccccacgcac 9000 gagaaggtgc tggcgatcgt aaacccgctg gccgaaaaca gggccatccg gcccgatgag 9060 gccggcctgg tctacgacgc gctgcttcag cgcgtggctc gttacaacag cagcaacgtg 9120 cagaccaacc tggaccggct ggtgggggat gtgcgcgagg ccgtggcgca gcgtgagcgc 9180 gcgcagcagc agggcaacct gggctccatg gttgcactaa acgccttcct gagtacacag 9240 cccgccaacg tgccgcgggg acaggaggac tacaccaact ttgtgagcgc actgcggcta 9300 atggtgactg agacaccgca aagtgaggtg tatcagtccg ggccagacta ttttttccag 9360 accagtagac aaggcctgca gaccgtaaac ctgagccagg ctttcaagaa cttgcagggg 9420 ctgtgggggg tgcgggctcc cacaggcgac cgcgcgaccg tgtctagctt gctgacgccc 9480 aactcgcgcc tgttgctgct gctaatagcg cccttcacgg acagtggcag cgtgtcccgg 9540 gacacatacc taggtcactt gctgacactg taccgcgagg ccataggtca ggcgcatgtg 9600 gacgagcata ctttccagga gattacaagt gttagccgcg cgctggggca ggaggacacg 9660 ggcagcctgg aggcaaccct gaactacctg ctgaccaacc ggcggcaaaa aatcccctcg 9720 ttgcacagtt taaacagcga ggaggagcgc attttgcgct atgtgcagca gagcgtgagc 9780 cttaacctga tgcgcgacgg ggtaacgccc agcgtggcgc tggacatgac cgcgcgcaac 9840 atggaaccgg gcatgtatgc ctcaaaccgg ccgtttatca atcgcctaat ggactacttg 9900 catcgcgcgg ccgccgtgaa ccccgagtat ttcaccaatg ccatcttgaa cccgcactgg 9960 ctaccgcccc ctggtttcta caccggggga ttcgaggtgc ccgagggtaa cgatggattc 10020 ctctgggacg acatagacga cagcgtgttt tccccgcaac cgcagaccct gctagagttg 10080 caacaacgcg agcaggcaga ggcggcgctg cgaaaggaaa gcttccgcag gccaagcagc 10140 ttgtccgatc taggcgctgc ggccccgcgg tcagatgcta gtagcccatt tccaagcttg 10200 atagggtctc ttaccagcac tcgcaccacc cgcccgcgcc tgctgggcga ggaggagtac 10260 ctaaacaact cgctgctgca gccgcagcgc gaaaagaacc tgcctccggc gtttcccaac 10320 aacgggatag agagcctagt ggacaagatg agtagatgga agacgtatgc gcaggagcac 10380 agggatgtgc ccggcccgcg cccgcccacc cgtcgtcaaa ggcacgaccg tcagcggggt 10440 ctggtgtggg aggacgatga ctcggcagac gacagcagcg tcttggattt gggagggagt 10500 ggcaacccgt ttgcacacct tcgccccagg ctggggagaa tgttttaaaa aaagcatgat 10560 gcaaaataaa aaactcacca aggcnatggc accgagcgtt ggttttcttg tattcccctt 10620 agtatgcggc gcgcggcgat gtatgaggaa ggtcctcctc cctcctacga gagcgtggtg 10680 agcgcggcgc cagtggcggc ggcgctgggt tcacccttcg atgctcccct ggacccgccg 10740 ttcgtgcctc cgcggtacct gcggcctacc ggggggagaa acagcatccg ttactctgag 10800 ttggcacccc tattcgacac cacccgtgtg taccttgtgg acaacaagtc aacggatgtg 10860 gcatccctga actaccagaa cgaccacagc aactttctaa ccacggtcat tcaaaacaat 10920 gactacagcc cgggggaggc aagcacacag accatcaatc ttgacgaccg gtcgcactgg 10980 ggcggcgacc tgaaaaccat cctgcatacc aacatgccaa atgtgaacga gttcatgttt 11040 accaataagt ttaaggcgcg ggtgatggtg tcgcgctcgc ttactaagga caaacaggtg 11100 gagctgaaat acgagtgggt ggagttcacg ctgcccgagg gcaactactc cgagaccatg 11160 accatagacc ttatgaacaa cgcgatcgtg gagcactact tgaaagtggg caggcagaac 11220 ggggttctgg aaagcgacat cggggtaaag tttgacaccc gcaacttcag actggggttt 11280 gacccagtca ctggtcttgt catgcctggg gtatatacaa acgaagcctt ccatccagac 11340 atcattttgc tgccaggatg cggggtggac ttcacccaca gccgcctgag caacttgttg 11400 ggcatccgca agcggcaacc cttccaggag ggctttagga tcacctacga tgacctggag 11460 ggtggtaaca ttcccgcact gttggatgtg gacgcctacc aggcaagctt gaaagatgac 11520 accgaacagg gcgggggtgg cgcaggcggc ggcaacaaca gtggcagcgg cgcggaagag 11580 aactccaacg cggcagctgc ggcaatgcag ccggtggagg acatgaacga tcatgccatt 11640 cgcggcgaca cctttgccac acgggcggag gagaagcgcg ctgaggccga ggcagcggcc 11700 gaagctgccg cccccgctgc ggaggctgca caacccgagg tcgagaagcc tcagaagaaa 11760 ccggtgatta aacccctgac agaggacagc aagaaacgca gttacaacct aataagcaat 11820 gacagcacct tcacccagta ccgcagctgg taccttgcat acaactacgg cgaccctcag 11880 gccgggatcc gctcatggac cctgctttgc actcctgacg taacctgcgg ctcggagcag 11940 gtatactggt cgttgcccga catgatgcaa gaccccgtga ccttccgctc cacgcgccag 12000 atcagcaact ttccggtggt gggcgccgag ctgttgcccg tgcactccaa gagcttctac 12060 aacgaccagg ccgtctactc ccagctcatc cgccagttta cctctctgac ccacgtgttc 12120 aatcgctttc ccgagaacca gattttggcg cgcccgccag cccccaccat caccaccgtc 12180 agtgaaaacg ttcctgctct cacagatcac gggacgctac cgctgcgcaa cagcatcgga 12240 ggagtccagc gagtgaccat tactgacgcc agacgccgca cctgccccta cgtttacaag 12300 gccctgggca tagtctcgcc gcgcgtccta tcgagccgca ctttttgagc aagcatgtcc 12360 atccttatat cgcccagcaa taacacaggc tggggcctgc gcttcccaag caagatgttt 12420 ggcggggcca agaagcgctc cgaccaacac ccagtgcgcg tgcgcgggca ctaccgcgcg 12480 ccctggggcg cgcacaaacg cggccgcact gggcgcacca ccgtcgatga cgccatcgac 12540 gcggtggtgg aggaggcgcg caactacacg cccacgccgc cgccagtgtc caccgtggac 12600 gcggccattc agaccgtggt gcgcggagcc cggcgctacg ctaaaatgaa gagacggcgg 12660 aggcgcgtag cacgtcgcca ccgccgccga cccggcactg ccgcccaacg cgcggcggcg 12720 gccctgctta accgcgcacg tcgcaccggc cgacgggcgg ccatgcgagc cgctcgaagg 12780 ctggccgcgg gtattgtcac tgtgcccccc aggtccaggc gacgagcggc cgccgcagca 12840 gccgcggcca ttagtgttat gactcagggt cgcaggggca acgtgtactg ggtgcgcgac 12900 tcggttagcg gcctgcgcgt gcccgtgcgc acccgccccc cgcgcaacta gattgcaata 12960 aaaaactact tagactcgta ctgttgtatg tatccagcgg cggcggcgcg catcgaagct 13020 atgtccaagc gcaaaatcaa agaagagatg ctccaggtca tcgcgccgga gatctatggc 13080 cccccgaaga aggaagagca ggattacaag ccccgaaagc taaagcgggt caaaaagaaa 13140 aagaaagatg atgatgatga tgaacttgac gacgaggtgg aactgttgca cgcgaccgcg 13200 cccaggcgac gggtacagtg gaaaggtcga cgcgtaagac gtgttttgcg acccggcacc 13260 accgtagtct ttacgcccgg tgagcgctcc acccgcacct acaagcgcgt gtatgatgag 13320 gtgtacggcg acgaggacct gcttgagcag gccaacgagc gcctcgggga gtttgcctac 13380 ggaaagcggc ataaggacat gctggcgttg ccgctggacg agggcaaccc aacacctagc 13440 ctaaagcccg tgacactgca gcaggtgctg cccgcgcttg caccgtccga agaaaagcgc 13500 ggcctaaagc gcgagtctgg tgacttggca cccaccgtgc agctgatggt acccaagcgt 13560 cagcgactgg aagatgtctt ggaaaaaatg accgtggagc ctgggctgga gcccgaggtc 13620 cgcgtgcggc caatcaagca ggtggcaccg ggactgggcg tgcagaccgt ggacgttcag 13680 atacccacca ccagtagcac tagtattgcc actgccacag agggcatgga gacacaaacg 13740 tccccggttg cctcggcggt ggcagatgcc gcggtgcagg cggccgctgc ggccgcgtcc 13800 aagacctcta cggaggtgca aacggacccg tggatgtttc gtgtttcagc cccccggcgt 13860 ccgcgccgtt caaggaagta cggcgccgcc agcgcgctac tgcccgaata tgccctacat 13920 ccttccatcg cgcctacccc cggctatcgt ggctacacct accgccccag aagacgagca 13980 actacccgac gccgaaccac cactggaacc cgccgccgcc gtcgccgtcg ccagcccgtg 14040 ctggccccga tttccgtgcg cagggtggct cgcgaaggag gcaggaccct ggtgctgcca 14100 acagcgcgct accaccccag catcgtttaa aagccggtct ttgtggttct tgcagatatg 14160 gccctcacct gccgcctccg tttcccggtg ccgggattcc gaggaagaat gcaccgtagg 14220 aggggcatgg ccggccacgg cctgacgggc ggcatgcgtc gtgcgcacca ccggcggcgg 14280 cgcgcgtcgc accgtcgcat gcgcgccggt atcctgcccc tccttattcc actgatcgcc 14340 gcggcgattg gcgccgtgcc cggaattgca tccgtggcct tgcaggcgca gagacactga 14400 ttaaaaacaa gttacatgtg gaaaaatcaa aataaaagtc tggactctca cgctcgcttg 14460 gtcctgtaac tattttgtag aatggaagac atcaactttg cgtcactggc cccgcgacac 14520 ggctcgcgcc cgttcatggg aaactggcaa gatatcggca ccagcaatat gagcggtggc 14580 gccttcagct ggggctcgct gtggagcggc attaaaaatt tcggttccgc cgttaagaac 14640 tatggcagca aagcctggaa cagcagcaca ggccagatgc tgagggacaa gttgaaagag 14700 caaaatttcc aacaaaaggt ggtagatggc ctggcctctg gcattagcgg ggtggtggac 14760 ctggccaacc aggcagtgca aaataagatt aacagtaagc ttgatccccg ccctcccgta 14820 gaggagcctc caccggccgt ggagacagtg tctccagagg ggcgtggcga aaagcgtccg 14880 cgacccgaca gggaagaaac tctggtgacg caaatagacg agcctccctc gtacgaggag 14940 gcactaaagc aaggcctgcc caccacccgt cccatcgcgc ccatggctac cggagtgctg 15000 ggccagcaca cacccgtaac gctggacctg cctccccccg ccgacaccca gcagaaacct 15060 gtgctgccag gcccgtccgc cgttgttgta acccgtccta gccgcgggtc cctgcgccgc 15120 gccgccagcg gtccgcgatc gttgcggccc gtagccagtg gcaactggca aagcacactg 15180 aacagcatcg tgggtttggg ggtgcaatcc ctgaagcgcc gacgatgctt ctgatagcta 15240 acgtgtcgta tgtgtgtcat gtatgcgtcc atgtcgccgc cagaggagct gctgagccgc 15300 cgcgcgcccg ctttccaaga tggctacccc ttcgatgatg ccgcagtggt cttacatgca 15360 catctcgggc caggacgcct cggagtacct gagccccggg ctggtgcagt tcgcccgcgc 15420 caccgagacg tacttcagcc tgaataacaa gtttagaaac cccacggtgg cgcctacgca 15480 cgacgtgacc acagaccggt ctcagcgttt gacgctgcgg ttcatccccg tggaccgcga 15540 ggatactgcg tactcgtaca aggcgcggtt caccctagct gtgggtgata accgtgtgct 15600 agacatggct tccacgtact ttgacatccg cggcgtgctg gacaggggcc ctacttttaa 15660 gccctactct ggcactgcct acaacgcact ggcccccaag ggtgccccca actcgtgcga 15720 gtgggaacaa aatgaaactg cacaagtgga tgctcaagaa cttgacgaag aggagaatga 15780 agccaatgaa gctcaggcgc gagaacagga acaagctaag aaaacccatg tatatgccca 15840 ggctccactg tccggaataa aaataactaa agaaggtcta caaataggaa ctgccgacgc 15900 cacagtagca ggtgccggca aagaaatttt cgcagacaaa acttttcaac ctgaaccaca 15960 agtaggagaa tctcaatgga acgaagcgga tgccacagca gctggtggaa gggttcttaa 16020 aaagacaact cccatgaaac cctgctatgg ctcatacgct agacccacca attccaacgg 16080 cggacagggc gttatggttg aacaaaatgg taaattggaa agtcaagtcg aaatgcaatt 16140 tttttccaca tccacaaatg ccacaaatga agttaacaat atacaaccaa cagttgtatt 16200 gtacagcgaa gatgtaaaca tggaaactcc agatactcat ctttcttata aacctaaaat 16260 gggggataaa aatgccaaag tcatgcttgg acaacaagca atgccaaaca gaccaaatta 16320 cattgctttt agagacaatt ttattggtct catgtattac aacagcacag gtaacatggg 16380 tgtccttgct ggtcaggcat cgcagttgaa cgctgttgta gatttgcaag acagaaacac 16440 agagctgtcc taccagcttt tgcttgattc aattggcgac agaacaagat acttttcaat 16500 gtggaatcaa gctgttgaca gctatgatcc agatgtcaga attattgaga accatggaac 16560 tgaggatgag ttgccaaatt attgctttcc tcttggtgga attgggatta ctgacacttt 16620 tcaagctgtt aaaacaactg ctgctaacgg ggaccaaggc aatactacct ggcaaaaaga 16680 ttcaacattt gcagaacgca atgaaatagg ggtgggaaat aactttgcca tggaaattaa 16740 cctgaatgcc aacctatgga gaaatttcct ttactccaat attgcgctgt acctgccaga 16800 caagctaaaa tacaacccca ccaatgtgga aatatctgac aaccccaaca cctacgacta 16860 catgaacaag cgagtggtgg ctcctgggct tgtagactgc tacattaacc ttggggcgcg 16920 ctggtctctg gactacatgg acaacgttaa tccctttaac cacccccgcc atgcgggcct 16980 gcgttaccgc tccatgttgt tgggaaacgg ccgctacgtg ccctttcaca ttcaggtgcc 17040 ccaaaagttt tttgccatta aaaacctcct cctcctgcca ggctcataca catatgaatg 17100 gaacttcagg aaggatgtta acatggttct gcagagctct ctgggaaacg accttagagt 17160 tgacggggct agcattaagt ttgacagcat ttgtctttac gccaccttct tccccatggc 17220 ccacaacacg gcctccacgc tggaagccat gctcagaaat gacaccaacg accagtcctt 17280 taatgactac ctttccgccg ccaacatgct atatcccata cccgccaacg ccaccaacgt 17340 gcccatctcc atcccatcgc gcaactgggc agcatttcgc ggttgggcct tcacacgctt 17400 gaagacaaag gaaacccctt ccctgggatc aggctacgac ccttactaca cctactctgg 17460 ctccatacca taccttgacg gaaccttcta tcttaatcac acctttaaga aggtggccat 17520 tacttttgac tcttctgtta gctggccggg caacgaccgc ctgcttactc ccaatgagtt 17580 tgagattaag cgctcagttg acggggaggg ctataacgta gctcagtgca acatgacaaa 17640 ggactggttc ctagtgcaga tgttggccaa ctacaatatt ggctaccagg gcttctacat 17700 tccagaaagc tacaaagacc gcatgtactc gttcttcaga aacttccagc ccatgagccg 17760 gcaagtggtg gacgatacta aatacaaaga ttatcagcag gttggaatta tccaccagca 17820 taacaactca ggcttcgtag gctacctcgc tcccaccatg cgcgagggac aagcttaccc 17880 cgctaatgtt ccctacccac taataggcaa aaccgcggtt gatagtatta cccagaaaaa 17940 gtttctttgc gaccgcaccc tgtggcgcat ccccttctcc agtaacttta tgtccatggg 18000 tgcgctcaca gacctgggcc aaaaccttct ctacgcaaac tccgcccacg cgctagacat 18060 gacctttgag gtggatccca tggacgagcc cacccttctt tatgttttgt ttgaagtctt 18120 tgacgtggtc cgtgtgcacc agccgcaccg cggcgtcatc gagaccgtgt acctgcgcac 18180 gcccttctcg gccggcaacg ccacaacata aagaagcaag caacatcaac aacagctgcc 18240 gccatgggct ccagtgagca ggaactgaaa gccattgtca aagatcttgg ttgtgggcca 18300 tattttttgg gcacctatga caagcgcttc ccaggctttg tttccccaca caagctcgcc 18360 tgcgccatag ttaacacggc cggtcgcgag actgggggcg tacactggat ggcctttgcc 18420 tggaacccgc gctcaaaaac atgctacctc tttgagccct ttggcttttc tgaccaacgt 18480 ctcaagcagg tttaccagtt tgagtacgag tcactcctgc gccgtagcgc cattgcctct 18540 tcccccgacc gctgtataac gctggaaaag tccacccaaa gcgtgcaggg gcccaactcg 18600 gccgcctgtg gcctattctg ctgcatgttt ctccacgcct ttgccaactg gccccaaact 18660 cccatggatc acaaccccac catgaacctt attaccgggg tacccaactc catgcttaac 18720 agtccccagg tacagcccac cctgcgccgc aaccaggaac agctctacag cttcctggag 18780 cgccactcgc cctacttccg cagccacagt gcgcaaatta ggagcgccac ttctttttgt 18840 cacttgaaaa acatgtaaaa ataatgtact aggagacact ttcaataaag gcaaatgttt 18900 ttatttgtac actctcgggt gattatttac ccccaccctt gccgtctgcg ccgtttaaaa 18960 atcaaagggg ttctgccgcg catcgctatg cgccactggc agggacacgt tgcgatactg 19020 gtgtttagtg ctccacttaa actcaggcac aaccatccgc ggcagctcgg tgaagttttc 19080 actccacagg ctgcgcacca tcaccaacgc gtttagcagg tcgggcgccg atatcttgaa 19140 gtcgcagttg gggcctccgc cctgcgcgcg cgagttgcga tacacagggt tacagcactg 19200 gaacactatc agcgccgggt ggtgcacgct ggccagcacg ctcttgtcgg agatcanatc 19260 cgcgtccagg tcctccgcgt tgctcagggc gaacggagtc aactttggta gctgccttcc 19320 caaaaagggt gcatgcccag gctttgagtt gcactcgcac cgtagtggca tcagaaggtg 19380 accgtgccca gtctgggcgt taggatacag cgcctgcatg aaagccttga tctgcttaaa 19440 agccacctga gcctttgcgc cttcagagaa gaacatgccg caagacttgc cggaaaactg 19500 attggccgga caggccgcgt catgcacgca gcaccttgcg tcggtgttgg agatctgcac 19560 cacatttcgg ccccaccggt tcttcacgat cttggccttg ctagactgct ccttcagcgc 19620 gcgctgcccg ttttcgctcg tcacatccat ttcaatcacg tgctccttat ttatcataat 19680 gctcccgtgt agacacttaa gctcgccttc gatctcagcg cagcggtgca gccacaacgc 19740 gcagcccgtg ggctcgtggt gcttgtaggt tacctctgca aacgactgca ggtacgcctg 19800 caggaatcgc cccatcatcg tcacaaaggt cttgttgctg gtgaaggtca gctgcaaccc 19860 gcggtgctcc tcgtttagcc aggtcttgca tacggccgcc agagcttcca cttggtcagg 19920 cagtagcttg aagtttgcct ttagatcgtt atccacgtgg tacttgtcca tcaacgcgcg 19980 cgcagcctcc atgcccttct cccacgcaga cacgatcggc aggctcagcg ggtttatcac 20040 cgtgctttca ctttccgctt cactggactc ttccttttcc tcttgcatcc gcataccccg 20100 cgccactggg tcgtcttcat tcagccgccg caccgtgcgc ttacctccct tgccgtgctt 20160 gattagcacc ggtgggttgc tgaaacccac catttgtagc gccacatctt ctctttcttc 20220 ctcgctgtcc acgatcacct ctggggatgg cgggcgctcg ggcttgggag aggggcgctt 20280 ctttttcttt ttggacgcaa tggccaaatc cgccgtcgag gtcgatggcc gcgggctggg 20340 tgtgcgcggc accagcgcat cttgtgacga gtcttcttcg tcctcggact cgagacgccg 20400 cctcagccgc ttttttgggg gcgcgcgggg aggcggcggc gacggcgacg gggacgagac 20460 gtcctccatg gttggtggac gtcgcgccgc accgcgtccg cgctcggggg tggtttcgcg 20520 ctgctcctct tcccgactgg ccatttcctt ctcctatagg cagaaaaaga tcatggagtc 20580 agtcgagaag gaggacagcc taaccgcccc ctttgagttc gccaccaccg cctccaccga 20640 tgccgccaac gcgcctacca ccttccccgt cgaggcaccc ccgcttgagg aggaggaagt 20700 gattatcgag caggacccag gttttgtaag cgaagacgac gaagatcgct cagtaccaac 20760 agaggataaa aagcaagacc aggacgacgc agaggcaaac gaggaacaag tcgggcgggg 20820 ggaccaaagg catggcgact acctagatgt gggagacgac gtgctgttga agcatctgca 20880 gcgccagtgc gccattatct gcgacgcgtt gcaagagcgc agcgatgtgc ccctcgccat 20940 agcggatgtc agccttgcct acgaacgcca cctgttctca ccgcgcgtac cccccaaacg 21000 ccaagaaaac ggcacatgcg agcccaaccc gcgcctcaac ttctaccccg tatttgccgt 21060 gccagaggtg cttgccacct atcacatctt tttccaaaac tgcaagatac ccctatcctg 21120 ccgtgccaac cgcagccgag cggacaagca gctggccttg cggcagggcg ctgtcatacc 21180 tgatatcgcc tcgctcgacg aagtgccaaa aatctttgag ggtcttggac gcgacgagaa 21240 gcgcgcggca aacgctctgc aacaagaaaa cagcgaaaat gaaagtcact gtggagtgct 21300 ggtggaactt gagggtgaca acgcgcgcct agccgtgctg aaacgcagca tcgaggtcac 21360 ccactttgcc tacccggcac ttaacctacc ccccaaggtt atgagcacag tcatgagcga 21420 gctgatcgtg cgccgtgcac gacccctgga gagggatgca aacttgcaag aacaaaccga 21480 ggagggccta cccgcagttg gcgatgagca gctggcgcgc tggcttgaga cgcgcgagcc 21540 tgccgacttg gaggagcgac gcaagctaat gatggccgca gtgcttgtta ccgtggagct 21600 tgagtgcatg cagcggttct ttgctgaccc ggagatgcag cgcaagctag aggaaacgtt 21660 gcactacacc tttcgccagg gctacgtgcg ccaggcctgc aaaatttcca acgtggagct 21720 ctgcaacctg gtctcctacc ttggaatttt gcacgaaaac cgccttgggc aaaacgtgct 21780 tcattccacg ctcaagggcg aggcgcgccg cgactacgtc cgcgactgcg tttacttatt 21840 tctgtgctac acctggcaaa cggccatggg cgtgtggcag cagtgcctgg aggagcgcaa 21900 cctgaaggag ctgcagaagc tgctaaagca aaacttgaag gacctatgga cggccttcaa 21960 cgagcgctcc gtggccgcgc acctggcgga cattatcttc cccgaacgcc tgcttaaaac 22020 cctgcaacag ggtctgccag acttcaccag tcaaagcatg ttgcaaaact ttaggaactt 22080 tatcctagag cgttcaggaa ttctgcccgc cacctgctgt gcgcttccta gcgactttgt 22140 gcccattaag taccgtgaat gccctccgcc gctttggggt cactgctacc ttntgcagct 22200 agccaactac cttgcctacc actccgacat catggaagac gtgagcggtg acggcctact 22260 ggagtgtcac tgtcgctgca acctatgcac cccgcaccgc tccctggtct gcaattcaca 22320 actgcttagc gaaagtcaaa ttatcggtac ctttgagctg cagggtccct cgcctgacga 22380 aaagtccgcg gctccggggt tgaaactcac tccggggctg tggacgtcgg cttaccttcg 22440 caaatttgta cctgaggact accacgccca cgagattagg ttctacgaag accaatcccg 22500 cccgccaaat gcggagctta ccgcctgcgt cattacccag ggccacatcc ttggccaatt 22560 gcaagccatt aacaaagccc gccaagagtt tctgctacga aagggacggg gggtttactt 22620 ggacccccag tccggcgagg agctcaaccc aatccccccg ccgccgcagc cctatcagca 22680 gccgcgggcc cttgcttccc aggatggcac ccaaaaagaa gctgcagctg ccgccgccgc 22740 cacccacgga cgaggaggaa tactgggaca gtcaggcaga ggaggttttg gacgaggagg 22800 aggagatgat ggaagactgg gacagcctag acgaggaagc ttccgaggcc gaagaggtgt 22860 cagacgaaac accgtcaccc tcggtcgcat tcccctcgcc ggcgccccag aaatcggcaa 22920 ccgttcccag cattgctaca acctccgctc ctcaggcgcc gccggcactg cccgttcgcc 22980 gacccaaccg tagatgggac accactggaa ccagggccgg taagtctaag cagccgccgc 23040 cgttagccca agagcaacaa cagcgccaag gctaccgctc gtggcgcgtg cacaagaacg 23100 ccatagttgc ttgcttgcaa gactgtgggg gcaacatctc cttcgcccgc cgctttcttc 23160 tctaccatca cggcgtggcc ttcccccgta acatcctgca ttactaccgt catctctaca 23220 gcccctactg caccggcggc agcggcagca acagcagcgg ccacgcagaa gcaaaggcga 23280 ccggatagca agactctgac aaagcccaag aaatccacag cggcggcagc agcaggagga 23340 ggagcactgc gtctggcgcc caacgaaccc gtatcgaccc gcgagcttag aaacaggatt 23400 tttcccactc tgtatgctat atttcaacag agcaggggcc aagaacaaga gctgaaaata 23460 aaaaacaggt ctctgcgctc cctcacccgc agctgcctgt atcacaaaag cgaagatcag 23520 cttcggcgca cgctggaaga cgcggaggct ctcttcagca aatactgcgc gctgactctt 23580 aaggactagt ttcgcgccct ttctcaaatt taagcgcgaa aactacgtca tctccagcgg 23640 ccacacccgg cgccagcacc tgtcgtcagc gccattatga gcaaggaaat tcccacgccc 23700 tacatgtgga gttaccagcc acaaatggga cttgcggctg gagctgccca agactactca 23760 acccgaataa actacatgag cgcgggaccc cacatgatat cccgggtcaa cggaatccgc 23820 gcccaccgaa accgaattct cctcgaacag gcggctatta ccaccacacc tcgtaataac 23880 cttaatcccc gtagttggcc cgctgccctg gtgtaccagg aaagtcccgc tcccaccact 23940 gtggtacttc ccagagacgc ccaggccgaa gttcagatga ctaactcagg ggcgcagctt 24000 gcgggcggct ttcgtcacag ggtgcggtcg cccgggcagg gtataactca cctgaaaatc 24060 agagggcgag gtattcagct caacgacgag tcggtgagct cctctcttgg tctccgtccg 24120 gacgggacat ttcagatcgg cggcgcgtgg ccgctcttca tttacgcccc gtcaggcgat 24180 cctaactctg cagacctcgt cctcggagcc gcgctccgga ggcattggaa ctctacaatt 24240 tattgaggag ttcgtgcctt cggtttactt caaccccttt tctggacctc ccggccacta 24300 cccggaccag tttattccca actttgacgc ggtaaaagac tcggcggacg gctacgactg 24360 aatgaccagt ggagaggcag agcaactgcg cctgacacac ctcgaccact gccgccgcca 24420 caagtgcttt gcccgcggct ccggtgagtt ttgttacttt gaattgcccg aagagcatat 24480 cgagggcccg gcgcacggcg tccggctcac cacccaggta gagcttacac gtagcctgat 24540 tcgggagttt accaagcgcc ccctgctagt ggagcgggag cggggtccct gtgttctgac 24600 cgtggtttgc aactgtccta accctggatt acatcaagat ctttgttgtc atctctgtgc 24660 tgagtataat aaatacagaa attagaatct actggggctc ctgtcgccat cctgtgaacg 24720 ccaccgtttt tacccaccca aagcagacca aagcaaacct cacctccggt ttgcacaagc 24780 gggccaataa gtaccttacc tggtacttta acggctcttc atttgtaatt tacaacagtt 24840 tccagcgaga cgaagtaagt ttgccacaca accttctcgg cttcaactac accgtcaaga 24900 aaaacaccac caccaccctc ctcacctgcc gggaacgtac gagtgcgtca ccggttgctg 24960 cgcccacacc tacagcctga gcgtaaccag acattactcc cattttccca aaacaggagg 25020 tgagctcaac tcccggaact caggtcaaaa aagcattttg cggggtgctg ggatttttta 25080 attaagtata tgagcaattc aagtaactct acaagcttgt ctaatttttc tggaattggg 25140 gtcggggtta tccttactct tgtaattctg tttattctta tactagcact tctgtgcctt 25200 agggttgccg cctgctgcac gcacgtttgt acctattgtc agctttttaa acgctggggg 25260 cgacatccaa gatgaggtac atgattttag gcttgctcgc ccttgcggca gtctgcagcg 25320 ctgccaaaaa ggttgagttt aaggaaccag cttgcaatgt tacatttaaa tcagaagcta 25380 atgaatgcac tactcttata aaatgcacca cagaacatga aaagcttatt attcgccaca 25440 aagacaaaat tggcaagtat gctgtatatg ctatttggca gccaggtgac actaacgact 25500 ataatgtcac agtcttccaa ggtgaaaatc gtaaaacttt tatgtataaa tttccatttt 25560 atgaaatgtg cgatattacc atgtacatga gcaaacagta caagttgtgg cccccacaaa 25620 agtgtttaga gaacactggc accttttgtt ccaccgctct gcttattaca gcgcttgctt 25680 tggtatgtac cttactttat ctcaaataca aaagcagacg cagttttatt gatgaaaaga 25740 aaatgccttg attttccgct tgcttgtatt cccctggaca atttactcta tgtgggatat 25800 gcgccaggcg ggaaagatta tacccacaac cttcaaatca aactttcctg gacgttagcg 25860 cctgacttct gccagcgcct gcactgcaaa tttgatcaaa cccagcttca gcttgcctgc 25920 tccagagatg accggctcaa ccatcgcgcc cacaacggac tatcgcaaca ccactgctac 25980 cggactaaaa tctgccctaa atttacccca agttcatgcc tttgtcaatg actgggcgag 26040 cttgggcatg tggtggtttt ccatagcgct tatgtttgtt tgccttatta ttatgtggct 26100 tatttgttgc ctaaagcgca gacgcgccag accccccatc tataggccta tcattgtgct 26160 caacccacac aatgaaaaaa ttcatagatt ggacggtctc aaaccatgtt ctcttctttt 26220 acagtatgat taaatgagac atgattcctc gagtccttat attattgacc cttgttgcgc 26280 ttttctgtgc gtgctctaca ttggctgcgg tcgctcacat cgaagtagat tgcatcccac 26340 ctttcacagt ttacctgctt tacggatttg tcacccttat cctcatctgc agcctcgtca 26400 ctgtagtcat cgccttcatt cagttcattg actggatttg tgtgcgcatt gcgtacctta 26460 ggcaccatcc gcaatacaga gacaggacta tagctgatct tctcagaatt ctttaattat 26520 gaaacggatt gtcacttttg ttttgctgat tttctgcgcc ctacctgtgc tttgctccca 26580 aacctcagcg cctcccaaaa gacatatttc ctgcagattc actcaaatat ggaacattcc 26640 cagctgctac aacaaacaga gcgatttgtc agaagcctgg ttatacgcca tcatctctgt 26700 catggttttt tgcagtacca tttttgccct agccatatac ccataccttg acattggttg 26760 gaatgccata gatgccatga accaccctac tttcccagcg cccaatgtca taccactgca 26820 acaggttatt gccccaatca atcagcctcg ccccccttct cccaccccca ctgagattag 26880 ctactttaat ttgacaggtg gagatgactg aatctctaga tctagaattg gatggaatta 26940 acaccgaaca gcgcctacta gaaaggcgca aggcggcgtc cgagcgagaa cgcctaaaac 27000 aagaagttga agacatggtt aacctgcacc agtgtaaaag aggtatcttt tgtgtggtca 27060 agcaggccaa acttacctac gaaaaaacca ctaccggcaa ccgccttagc tacaagctac 27120 ccacccagcg ccaaaaactg gtgcttatgg tgggagaaaa acctatcacc gtcacccagc 27180 actcggcaga aacagaaggc tgcctgcact tcccctatca gggtccagag gacctctgca 27240 ctcttattaa aaccatgtgt ggcattagag atcttattcc attcaactaa caataaacac 27300 acaataaatt acttacttaa aatcagtcag caaatctttg tccagcttat tcagcatcac 27360 ctcctttccc tcctcccaac tctggtattt cagcagcctt ttagctgcga actttctcca 27420 aagtctaaat gggatgtcaa attcctcatg ttcttgtccc tccgcaccca ctatcttcat 27480 attgttgcag atgaaacgcg ccagaccgtc tgaagacacc ttcaaccctg tgtacccata 27540 tgacacggaa accggccctc caactgtgcc tttccttacc cctccctttg tgtcgccaaa 27600 tgggttccaa gaaagtcccc ccggagtgct ttctttgcgt ctttcagaac ctttggttac 27660 ctcacacggc atgcttgcgc taaaaatggg cagcggcctg tccctggatc aggcaggcaa 27720 ccttacatca aatacaatca ctgtttctca accgctaaaa aaaacaaagt ccaatataac 27780 tttggaaaca tccgcgcccc ttacagtcag ctcaggcgcc ctaaccatgg ccacaacttc 27840 gcctttggtg gtctctgaca acactcttac catgcaatca caagcaccgc taaccgtgca 27900 agactcaaaa cttagcattg ctaccaaaga gccacttaca gtgttagatg gaaaactggc 27960 cctgcagaca tcagcccccc tctctgccac tgataacaac gccctcacta tcactgcctc 28020 acctcctctt actactgcaa atggtagtct ggctgttacc atggaaaacc cactttacaa 28080 caacaatgga aaacttgggc tcaaaattgg cggtcctttg caagtggcca ccgactcaca 28140 tgcactaaca ctaggtactg gtcagggggt tgcagttcat aacaatttgc tacatacaaa 28200 agttacaggc gcaatagggt ttgatacatc tggcaacatg gaacttaaaa ctggagatgg 28260 cctctatgtg gatagcgccg gtcctaacca aaaactacat attaatctaa ataccacaaa 28320 aggccttgct tttgacaaca ccgcaataac aattaacgct ggaaaagggt tggaatttga 28380 aacagactcc tcaaacggaa atcccataaa aacaaaaatt ggatcaggca tacaatataa 28440 taccaatgga gctatggttg caaaacttgg aacaggcctc agttttgaca gctccggagc 28500 cataacaatg ggcagcataa acaatgacag acttactctt tggacaacac cagacccatc 28560 cccaaattgc agaattgctt cagataaaga ctgcaagcta actctggcgc taacaaaatg 28620 tggcagtcaa attttgggca ctgtttcagc tttggcagta tcaggtaata tggcctccat 28680 caatggaact ctaagcagtg taaacttggt tcttagattt gatgacaacg gagtgcttat 28740 gtcaaattca tcactggaca aacagtattg gaactttaga aacggggact ccactaacgg 28800 tcaaccatac acttatgctg ttgggtttat gccaaaccta aaagcttacc caaaaactca 28860 aagtaaaact gcaaaaagta atattgttag ccaggtgtat cttaatggtg acaagtctaa 28920 accattgcat tttactatta cgctaaatgg aacagatgaa accaaccaag taagcaaata 28980 ctcaatatca ttcagttggt cctggaacag tggacaatac actaatgaca aatttgccac 29040 caattcctat accttctcct acattgccca ggaataaaga atcgtgaacc tgttgcatgt 29100 tatgtttcaa cgtgtttatt tttcaattgc agaaaatttc aagtcatttt tcattcagta 29160 gtatagcccc accaccacat agcttatact aatcaccgta ccttaatcaa actcacagaa 29220 ccctagtatt caacctgcca cctccctccc aacacacaga gtacacagtc ctttctcccc 29280 ggctggcctt aaacagcatc atatcatggg taacagacat attcttaggt gttatattcc 29340 acacggtctc ctgtcgagcc aaacgctcat cagtgatgtt aataaactcc ccgggcagct 29400 cgcttaagtt catgtcgctg tccagctgct gagccacagg ctgctgtcca acttgcggtt 29460 gctcaacggg cggcgaagga gaagtccacg cctacatggg ggtagagtca taatcgtgca 29520 tcaggatagg gcggtggtgc tgcagcagcg cgcgaataaa ctgctgccgc cgccgctccg 29580 tcctgcagga atacaacatg gcagtggtct cctcagcgat gattcgcacc gcccgcagca 29640 taaggcgcct tgtcctccgg gcacagcagc gcaccctgat ctcacttaag tcagcacagt 29700 aactgcagca cagtaccaca atattgttta aaatcccaca gtgcaaggcg ctgtatccaa 29760 agctcatggc ggggaccaca gaacccacgt ggccatcata ccacaagcgc aggtagatta 29820 agtggcgacc cctcataaac acgctggaca taaacattac ctcttttggc atgttgtaat 29880 tcaccacctc ccggtaccat ataaacctct gattaaacat ggcgccatcc accaccatcc 29940 taaaccagct ggccaaaacc tgcccgccgg ctatgcactg cagggaaccg ggactggaac 30000 aatgacagtg gagagcccag gactcgtaac catggatcat catgctcgtc atgatatcaa 30060 tgttggcaca acacaggcac acgtgcatac acttcctcag gattacaagc tcctcccgcg 30120 tcagaaccat atcccaggga acaacccatt cctgaatcag cgtaaatccc acactgcagg 30180 gaagacctcg cacgtaactc acgttgtgca ttgtcaaagt gttacattcg ggcagcagcg 30240 gatgatcctc cagtatggta gcgcgtgtct ctgtctcaaa aggaggtagg cgatccctac 30300 tgtacggagt gcgccgagac aaccgagatc gtgttggtcg tagtgtcatg ccaaatggaa 30360 cgccggacgt agtcatattt cctgaagcaa aaccaggtgc gggcgtgaca aacagatctg 30420 cgtctccggt ctcgtcgctt agctcgctct gtgtagtagt tgtagtatat ccactctctc 30480 aaagcatcca ggcgccccct ggcttcgggt tctatgtaaa ctccttcatg cgccgctgcc 30540 ctgataacat ccaccaccgc agaataagcc acacccagcc aacctacaca ttcgttctgc 30600 gagtcacaca cgggaggagc gggaagagct ggaagaacca tgtttttttt ttttattcca 30660 aaagattatc caaaacctca aaatgaagat ctattaagtg aacgcgctcc cctccggtgg 30720 cgtggtcaaa ctctacagcc aaagaacaga taatggcatt tgtaagatgt tgcacaatgg 30780 cttccaaaag gcaaactgcc ctcacgtcca agtggacgta aaggctaaac ccttcanggt 30840 gaatctcctc tataaacatt ccagcacctt caaccatgcc caaataattt tcatctcgcc 30900 accttatcaa tatgtctcta agcaaatccc gaatattaag tccggccatt gtaaaaatct 30960 gctccagagc gccctccacc ttcagcctca agcagcgaat catgattgca aaaattcagg 31020 ttcctcacag acctgtataa gattcaaaag cggaacatta acaaaaatac cgcgatcccg 31080 taggtccctt cgcagggcca gctgaacata atcgtgcagg tctgcacgga ccagcgcggc 31140 cacttccccg ccaggaacca tgacaaaaga acccacactg attatgacac gcatactcgg 31200 agctatgcta accagcgtag ccccgatgta agcttgttgc atgggcggcg atataaaatg 31260 caaggtactg ctcaaaaaat caggcaaagc ctcgcgcaaa aaagcaagca catcgtagtc 31320 atgctcatgc agataaaggc aggtaagttc cggaaccacc acagaaaaag acaccatttt 31380 tctctcaaac atgtctgcgg gttcctgcat aaacacaaaa taaaataaca aaaaaaaaaa 31440 aacatttaaa cattagaagc ctgtcttaca acaggaaaaa caacccttat aagcataaga 31500 cggactacgg ccatgccggc gtgaccgtaa aaaaactggt caccgtgatt aaaaagcacc 31560 accgacagtt cctcggtcat gtccggagtc ataatgtaag actcggtaaa cacatcaggt 31620 tggttaacat cggtcagtgc taaaaagcga ccgaaatagc ccgggggaat acatacccgc 31680 aggcgtagag acaacattac agcccccata ggaggtataa caaaattaat aggagagaaa 31740 aacacataaa cacctgaaaa accctcctgc ctaggcaaaa tagcaccctc ccgctccaga 31800 acaacataca gcgcttccac agcggcagcc ataacagtca gccttaccag taaaaaaacc 31860 tattaaaaaa caccactcga cacggcacca gctcaatcag tcacagtgta aaaagggcca 31920 agtacagagc gagtatatat aggactaaaa aatgacgtaa cggttaaagt ccacaaaaac 31980 cacccagaaa accgcacgcg aacctacgcc cagaaacgaa agccaaaaaa cccacaactt 32040 cctcaaatct tcacttccgt tttcccacga tacgtcactt cccattttaa aaaaaaacta 32100 caattcccaa tacatgcaag ttactccgcc ctaaaaccta cgtcacccgc cccgttccca 32160 cgccccgcgc cacgtcacaa actccacccc ctcattatca tattggcttc aatccaaaat 32220 aaggtatatt attgatgatg aaattctaga aatcgataag cttgagtatt ctatagtgtc 32280 acctaaatag cttggcgtaa tcatggtcat agctgtttcc tgtgtgaaat tgttatccgc 32340 tcacaattcc acacaacata cgagccggaa gcataaagtg taaagcctgg ggtgcctaat 32400 gagtgagcta actcacatta attgcgttgc gctcactgcc cgctttccag tcgggaaacc 32460 tgtcgtgcca gctgcattaa tgaatcggcc aacgcgcggg gagaggcggt ttgcgtattg 32520 ggcgctcttc cgcttcctcg ctcactgact cgctgcgctc ggtcgttcgg ctgcggcgag 32580 cggtatcagc tcactcaaag gcggtaatac ggttatccac agaatcaggg gataacgcag 32640 gaaagaacat gtgagcaaaa ggccagcaaa aggccaggaa ccgtaaaaag gccgcgttgc 32700 tggcgttttt ccataggctc cgcccccctg acgagcatca caaaaatcga cgctcaagtc 32760 agaggtggcg aaacccgaca ggactataaa gataccaggc gtttccccct ggaagctccc 32820 tcgtgcgctc tcctgttccg accctgccgc ttaccggata cctgtccgcc tttctccctt 32880 cgggaagcgt ggcgctttct catagctcac gctgtaggta tctcagttcg gtgtaggtcg 32940 ttcgctccaa gctgggctgt gtgcacgaac cccccgttca gcccgaccgc tgcgccttat 33000 ccggtaacta tcgtcttgag tccaacccgg taagacacga cttatcgcca ctggcagcag 33060 ccactggtaa caggattagc agagcgaggt atgtaggcgg tgctacagag ttcttgaagt 33120 ggtggcctaa ctacggctac actagaagaa cagtatttgg tatctgcgct ctgctgaagc 33180 cagttacctt cggaaaaaga gttggtagct cttgatccgg caaacaaacc accgctggta 33240 gcggtggttt ttttgtttgc aagcagcaga ttacgcgcag aaaaaaagga tctcaagaag 33300 atcctttgat cttttctacg gggtctgacg ctcagtggaa cgaaaactca cgttaaggga 33360 ttttggtcat gagattatca aaaaggatct tcacctagat ccttttaaat taaaaatgaa 33420 gttttaaatc aatctaaagt atatatgagt aaacttggtc tgacagttac caatgcttaa 33480 tcagtgaggc acctatctca gcgatctgtc tatttcgttc atccatagtt gcctgactcc 33540 ccgtcgtgta gataactacg atacgggagg gcttaccatc tggccccagt gctgcaatga 33600 taccgcgaga cccacgctca ccggctccag atttatcagc aataaaccag ccagccggaa 33660 gggccgagcg cagaagtggt cctgcaactt tatccgcctc catccagtct attaattgtt 33720 gccgggaagc tagagtaagt agttcgccag ttaatagttt gcgcaacgtt gttgccattg 33780 ctacaggcat cgtggtgtca cgctcgtcgt ttggtatggc ttcattcagc tccggttccc 33840 aacgatcaag gcgagttaca tgatccccca tgttgtgcaa aaaagcggtt agctccttcg 33900 gtcctccgat cgttgtcaga agtaagttgg ccgcagtgtt atcactcatg gttatggcag 33960 cactgcataa ttctcttact gtcatgccat ccgtaagatg cttttctgtg actggtgagt 34020 actcaaccaa gtcattctga gaatagtgta tgcggcgacc gagttgctct tgcccggcgt 34080 caatacggga taataccgcg ccacatagca gaactttaaa agtgctcatc attggaaaac 34140 gttcttcggg gcgaaaactc tcaaggatct taccgctgtt gagatccagt tcgatgtaac 34200 ccactcgtgc acccaactga tcttcagcat cttttacttt caccagcgtt tctgggtgag 34260 caaaaacagg aaggcaaaat gccgcaaaaa agggaataag ggcgacacgg aaatgttgaa 34320 tactcatact cttccttttt caatattatt gaagcattta tcagggttat tgtctcatga 34380 gcggatacat atttgaatgt atttagaaaa ataaacaaat aggggttccg cgcacatttc 34440 cccgaaaagt gccacctgac gtctaagaaa ccattattat catgacatta acctataaaa 34500 ataggcgtat cacgaggccc tttcgtctcg cgcgtttcgg tgatgacggt gaaaacctct 34560 gacacatgca gctcccggag acggtcacag cttgtctgta agcggatgcc gggagcagac 34620 aagcccgtca gggcgcgtca gcgggtgttg gcgggtgtcg gggctggctt aactatgcgg 34680 catcagagca gattgtactg agagtgcacc atatgcggtg tgaaataccg cacagatgcg 34740 taaggagaaa ataccgcatc aggaaattgt aagcgttaat attttgttaa aattcgcgtt 34800 aaatttttgt taaatcagct cattttttaa ccaataggcc gaaatcggca aaatccctta 34860 taaatcaaaa gaatagaccg agatagggtt gagtgttgtt ccagtttgga acaagagtcc 34920 actattaaag aacgtggact ccaacgtcaa agggcgaaaa accgtctatc agggcgatgg 34980 cccactacgt gaaccatcac cctaatcaag ttttttgggg tcgaggtgcc gtaaagcact 35040 aaatcggaac cctaaaggga gcccccgatt tagagcttga cggggaaagc cggcgaacgt 35100 ggcgagaaag gaagggaaga aagcgaaagg agcgggcgct agggcgctgg caagtgtagc 35160 ggtcacgctg cgcgtaacca ccacacccgc cgcgcttaat gcgccgctac agggcgcgtc 35220 cattcgccat tcaggctgcg caactgttgg gaagggcgat cggtgcgggc ctcttcgcta 35280 ttacgccagc tggcgaaagg gggatgtgct gcaaggcgat taagttgggt aacgccaggg 35340 ttttcccagt cacgacgttg taaaacgacg gccagtgaat tgtaatacga ctcactata 35399 <210> 3 <211> 73 <212> DNA <213> Artificial Sequence <220> <223> Restriction enzyme site <400> 3 ggccaagtcg gccttaatta acttaaggtt taaacgatat catttaaatt acgtactcga 60 gggatccaag ctt 73 <210> 4 <211> 42 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 4 atgcttaatt aaatcatcaa taatatacct tattttggat tg 42 <210> 5 <211> 40 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 5 atgccttaag tttcagtccc ggtgtcggag cggctcggag 40 <210> 6 <211> 48 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 6 atttaattaa gcgatcgcat catcaataat ataccttatt ttggattg 48 <210> 7 <211> 24 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 7 atgcttccat caaacgagtt ggcg 24 <210> 8 <211> 24 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 8 tcttacctct ggtttccatg agcc 24 <210> 9 <211> 45 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 9 atttaattaa gcgatcgcca tcatcaataa tataccttat tttgg 45 <210> 10 <211> 78 <212> DNA <213> Artificial Sequence <220> <223> Restriction enzyme site <400> 10 cttaaggagc tcttcgaact cgaggtttaa acgatatctt aattaaggat ccatttaaat 60 tctagaatcg ataagctt 78 <210> 11 <211> 26 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 11 atcatcaata atatacctta ttttgg 26 <210> 12 <211> 26 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 12 tccggctcgt atgttgtgtg gaattg 26 <210> 13 <211> 25 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 13 tagaatcgat aagcttgagt attct 25 <210> 14 <211> 34 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 14 atgccttaag aattcgccct atagtgagtc gtat 34 <210> 15 <211> 27 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 15 ctgggatttt ttaattaagt atatgag 27 <210> 16 <211> 41 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 16 tactcaagct tatcgcatca tcaataatat accttatttt g 41 <110> SCT          Industry Academy Coopteration Groop of Chungbuk Health & Science University <120> Vectors for Prepaing Serotype 6 Recombinant Adenovirus <130> P13-B078 <160> 16 <170> Kopatentin 2.0 <210> 1 <211> 7022 <212> DNA <213> Artificial Sequence <220> <223> Total sequence of pAd6-Transfer <400> 1 catgcatgga tccatatgcg gtgtgaaata ccgcacagat gcgtaaggag aaaataccgc 60 atcaggcgct cttccgcttc ctcgctcact gactcgctgc gctcggtcgt tcggctgcgg 120 cgagcggtat cagctcactc aaaggcggta atacggttat ccacagaatc aggggataac 180 gcaggaaaga acatgtgagc aaaaggccag caaaaggcca ggaaccgtaa aaaggccgcg 240 ttgctggcgt ttttccatag gctccgcccc cctgacgagc atcacaaaaa tcgacgctca 300 agtcagaggt ggcgaaaccc gacaggacta taaagatacc aggcgtttcc ccctggaagc 360 tccctcgtgc gctctcctgt tccgaccctg ccgcttaccg gatacctgtc cgcctttctc 420 ccttcgggaa gcgtggcgct ttctcatagc tcacgctgta ggtatctcag ttcggtgtag 480 gtcgttcgct ccaagctggg ctgtgtgcac gaaccccccg ttcagcccga ccgctgcgcc 540 ttatccggta actatcgtct tgagtccaac ccggtaagac acgacttatc gccactggca 600 gcagccactg gtaacaggat tagcagagcg aggtatgtag gcggtgctac agagttcttg 660 aagtggtggc ctaactacgg ctacactaga aggacagtat ttggtatctg cgctctgctg 720 aagccagtta ccttcggaaa aagagttggt agctcttgat ccggcaaaca aaccaccgct 780 ggtagcggtg gtttttttgt ttgcaagcag cagattacgc gcagaaaaaa aggatctcaa 840 gaagatcctt tgatcttttc tacggggtct gacgctcagt ggaacgaaaa ctcacgttaa 900 gggattttgg tcatgagatt atcaaaaagg atcttcacct agatcctttt aaattaaaaa 960 tgaagtttta aatcaatcta aagtatatat gagtaaactt ggtctgacag ttaccaatgc 1020 ttaatcagtg aggcacctat ctcagcgatc tgtctatttc gttcatccat agttgcctga 1080 ctccccgtcg tgtagataac tacgatacgg gagggcttac catctggccc cagtgctgca 1140 atgataccgc gagacccacg ctcaccggct ccagatttat cagcaataaa ccagccagcc 1200 ggaagggccg agcgcagaag tggtcctgca actttatccg cctccatcca gtctattaat 1260 tgttgccggg aagctagagt aagtagttcg ccagttaata gtttgcgcaa cgttgttgcc 1320 attgctgcag ccatgagatt atcaaaaagg atcttcacct agatcctttt cacgtagaaa 1380 gccagtccgc agaaacggtg ctgaccccgg atgaatgtca gctactgggc tatctggaca 1440 agggaaaacg caagcgcaaa gagaaagcag gtagctggag gtgggcttac atggcgatag 1500 ctagactggg cggttttatg gacagcaagc gaaccggaat tgccagctgg ggcgccctct 1560 ggtaaggttg ggaagccctg caaagtaaac tggatggctt tctcgccgcc aaggatctga 1620 tggcgcaggg gatcaagctc tgatcaagag acaggatgag gatcgtttcg catgattgaa 1680 caagatggat tgcacgcagg ttctccggcc gcttgggtgg agaggctatt cggctatgac 1740 tgggcacaac agacaatcgg ctgctctgat gccgccgtgt tccggctgtc agcgcagggg 1800 cgcccggttc tttttgtcaa gaccgacctg tccggtgccc tgaatgaact gcaagacgag 1860 gcagcgcggc tatcgtggct ggccacgacg ggcgttcctt gcgcagctgt gctcgacgtt 1920 gtcactgaag cgggaaggga ctggctgcta ttgggcgaag tgccggggca ggatctcctg 1980 tcatctcacc ttgctcctgc cgagaaagta tccatcatgg ctgatgcaat gcggcggctg 2040 catacgcttg atccggctac ctgcccattc gaccaccaag cgaaacatcg catcgagcga 2100 gcacgtactc ggatggaagc cggtcttgtc gatcaggatg atctggacga agagcatcag 2160 gggctcgcgc cagccgaact gttcgccagg ctcaaggcga gcatgcccga cggcgaggat 2220 ctcgtcgtga cccatggcga tgcctgcttg ccgaatatca tggtggaaaa tggccgcttt 2280 tctggattca tcgactgtgg ccggctgggt gtggcggacc gctatcagga catagcgttg 2340 gctacccgtg atattgctga agagcttggc ggcgaatggg ctgaccgctt cctcgtgctt 2400 tcggtatcg ccgctcccga ttcgcagcgc atcgccttct atcgccttct tgacgagttc 2460 ttctgaattt tgttaaaatt tttgttaaat cagctcattt tttaaccaat aggccgaaat 2520 cggcaacatc ccttataaat caaaagaata gaccgcgata gggttgagtg ttgttccagt 2580 ttggaacaag agtccactat taaagaacgt ggactccaac gtcaaagggc gaaaaaccgt 2640 ctatcagggc gatggcccac tacgtgaacc atcacccaaa tcaagttttt tgcggtcgag 2700 gtgccgtaaa gctctaaatc ggaaccctaa agggagcccc cgatttagag cttgacgggg 2760 aaagccggcg aacgtggcga gaaaggaagg gaagaaagcg aaaggagcgg gcgctagggc 2820 gctggcaagt gtagcggtca cgctgcgcgt aaccaccaca cccgcgcgct taatgcgccg 2880 ctacagggcg cgtccattcg ccattcagga tcgaattaat tcttaattaa gcgatcgcat 2940 catcaataat ataccttatt ttggattgaa gccaatatga taatgagggg gtggagtttg 3000 tgacgtggcg cggggcgtgg gaacggggcg ggtgacgtag tagtgtggcg gaagtgtgat 3060 gttgtaagtg tggcggaaca catgtaagcg ccggatgtgg taaaagtgac gtttttggtg 3120 tgcgccggtg tacacgggaa gtgacaattt tcgcgcggtt ttaggcggat gttgtagtaa 3180 atttgggcgt aaccaagtaa tatttggcca ttttcgcggg aaaactgaat aagaggaagt 3240 gaaatctgaa taattctgtg ttactcatag cgcgtaatat ttgtctaggg ccgcggggac 3300 tttgaccgtt tacgtggaga ctcgcccagg tgtttttctc aggtgttttc cgcgttccgg 3360 gtcaaagttg gcgttttatt attatagtca gctgacgcgc agtgtattta tacccggtga 3420 gttcctcaag aggccactct tgagtgccag cgagtagagt tttctcctcc gagccgctcc 3480 gacaccggga ctgaaactta aggtcgacat cgattctaga gtttaaacgc ggccgcgata 3540 tcgaattcag tactatttaa atgctagctt cgaaagatct tacgtaacta gtacgcgtct 3600 taaggtggga aagaatatat aaggtggggg tctcatgtag ttttgtatct gttttgcagc 3660 agccgccgcc atgagcgcca actcgtttga tggaagcatt gtgagctcat atttgacaac 3720 gcgcatgccc ccatgggccg gggtgcgtca gaatgtgatg ggctccagca ttgatggtcg 3780 ccccgtcctg cccgcaaact ctactacctt gacctacgag accgtgtctg gaacgccgtt 3840 ggagactgca gcctccgccg ccgcttcagc cgctgcagcc accgcccgcg ggattgtgac 3900 tgactttgct ttcctgagcc cgcttgcaag cagtgcagct tcccgttcat ccgcccgcga 3960 tgacaagttg acggctcttt tggcacaatt ggattctttg acccgggaac ttaatgtcgt 4020 ttctcagcag ctgttggatc tgcgccagca ggtttctgcc ctgaaggctt cctcccctcc 4080 caatgcggtt taaaacataa ataaaaacca gactctgttt ggatttggat caagcaagtg 4140 tcttgctgtc tttatttagg ggttttgcgc gcgcggtagg cccgggacca gcggtctcgg 4200 tcgttgaggg tcctgtgtat tttttccagg acgtggtaaa ggtgactctg gatgttcaga 4260 tacatgggca taagcccgtc tctggggtgg aggtagcacc actgcagagc ttcatgctgc 4320 ggggtggtgt tgtagatgat ccagtcgtag caggagcgct gggcgtggtg cctaaaaatg 4380 tctttcagta gcaagctgat tgccaggggc aggcccttgg tgtaagtgtt tacaaagcgg 4440 ttaagctggg atgggtgcat acgtggggat atgagatgca tcttggactg tatttttagg 4500 ttggctatgt tcccagccat atccctccgg ggattcatgt tgtgcagaac caccagcaca 4560 gtgtatccgg tgcacttggg aaatttgtca tgtagcttag aaggaaatgc gtggaagaac 4620 ttggagacgc ccttgtgacc tccaagattt tccatgcatt cgtccataat gatggcaatg 4680 ggcccacggg cggcggcctg ggcgaagata tttctgggat cactaacgtc atagttgtgt 4740 tccaggatga gatcgtcata ggccattttt acaaagcgcg ggcggagggt gccagactgc 4800 ggtataatgg ttccatccgg cccaggggcg tagttaccct cacagatttg catttcccac 4860 gctttgagtt cagatggggg gatcatgtct acctgcgggg cgatgaagaa aaccgtttcc 4920 ggggtagggg agatcagctg ggaagaaagc aggttcctaa gcagctgcga cttaccgcag 4980 ccggtgggcc cgtaaatcac acctattacc ggctgcaact ggtagttaag agagctgcag 5040 ctgccgtcat ccctgagcag gggggccact tcgttaagca tgtccctgac ttgcatgttt 5100 tccctgacca aatccgccag aaggcgctcg ccgcccagcg atagcagttc ttgcaaggaa 5160 gcaaagtttt tcaacggttt gaggccgtcc gccgtaggca tgcttttgag cgtttgacca 5220 agcagttcca ggcggtccca cagctcggtc acgtgctcta cggcatctcg atccagcata 5280 tctcctcgtt tcgcgggttg gggcggcttt cgctgtacgg cagtagtcgg tgctcgtcca 5340 gacgggccag ggtcatgtct ttccacgggc gcagggtcct cgtcagcgta gtctgggtca 5400 cggtgaaggg gtgcgctccg ggttgcgcgc tggccagggt gcgcttgagg ctggtcctgc 5460 tggtgctgaa gcgctgccgg tcttcgccct gcgcgtcggc caggtagcat ttgaccatgg 5520 tgtcatagtc cagcccctcc gcggcgtggc ccttggcgcg cagcttgccc ttggaggagg 5580 cgccgcacga ggggcagtgc agacttttaa gggcgtagag cttgggcgcg agaaataccg 5640 attccgggga gtaggcatcc gcgccgcagg ccccgcagac ggtctcgcat tccacgagcc 5700 aggtgagctc tggccgttcg gggtcaaaaa ccaggtttcc cccatgcttt ttgatgcgtt 5760 tcttacctct ggtttccatg agccggtgtc cacgctcggt gacgaaaagg ctgtccgtgt 5820 ccccgtatac agacttgaga ggcctgtcct cgagttcgca gggccagctg aacataatcg 5880 tgcaggtctg cacggaccag cgcggccact tccccgccag gaaccatgac aaaagaaccc 5940 acctgatta tgacacgcat actcggagct atgctaacca gcgtagcccc gatgtaagct 6000 tgttgcatgg gcggcgatat aaaatgcaag gtactgctca aaaaatcagg caaagcctcg 6060 cgcaaaaaag caagcacatc gtagtcatgc tcatgcagat aaaggcaggt aagttccgga 6120 accaccacag aaaaagacac catttttctc tcaaacatgt ctgcgggttc ctgcataaac 6180 acaaaataaa ataacaaaaa aaaaaaaaca tttaaacatt agaagcctgt cttacaacag 6240 gaaaaacaac ccttataagc ataagacgga ctacggccat gccggcgtga ccgtaaaaaa 6300 actggtcacc gtgattaaaa agcaccaccg acagttcctc ggtcatgtcc ggagtcataa 6360 tgtaagactc ggtaaacaca tcaggttggt taacatcggt cagtgctaaa aagcgaccga 6420 aatagcccgg gggaatacat acccgcaggc gtagagacaa cattacagcc cccataggag 6480 gtataacaaa attaatagga gagaaaaaca cataaacccc tgaaaaaccc tcctgcctag 6540 gcaaaatagc accctcccgc tccagaacaa catacagcgc ttccacagcg gcagccataa 6600 cagtcagcct taccagtaaa aaaacctatt aaaaaacacc actcgacacg gcaccagctc 6660 aatcagtcac agtgtaaaaa gggccaagta cagagcgagt atatatagga ctaaaaaatg 6720 acgtaacggt taaagtccac aaaaaccacc cagaaaaccg cacgcgaacc tacgcccaga 6780 aacgaaagcc aaaaaaccca caacttcctc aaatcttcac ttccgttttc ccacgatacg 6840 tcacttccca ttttaaaaaa aaactacaat tcccaataca tgcaagttac tccgccctaa 6900 aacctacgtc acccgccccg ttcccacgcc ccgcgccacg tcacaaactc caccccctca 6960 ttatcatatt ggcttcaatc caaaataagg tatattattg atgatggcga tcgcttaatt 7020 aa 7022 <210> 2 <211> 35399 <212> DNA <213> Artificial Sequence <220> <223> Total sequence of pAd6-Simple2 <400> 2 gggcgaattc ttaagggtgg gaaagaatat ataaggtggg ggtctcatgt agttttgtat 60 ctgttttgca gcagccgccg ccatgagcgc caactcgttt gatggaagca ttgtgagctc 120 atatttgaca acgcgcatgc ccccatgggc cggggtgcgt cagaatgtga tgggctccag 180 cattgatggt cgccccgtcc tgcccgcaaa ctctactacc ttgacctacg agaccgtgtc 240 tggaacgccg ttggagactg cagcctccgc cgccgcttca gccgctgcag ccaccgcccg 300 cgggattgtg actgactttg ctttcctgag cccgcttgca agcagtgcag cttcccgttc 360 atccgcccgc gatgacaagt tgacggctct tttggcacaa ttggattctt tgacccggga 420 acttaatgtc gtttctcagc agctgttgga tctgcgccag caggtttctg ccctgaaggc 480 ttcctcccct cccaatgcgg tttaaaacat aaataaaaac cagactctgt ttggatttgg 540 atcaagcaag tgtcttgctg tctttattta ggggttttgc gcgcgcggta ggcccgggac 600 cagcggtctc ggtcgttgag ggtcctgtgt attttttcca ggacgtggta aaggtgactc 660 tggatgttg gatacatggg cataagcccg tctctggggt ggaggtagca ccactgcaga 720 gcttcatgct gcggggtggt gttgtagatg atccagtcgt agcaggagcg ctgggcgtgg 780 tgcctaaaaa tgtctttcag tagcaagctg attgccaggg gcaggccctt ggtgtaagtg 840 tttacaaagc ggttaagctg ggatgggtgc atacgtgggg atatgagatg catcttggac 900 tgtattttta ggttggctat gttcccagcc atatccctcc ggggattcat gttgtgcaga 960 accaccagca cagtgtatcc ggtgcacttg ggaaatttgt catgtagctt agaaggaaat 1020 gcgtggaaga acttggagac gcccttgtga cctccaagat tttccatgca ttcgtccata 1080 atgatggcaa tgggcccacg ggcggcggcc tgggcgaaga tatttctggg atcactaacg 1140 tcatagttgt gttccaggat gagatcgtca taggccattt ttacaaagcg cgggcggagg 1200 gtgccagact gcggtataat ggttccatcc ggcccagggg cgtagttacc ctcacagatt 1260 tgcatttccc acgctttgag ttcagatggg gggatcatgt ctacctgcgg ggcgatgaag 1320 aaaaccgttt ccggggtagg ggagatcagc tgggaagaaa gcaggttcct aagcagctgc 1380 gacttaccgc agccggtggg cccgtaaatc acacctatta ccggctgcaa ctggtagtta 1440 agaggctgc agctgccgtc atccctgagc aggggggcca cttcgttaag catgtccctg 1500 acttgcatgt tttccctgac caaatccgcc agaaggcgct cgccgcccag cgatagcagt 1560 tcttgcaagg aagcaaagtt tttcaacggt ttgaggccgt ccgccgtagg catgcttttg 1620 agcgtttgac caagcagttc caggcggtcc cacagctcgg tcacgtgctc tacggcatct 1680 cgatccagca tatctcctcg tttcgcgggt tggggcggct ttcgctgtac ggcagtagtc 1740 ggtgctcgtc cagacgggcc agggtcatgt ctttccacgg gcgcagggtc ctcgtcagcg 1800 tagtctgggt cacggtgaag gggtgcgctc cgggttgcgc gctggccagg gtgcgcttga 1860 ggctggtcct gctggtgctg aagcgctgcc ggtcttcgcc ctgcgcgtcg gccaggtagc 1920 atttgaccat ggtgtcatag tccagcccct ccgcggcgtg gcccttggcg cgcagcttgc 1980 ccttggagga ggcgccgcac gaggggcagt gcagactttt aagggcgtag agcttgggcg 2040 cgagaaatac cgattccggg gagtaggcat ccgcgccgca ggccccgcag acggtctcgc 2100 attccacgag ccaggtgagc tctggccgtt cggggtcaaa aaccaggttt cccccatgct 2160 ttttgatgcg tttcttacct ctggtttcca tgagccggtg tccacgctcg gtgacgaaaa 2220 ggctgtccgt gtccccgtat acagacttga gaggcctgtc ctcgagcggt gttccgcggt 2280 cctcctcgta tagaaactcg gaccactctg agacgaaggc tcgcgtccag gccagcacga 2340 aggaggctaa gtgggagggg tagcggtcgt tgtccactag ggggtccact cgctccaggg 2400 tgtgaagaca catgtcgccc tcttcggcat caaggaaggt gattggttta taggtgtagg 2460 ccacgtgacc gggtgttcct gaaggggggc tataaaaggg ggtgggggcg cgttcgtcct 2520 cactctcttc cgcatcgctg tctgcgaggg ccagctgttg gggtgagtac tccctctcaa 2580 aagcgggcat gacttctgcg ctaagattgt cagtttccaa aaacgaggag gatttgatat 2640 tcacctggcc cgcggtgatg cctttgaggg tggccgcgtc catctggtca gaaaagacaa 2700 tctttttgtt gtcaagcttg gtggcaaacg acccgtagag ggcgttggac agcaacttgg 2760 cgatggagcg cagggtttgg tttttgtcgc gatcggcgcg ctccttggcc gcgatgttta 2820 gctgcacgta ttcgcgcgca acgcaccgcc attcgggaaa gacggtggtg cgctcgtcgg 2880 gcactaggtg cacgcgccaa ccgcggttgt gcagggtgac aaggtcaacg ctggtggcta 2940 cctctccgcg taggcgctcg ttggtccagc agaggcggcc gcccttgcgc gagcagaatg 3000 gcggtagtgg gtctagctgc gtctcgtccg gggggtctgc gtccacggta aagaccccgg 3060 gcagcaggcg cgcgtcgaag tagtctatct tgcatccttg caagtctagc gcctgctgcc 3120 atgcgcgggc ggcaagcgcg cgctcgtatg ggttgagtgg gggaccccat ggcatggggt 3180 gggtgagcgc ggaggcgtac atgccgcaaa tgtcgtaaac gtagaggggc tctctgagta 3240 ttccaagata tgtagggtag catcttccac cgcggatgct ggcgcgcacg taatcgtata 3300 gttcgtgcga gggagcgagg aggtcgggac cgaggttgct acgggcgggc tgctctgctc 3360 ggaagactat ctgcctgaag atggcatgtg agttggatga tatggttgga cgctggaaga 3420 cgttgaagct ggcgtctgtg agacctaccg cgtcacgcac gaaggaggcg taggagtcgc 3480 gcagcttgtt gaccagctcg gcggtgacct gcacgtctag ggcgcagtag tccagggttt 3540 ccttgatgat gtcatactta tcctgtccct tttttttcca cagctcgcgg ttgaggacaa 3600 actcttcgcg gtctttccag tactcttgga tcggaaaccc gtcggcctcc gaacggtaag 3660 agcctagcat gtagaactgg ttgacggcct ggtaggcgca gcatcccttt tctacgggta 3720 gcgcgtatgc ctgcgcggcc ttccggagcg aggtgtgggt gagcgcaaag gtgtccctaa 3780 ccatgacttt gaggtactgg tatttgaagt cagtgtcgtc gcatccgccc tgctcccaga 3840 gcaaaaagtc cgtgcgcttt ttggaacgcg ggtttggcag ggcgaaggtg acatcgttga 3900 agagtatctt tcccgcgcga ggcataaagt tgcgtgtgat gcggaagggt cccggcacct 3960 cggaacggtt gttaattacc tgggcggcga gcacgatctc gtcaaagccg ttgatgttgt 4020 ggcccacaat gtaaagttcc aagaagcgcg ggatgccctt gatggaaggc aattttttaa 4080 gttcctcgta ggtgagctct tcaggggagc tgagcccgtg ctctgaaagg gcccagtctg 4140 caagatgagg gttggaagcg acgaatgagc tccacaggtc acgggccatt agcatttgca 4200 ggtggtcgcg aaaggtccta aactggcgac ctatggccat tttttctggg gtgatgcagt 4260 agaaggtaag cgggtcttgt tcccagcggt cccatccaag gtccgcggct aggtctcgcg 4320 cggcggtcac tagaggctca tctccgccga acttcatgac cagcatgaag ggcacgagct 4380 gcttcccaaa ggcccccatc caagtatagg tctctacatc gtaggtgaca aagagacgct 4440 cggtgcgagg atgcgagccg atcgggaaga actggatctc ccgccaccag ttggaggagt 4500 ggctgttgat gtggtgaaag tagaagtccc tgcgacgggc cgaacactcg tgctggcttt 4560 tgtaaaaacg tgcgcagtac tggcagcggt gcacgggctg tacatcctgc acgaggttga 4620 cctgacgacc gcgcacaagg aagcagagtg ggaatttgag cccctcgcct ggcgggtttg 4680 gctggtggtc ttctacttcg gctgcttgtc cttgaccgtc tggctgctcg aggggagtta 4740 cggtggatcg gaccaccacg ccgcgcgagc ccaaagtcca gatgtccgcg cgcggcggtc 4800 ggagcttgat gacaacatcg cgcagatggg agctgtccat ggtctggagc tcccgcggcg 4860 tcaggtcagg cgggagctcc tgcaggttta cctcgcatag ccgggtcagg gcgcgggcta 4920 ggtccaggtg atacctgatt tccaggggct ggttggtggc ggcgtcgatg gcttgcaaga 4980 ggccgcatcc ccgcggcgcg actacggtac cgcgcggcgg gcggtgggcc gcgggggtgt 5040 ccttggatga tgcatctaaa agcggtgacg cgggcgggcc cccggaggta gggggggctc 5100 gggacccgcc gggagagggg gcaggggcac gtcggcgccg cgcgcgggca ggagctggtg 5160 ctgcgcgcgg aggttgctgg cgaacgcgac gacgcggcgg ttgatctcct gaatctggcg 5220 cctctgcgtg aagacgacgg gcccggtgag cttgaacctg aaagagagtt cgacagaatc 5280 aatttcggtg tcgttgacgg cggcctggcg caaaatctcc tgcacgtctc ctgagttgtc 5340 ttgataggcg atctcggcca tgaactgctc gatctcttcc tcctggagat ctccgcgtcc 5400 ggctcgctcc acggtggcgg cgaggtcgtt ggagatgcgg gccatgagct gcgagaaggc 5460 gttgaggcct ccctcgttcc agacgcggct gtagaccacg cccccttcgg catcgcgggc 5520 gcgcatgacc acctgcgcga gattgagctc cacgtgccgg gcgaagacgg cgtagtttcg 5580 caggcgctga aagaggtagt tgagggtggt ggcggtgtgt tctgccacga agaagtacat 5640 aacccagcgc cgcaacgtgg attcgttgat atcccccaag gcctcaaggc gctccatggc 5700 ctcgtagaag tccacggcga agttgaaaaa ctgggagttg cgcgccgaca cggttaactc 5760 ctcctccaga agacggatga gctcggcgac agtgtcgcgc acctcgcgct caaaggctac 5820 aggggcctct tcttcttctt caatctcctc ttccataagg gcctcccctt cttcttcttc 5880 tggcggcggt gggggagggg ggacacggcg gcgacgacgg cgcaccggga ggcggtcgac 5940 aaagcgctcg atcatctccc cgcggcgacg gcgcatggtc tcggtgacgg cgcggccgtt 6000 ctcgcggggg cgcagttgga agacgccgcc cgtcatgtcc cggttatggg ttggcggggg 6060 gctgccgtgc ggcagggata cggcgctaac gatgcatctc aacaattgtt gtgtaggtac 6120 tccgccaccg agggacctga gcgagtccgc atcgaccgga tcggaaaacc tctcgagaaa 6180 ggcgtctaac cagtcacagt cgcaaggtag gctgagcacc gtggcgggcg gcagcgggcg 6240 gcggtcgggg ttgtttctgg cggaggtgct gctgatgatg taattaaagt aggcggtctt 6300 gagacggcgg atggtcgaca gaagcaccat gtccttgggt ccggcctgct gaatgcgcag 6360 gcggtcggcc atgccccagg cttcgttttg acatcggcgc aggtctttgt agtagtcttg 6420 catgagcctt tctaccggca cttcttcttc tccttcctct tgtcctgcat ctcttgcatc 6480 tatcgctgcg gcggcggcgg agtttggccg taggtggcgc cctcttcctc ccatgcgtgt 6540 gccccgaag cccctcatcg gctgaagcag ggccaggtcg gcgacaacgc gctcggctaa 6600 tatggcctgc tgcacctgcg tgagggtaga ctggaagtcg tccatgtcca caaagcggtg 6660 gtatgcgccc gtgttgatgg tgtaagtgca gttggccata acggaccagt taacggtctg 6720 gtgacccggc tgcgagagct cggtgtacct gagacgcgag taagcccttg agtcaaagac 6780 gtagtcgttg caagtccgca ccaggtactg gtatcccacc aaaaagtgcg gcggcggctg 6840 gcggtagagg ggccagcgta gggtggccgg ggctccgggg gcgaggtctt ccaacataag 6900 gcgatgatat ccgtagatgt acctggacat ccaggtgatg ccggcggcgg tggtggaggc 6960 gcgcggaaag tcacggacgc ggttccagat gttgcgcagc ggcaaaaagt gctccatggt 7020 cgggacgctc tggccggtca ggcgcgcgca gtcgttgacg ctctagaccg tgcaaaagga 7080 gagcctgtaa gcgggcactc ttccgtggtc tggtggataa attcgcaagg gtatcatggc 7140 ggacgaccgg ggttcgaacc ccggatccgg ccgtccgccg tgatccatgc ggttaccgcc 7200 cgcgtgtcga acccaggtgt gcgacgtcag acaacggggg agcgctcctt ttggcttcct 7260 tccaggcgcg gcggatgctg cgctagcttt tttggccact ggccgcgcgc ggcgtaagcg 7320 gttaggctgg aaagcgaaag cattaagtgg ctcgctccct gtagccggag ggttattttc 7380 caagggttga gtcgcgggac ccccggttcg agtctcgggc cggccggact gcggcgaacg 7440 ggggtttgcc tccccgtcat gcaagacccc gcttgcaaat tcctccggaa acagggacga 7500 gccccttttt tgcttttccc agatgcatcc ggtgctgcgg cagatgcgcc cccctcctca 7560 gcagcggcaa gagcaagagc agcggcagac atgcagggca ccctcccctt ctcctaccgc 7620 gtcaggaggg gcaacatccg cggctgacgc ggcggcagat ggtgattacg aacccccgcg 7680 gcgccggacc cggcactact tggacttgga ggagggcgag ggcctggcgc ggctaggagc 7740 gccctctcct gagcgacacc caagggtgca gctgaagcgt gacacgcgcg aggcgtacgt 7800 gccgcggcag aacctgtttc gcgaccgcga gggagaggag cccgaggaga tgcgggatcg 7860 aaagttccat gcagggcgcg agttgcggca tggcctgaac cgcgagcggt tgctgcgcga 7920 ggaggacttt gagcccgacg cgcggaccgg gattagtccc gcgcgcgcac acgtggcggc 7980 cgccgacctg gtaaccgcgt acgagcagac ggtgaaccag gagattaact ttcaaaaaag 8040 ctttaacaac cacgtgcgca cgcttgtggc gcgcgaggag gtggctatag gactgatgca 8100 tctgtgggac tttgtaagcg cgctggagca aaacccaaat agcaagccgc tcatggcgca 8160 gctgttcctt atagtgcagc acagcaggga caacgaggca ttcagggatg cgctgctaaa 8220 catagtagag cccgagggcc gctggctgct cgatttgata aacattctgc agagcatagt 8280 ggtgcaggag cgcagcttga gcctggctga caaggtggcc gccattaact attccatgct 8340 cagtctgggc aagttttacg cccgcaagat ataccatacc ccttacgttc ccatagacaa 8400 ggaggtaaag atcgaggggt tctacatgcg catggcgctg aaggtgctta ccttgagcga 8460 cgacctgggc gtttatcgca acgagcgcat ccacaaggcc gtgagcgtga gccggcggcg 8520 cgagctcagc gaccgcgagc tgatgcacag cctgcaaagg gccctggctg gcacgggcag 8580 cggcgataga gaggccgagt cctactttga cgcgggcgct gacctgcgct gggccccaag 8640 ccgacgcgcc ctggaggcag ctggggccgg acctgggctg gcggtggcac ccgcgcgcgc 8700 tggcaacgtc ggcggcgtgg aggaatatga cgaggacgat gagtacgagc cagaggacgg 8760 cgagtactaa gcggtgatgt ttctgatcag atgatgcaag acgcaacgga cccggcggtg 8820 cgggcggcgc tgcagagcca gccgtccggc cttaactcca cggacgactg gcgccaggtc 8880 atggaccgca tcatgtcgct gactgcgcgc aaccctgacg cgttccggca gcagccgcag 8940 gccaaccggc tctccgcaat tctggaagcg gtggtcccgg cgcgcgcaaa ccccacgcac 9000 gagaaggtgc tggcgatcgt aaacccgctg gccgaaaaca gggccatccg gcccgatgag 9060 gccggcctgg tctacgacgc gctgcttcag cgcgtggctc gttacaacag cagcaacgtg 9120 cagaccaacc tggaccggct ggtgggggat gtgcgcgagg ccgtggcgca gcgtgagcgc 9180 gcgcagcagc agggcaacct gggctccatg gttgcactaa acgccttcct gagtacacag 9240 cccgccaacg tgccgcgggg acaggaggac tacaccaact ttgtgagcgc actgcggcta 9300 atggtgactg agacaccgca aagtgaggtg tatcagtccg ggccagacta ttttttccag 9360 accagtagac aaggcctgca gaccgtaaac ctgagccagg ctttcaagaa cttgcagggg 9420 ctgtgggggg tgcgggctcc cacaggcgac cgcgcgaccg tgtctagctt gctgacgccc 9480 aactcgcgcc tgttgctgct gctaatagcg cccttcacgg acagtggcag cgtgtcccgg 9540 gacacatacc taggtcactt gctgacactg taccgcgagg ccataggtca ggcgcatgtg 9600 gacgagcata ctttccagga gattacaagt gttagccgcg cgctggggca ggaggacacg 9660 ggcagcctgg aggcaaccct gaactacctg ctgaccaacc ggcggcaaaa aatcccctcg 9720 ttgcacagtt taaacagcga ggaggagcgc attttgcgct atgtgcagca gagcgtgagc 9780 cttaacctga tgcgcgacgg ggtaacgccc agcgtggcgc tggacatgac cgcgcgcaac 9840 atggaaccgg gcatgtatgc ctcaaaccgg ccgtttatca atcgcctaat ggactacttg 9900 catcgcgcgg ccgccgtgaa ccccgagtat ttcaccaatg ccatcttgaa cccgcactgg 9960 ctaccgcccc ctggtttcta caccggggga ttcgaggtgc ccgagggtaa cgatggattc 10020 ctctgggacg acatagacga cagcgtgttt tccccgcaac cgcagaccct gctagagttg 10080 caacaacgcg agcaggcaga ggcggcgctg cgaaaggaaa gcttccgcag gccaagcagc 10140 ttgtccgatc taggcgctgc ggccccgcgg tcagatgcta gtagcccatt tccaagcttg 10200 atagggtctc ttaccagcac tcgcaccacc cgcccgcgcc tgctgggcga ggaggagtac 10260 ctaaacaact cgctgctgca gccgcagcgc gaaaagaacc tgcctccggc gtttcccaac 10320 aacgggatag agagcctagt ggacaagatg agtagatgga agacgtatgc gcaggagcac 10380 agggatgtgc ccggcccgcg cccgcccacc cgtcgtcaaa ggcacgaccg tcagcggggt 10440 ctggtgtggg aggacgatga ctcggcagac gacagcagcg tcttggattt gggagggag 10500 ggcaacccgt ttgcacacct tcgccccagg ctggggagaa tgttttaaaa aaagcatgat 10560 gcaaaataaa aaactcacca aggcnatggc accgagcgtt ggttttcttg tattcccctt 10620 agtatgcggc gcgcggcgat gtatgaggaa ggtcctcctc cctcctacga gagcgtggtg 10680 agcgcggcgc cagtggcggc ggcgctgggt tcacccttcg atgctcccct ggacccgccg 10740 ttcgtgcctc cgcggtacct gcggcctacc ggggggagaa acagcatccg ttactctgag 10800 ttggcacccc tattcgacac cacccgtgtg taccttgtgg acaacaagtc aacggatgtg 10860 gcatccctga actaccagaa cgaccacagc aactttctaa ccacggtcat tcaaaacaat 10920 gactacagcc cgggggaggc aagcacacag accatcaatc ttgacgaccg gtcgcactgg 10980 ggcggcgacc tgaaaaccat cctgcatacc aacatgccaa atgtgaacga gttcatgttt 11040 accaataagt ttaaggcgcg ggtgatggtg tcgcgctcgc ttactaagga caaacaggtg 11100 ggctgaaat acgagtgggt ggagttcacg ctgcccgagg gcaactactc cgagaccatg 11160 accatagacc ttatgaacaa cgcgatcgtg gagcactact tgaaagtggg caggcagaac 11220 ggggttctgg aaagcgacat cggggtaaag tttgacaccc gcaacttcag actggggttt 11280 gacccagtca ctggtcttgt catgcctggg gtatataca acgaagcctt ccatccagac 11340 atcattttgc tgccaggatg cggggtggac ttcacccaca gccgcctgag caacttgttg 11400 ggcatccgca agcggcaacc cttccaggag ggctttagga tcacctacga tgacctggag 11460 ggtggtaaca ttcccgcact gttggatgtg gacgcctacc aggcaagctt gaaagatgac 11520 accgaacagg gcgggggtgg cgcaggcggc ggcaacaaca gtggcagcgg cgcggaagag 11580 aactccaacg cggcagctgc ggcaatgcag ccggtggagg acatgaacga tcatgccatt 11640 cgcggcgaca cctttgccac acgggcggag gagaagcgcg ctgaggccga ggcagcggcc 11700 gaagctgccg cccccgctgc ggaggctgca caacccgagg tcgagaagcc tcagaagaaa 11760 ccggtgatta aacccctgac agaggacagc aagaaacgca gttacaacct aataagcaat 11820 gacagcacct tcacccagta ccgcagctgg taccttgcat acaactacgg cgaccctcag 11880 gccgggatcc gctcatggac cctgctttgc actcctgacg taacctgcgg ctcggagcag 11940 gtatactggt cgttgcccga catgatgcaa gaccccgtga ccttccgctc cacgcgccag 12000 atcagcaact ttccggtggt gggcgccgag ctgttgcccg tgcactccaa gagcttctac 12060 aacgaccagg ccgtctactc ccagctcatc cgccagttta cctctctgac ccacgtgttc 12120 aatcgctttc ccgagaacca gattttggcg cgcccgccag cccccaccat caccaccgtc 12180 agtgaaaacg ttcctgctct cacagatcac gggacgctac cgctgcgcaa cagcatcgga 12240 ggagtccagc gagtgaccat tactgacgcc agacgccgca cctgccccta cgtttacaag 12300 gccctgggca tagtctcgcc gcgcgtccta tcgagccgca ctttttgagc aagcatgtcc 12360 atccttatat cgcccagcaa taacacaggc tggggcctgc gcttcccaag caagatgttt 12420 ggcggggcca agaagcgctc cgaccaacac ccagtgcgcg tgcgcgggca ctaccgcgcg 12480 ccctggggcg cgcacaaacg cggccgcact gggcgcacca ccgtcgatga cgccatcgac 12540 gcggtggtgg aggaggcgcg caactacacg cccacgccgc cgccagtgtc caccgtggac 12600 gcggccattc agaccgtggt gcgcggagcc cggcgctacg ctaaaatgaa gagacggcgg 12660 aggcgcgtag cacgtcgcca ccgccgccga cccggcactg ccgcccaacg cgcggcggcg 12720 gccctgctta accgcgcacg tcgcaccggc cgacgggcgg ccatgcgagc cgctcgaagg 12780 ctggccgcgg gtattgtcac tgtgcccccc aggtccaggc gacgagcggc cgccgcagca 12840 gccgcggcca ttagtgttat gactcagggt cgcaggggca acgtgtactg ggtgcgcgac 12900 tcggttagcg gcctgcgcgt gcccgtgcgc acccgccccc cgcgcaacta gattgcaata 12960 aaaaactact tagactcgta ctgttgtatg tatccagcgg cggcggcgcg catcgaagct 13020 atgtccaagc gcaaaatcaa agaagagatg ctccaggtca tcgcgccgga gatctatggc 13080 cccccgaaga aggaagagca ggattacaag ccccgaaagc taaagcgggt caaaaagaaa 13140 aagaaagatg atgatgatga tgaacttgac gacgaggtgg aactgttgca cgcgaccgcg 13200 cccaggcgac gggtacagtg gaaaggtcga cgcgtaagac gtgttttgcg acccggcacc 13260 accgtagtct ttacgcccgg tgagcgctcc acccgcacct acaagcgcgt gtatgatgag 13320 gtgtacggcg acgaggacct gcttgagcag gccaacgagc gcctcgggga gtttgcctac 13380 ggaaagcggc ataaggacat gctggcgttg ccgctggacg agggcaaccc aacacctagc 13440 ctaaagcccg tgacactgca gcaggtgctg cccgcgcttg caccgtccga agaaaagcgc 13500 ggcctaaagc gcgagtctgg tgacttggca cccaccgtgc agctgatggt acccaagcgt 13560 cagcgactgg aagatgtctt ggaaaaaatg accgtggagc ctgggctgga gcccgaggtc 13620 cgcgtgcggc caatcaagca ggtggcaccg ggactgggcg tgcagaccgt ggacgttcag 13680 atacccacca ccagtagcac tagtattgcc actgccacag agggcatgga gacacaaacg 13740 tccccggttg cctcggcggt ggcagatgcc gcggtgcagg cggccgctgc ggccgcgtcc 13800 aagacctcta cggaggtgca aacggacccg tggatgtttc gtgtttcagc cccccggcgt 13860 ccgcgccgtt caaggaagta cggcgccgcc agcgcgctac tgcccgaata tgccctacat 13920 ccttccatcg cgcctacccc cggctatcgt ggctacacct accgccccag aagacgagca 13980 actacccgac gccgaaccac cactggaacc cgccgccgcc gtcgccgtcg ccagcccgtg 14040 ctggccccga tttccgtgcg cagggtggct cgcgaaggag gcaggaccct ggtgctgcca 14100 acagcgcgct accaccccag catcgtttaa aagccggtct ttgtggttct tgcagatatg 14160 gccctcacct gccgcctccg tttcccggtg ccgggattcc gaggaagaat gcaccgtagg 14220 aggggcatgg ccggccacgg cctgacgggc ggcatgcgtc gtgcgcacca ccggcggcgg 14280 cgcgcgtcgc accgtcgcat gcgcgccggt atcctgcccc tccttattcc actgatcgcc 14340 gcggcgattg gcgccgtgcc cggaattgca tccgtggcct tgcaggcgca gagacactga 14400 ttaaaaacaa gttacatgtg gaaaaatcaa aataaaagtc tggactctca cgctcgcttg 14460 gtcctgtaac tattttgtag aatggaagac atcaactttg cgtcactggc cccgcgacac 14520 ggctcgcgcc cgttcatggg aaactggcaa gatatcggca ccagcaatat gagcggtggc 14580 gccttcagct ggggctcgct gtggagcggc attaaaaatt tcggttccgc cgttaagaac 14640 tatggcagca aagcctggaa cagcagcaca ggccagatgc tgagggacaa gttgaaagag 14700 caaaatttcc aacaaaaggt ggtagatggc ctggcctctg gcattagcgg ggtggtggac 14760 ctggccaacc aggcagtgca aaataagatt aacagtaagc ttgatccccg ccctcccgta 14820 gaggagcctc caccggccgt ggagacagtg tctccagagg ggcgtggcga aaagcgtccg 14880 cgacccgaca gggaagaaac tctggtgacg caaatagacg agcctccctc gtacgaggag 14940 gcactaaagc aaggcctgcc caccacccgt cccatcgcgc ccatggctac cggagtgctg 15000 ggccagcaca cacccgtaac gctggacctg cctccccccg ccgacaccca gcagaaacct 15060 gtgctgccag gcccgtccgc cgttgttgta acccgtccta gccgcgggtc cctgcgccgc 15120 gccgccagcg gtccgcgatc gttgcggccc gtagccagtg gcaactggca aagcacactg 15180 aacagcatcg tgggtttggg ggtgcaatcc ctgaagcgcc gacgatgctt ctgatagcta 15240 acgtgtcgta tgtgtgtcat gtatgcgtcc atgtcgccgc cagaggagct gctgagccgc 15300 cgcgcgcccg ctttccaaga tggctacccc ttcgatgatg ccgcagtggt cttacatgca 15360 catctcgggc caggacgcct cggagtacct gagccccggg ctggtgcagt tcgcccgcgc 15420 caccgagacg tacttcagcc tgaataacaa gtttagaaac cccacggtgg cgcctacgca 15480 cgacgtgacc acagaccggt ctcagcgttt gacgctgcgg ttcatccccg tggaccgcga 15540 ggatactgcg tactcgtaca aggcgcggtt caccctagct gtgggtgata accgtgtgct 15600 agacatggct tccacgtact ttgacatccg cggcgtgctg gacaggggcc ctacttttaa 15660 gccctactct ggcactgcct acaacgcact ggcccccaag ggtgccccca actcgtgcga 15720 gtgggaacaa aatgaaactg cacaagtgga tgctcaagaa cttgacgaag aggagaatga 15780 agccaatgaa gctcaggcgc gagaacagga acaagctaag aaaacccatg tatatgccca 15840 ggctccactg tccggaataa aaataactaa agaaggtcta caaataggaa ctgccgacgc 15900 cacagtagca ggtgccggca aagaaatttt cgcagacaaa acttttcaac ctgaaccaca 15960 agtaggagaa tctcaatgga acgaagcgga tgccacagca gctggtggaa gggttcttaa 16020 aaagacaact cccatgaaac cctgctatgg ctcatacgct agacccacca attccaacgg 16080 cggacagggc gttatggttg aacaaaatgg taaattggaa agtcaagtcg aaatgcaatt 16140 tttttccaca tccacaaatg ccacaaatga agttaacaat atacaaccaa cagttgtatt 16200 gtacagcgaa gatgtaaaca tggaaactcc agatactcat ctttcttata aacctaaaat 16260 gggggataaa aatgccaaag tcatgcttgg acaacaagca atgccaaaca gaccaaatta 16320 cattgctttt agagacaatt ttattggtct catgtattac aacagcacag gtaacatggg 16380 tgtccttgct ggtcaggcat cgcagttgaa cgctgttgta gatttgcaag acagaaacac 16440 agagctgtcc taccagcttt tgcttgattc aattggcgac agaacaagat acttttcaat 16500 gtggaatcaa gctgttgaca gctatgatcc agatgtcaga attattgaga accatggaac 16560 tgaggatgag ttgccaaatt attgctttcc tcttggtgga attgggatta ctgacacttt 16620 tcaagctgtt aaaacaactg ctgctaacgg ggaccaaggc aatactacct ggcaaaaaga 16680 ttcaacattt gcagaacgca atgaaatagg ggtgggaaat aactttgcca tggaaattaa 16740 cctgaatgcc aacctatgga gaaatttcct ttactccaat attgcgctgt acctgccaga 16800 caagctaaaa tacaacccca ccaatgtgga aatatctgac aaccccaaca cctacgacta 16860 catgaacaag cgagtggtgg ctcctgggct tgtagactgc tacattaacc ttggggcgcg 16920 ctggtctctg gactacatgg acaacgttaa tccctttaac cacccccgcc atgcgggcct 16980 gcgttaccgc tccatgttgt tgggaaacgg ccgctacgtg ccctttcaca ttcaggtgcc 17040 ccaaaagttt tttgccatta aaaacctcct cctcctgcca ggctcataca catatgaatg 17100 gaacttcagg aaggatgtta acatggttct gcagagctct ctgggaaacg accttagagt 17160 tgacggggct agcattaagt ttgacagcat ttgtctttac gccaccttct tccccatggc 17220 ccacaacacg gcctccacgc tggaagccat gctcagaaat gacaccaacg accagtcctt 17280 taatgactac ctttccgccg ccaacatgct atatcccata cccgccaacg ccaccaacgt 17340 gcccatctcc atcccatcgc gcaactgggc agcatttcgc ggttgggcct tcacacgctt 17400 gaagacaaag gaaacccctt ccctgggatc aggctacgac ccttactaca cctactctgg 17460 ctccatacca taccttgacg gaaccttcta tcttaatcac acctttaaga aggtggccat 17520 tacttttgg tcttctgtta gctggccggg caacgaccgc ctgcttactc ccaatgagtt 17580 tgagattaag cgctcagttg acggggaggg ctataacgta gctcagtgca acatgacaaa 17640 ggactggttc ctagtgcaga tgttggccaa ctacaatatt ggctaccagg gcttctacat 17700 tccagaaagc tacaaagacc gcatgtactc gttcttcaga aacttccagc ccatgagccg 17760 gcaagtggtg gacgatacta aatacaaaga ttatcagcag gttggaatta tccaccagca 17820 taacaactca ggcttcgtag gctacctcgc tcccaccatg cgcgagggac aagcttaccc 17880 cgctaatgtt ccctacccac taataggcaa aaccgcggtt gatagtatta cccagaaaaa 17940 gtttctttgc gaccgcaccc tgtggcgcat ccccttctcc agtaacttta tgtccatggg 18000 tgcgctcaca gacctgggcc aaaaccttct ctacgcaaac tccgcccacg cgctagacat 18060 gacctttgag gtggatccca tggacgagcc cacccttctt tatgttttgt ttgaagtctt 18120 tgacgtggtc cgtgtgcacc agccgcaccg cggcgtcatc gagaccgtgt acctgcgcac 18180 gcccttctcg gccggcaacg ccacaacata aagaagcaag caacatcaac aacagctgcc 18240 gccatgggct ccagtgagca ggaactgaaa gccattgtca aagatcttgg ttgtgggcca 18300 tattttttgg gcacctatga caagcgcttc ccaggctttg tttccccaca caagctcgcc 18360 tgcgccatag ttaacacggc cggtcgcgag actgggggcg tacactggat ggcctttgcc 18420 tggaacccgc gctcaaaaac atgctacctc tttgagccct ttggcttttc tgaccaacgt 18480 ctcaagcagg tttaccagtt tgagtacgag tcactcctgc gccgtagcgc cattgcctct 18540 tcccccgacc gctgtataac gctggaaaag tccacccaaa gcgtgcaggg gcccaactcg 18600 gccgcctgtg gcctattctg ctgcatgttt ctccacgcct ttgccaactg gccccaaact 18660 cccatggatc acaaccccac catgaacctt attaccgggg tacccaactc catgcttaac 18720 agtccccagg tacagcccac cctgcgccgc aaccaggaac agctctacag cttcctggag 18780 cgccactcgc cctacttccg cagccacagt gcgcaaatta ggagcgccac ttctttttgt 18840 cacttgaaaa acatgtaaaa ataatgtact aggagacact ttcaataaag gcaaatgttt 18900 ttatttgtac actctcgggt gattatttac ccccaccctt gccgtctgcg ccgtttaaaa 18960 atcaaagggg ttctgccgcg catcgctatg cgccactggc agggacacgt tgcgatactg 19020 gtgtttagtg ctccacttaa actcaggcac aaccatccgc ggcagctcgg tgaagttttc 19080 actccacagg ctgcgcacca tcaccaacgc gtttagcagg tcgggcgccg atatcttgaa 19140 gtcgcagttg gggcctccgc cctgcgcgcg cgagttgcga tacacagggt tacagcactg 19200 gaacactatc agcgccgggt ggtgcacgct ggccagcacg ctcttgtcgg agatcanatc 19260 cgcgtccagg tcctccgcgt tgctcagggc gaacggagtc aactttggta gctgccttcc 19320 caaaaagggt gcatgcccag gctttgagtt gcactcgcac cgtagtggca tcagaaggtg 19380 accgtgccca gtctgggcgt taggatacag cgcctgcatg aaagccttga tctgcttaaa 19440 agccacctga gcctttgcgc cttcagagaa gaacatgccg caagacttgc cggaaaactg 19500 attggccgga caggccgcgt catgcacgca gcaccttgcg tcggtgttgg agatctgcac 19560 cacatttcgg ccccaccggt tcttcacgat cttggccttg ctagactgct ccttcagcgc 19620 gcgctgcccg ttttcgctcg tcacatccat ttcaatcacg tgctccttat ttatcataat 19680 gctcccgtgt agacacttaa gctcgccttc gatctcagcg cagcggtgca gccacaacgc 19740 gcagcccgtg ggctcgtggt gcttgtaggt tacctctgca aacgactgca ggtacgcctg 19800 caggaatcgc cccatcatcg tcacaaaggt cttgttgctg gtgaaggtca gctgcaaccc 19860 gcggtgctcc tcgtttagcc aggtcttgca tacggccgcc agagcttcca cttggtcagg 19920 cagtagcttg aagtttgcct ttagatcgtt atccacgtgg tacttgtcca tcaacgcgcg 19980 cgcagcctcc atgcccttct cccacgcaga cacgatcggc aggctcagcg ggtttatcac 20040 cgtgctttca ctttccgctt cactggactc ttccttttcc tcttgcatcc gcataccccg 20100 cgccactggg tcgtcttcat tcagccgccg caccgtgcgc ttacctccct tgccgtgctt 20160 gattagcacc ggtgggttgc tgaaacccac catttgtagc gccacatctt ctctttcttc 20220 ctcgctgtcc acgatcacct ctggggatgg cgggcgctcg ggcttgggag aggggcgctt 20280 ctttttcttt ttggacgcaa tggccaaatc cgccgtcgag gtcgatggcc gcgggctggg 20340 tgtgcgcggc accagcgcat cttgtgacga gtcttcttcg tcctcggact cgagacgccg 20400 cctcagccgc ttttttgggg gcgcgcgggg aggcggcggc gacggcgacg gggacgagac 20460 gtcctccatg gttggtggac gtcgcgccgc accgcgtccg cgctcggggg tggtttcgcg 20520 ctgctcctct tcccgactgg ccatttcctt ctcctatagg cagaaaaaga tcatggagtc 20580 agtcgagaag gaggacagcc taaccgcccc ctttgagttc gccaccaccg cctccaccga 20640 tgccgccaac gcgcctacca ccttccccgt cgaggcaccc ccgcttgagg aggaggaagt 20700 gattatcgag caggacccag gttttgtaag cgaagacgac gaagatcgct cagtaccaac 20760 agaggataaa aagcaagacc aggacgacgc agaggcaaac gaggaacaag tcgggcgggg 20820 ggaccaaagg catggcgact acctagatgt gggagacgac gtgctgttga agcatctgca 20880 gcgccagtgc gccattatct gcgacgcgtt gcaagagcgc agcgatgtgc ccctcgccat 20940 agcggatgtc agccttgcct acgaacgcca cctgttctca ccgcgcgtac cccccaaacg 21000 ccaagaaaac ggcacatgcg agcccaaccc gcgcctcaac ttctaccccg tatttgccgt 21060 gccagaggtg cttgccacct atcacatctt tttccaaaac tgcaagatac ccctatcctg 21120 ccgtgccaac cgcagccgag cggacaagca gctggccttg cggcagggcg ctgtcatacc 21180 tgatatcgcc tcgctcgacg aagtgccaaa aatctttgag ggtcttggac gcgacgagaa 21240 gcgcgcggca aacgctctgc aacaagaaaa cagcgaaaat gaaagtcact gtggagtgct 21300 ggtggaactt gagggtgaca acgcgcgcct agccgtgctg aaacgcagca tcgaggtcac 21360 ccactttgcc tacccggcac ttaacctacc ccccaaggtt atgagcacag tcatgagcga 21420 gctgatcgtg cgccgtgcac gacccctgga gagggatgca aacttgcaag aacaaaccga 21480 ggagggccta cccgcagttg gcgatgagca gctggcgcgc tggcttgaga cgcgcgagcc 21540 tgccgacttg gaggagcgac gcaagctaat gatggccgca gtgcttgtta ccgtggagct 21600 tgagtgcatg cagcggttct ttgctgaccc ggagatgcag cgcaagctag aggaaacgtt 21660 gcactacacc tttcgccagg gctacgtgcg ccaggcctgc aaaatttcca acgtggagct 21720 ctgcaacctg gtctcctacc ttggaatttt gcacgaaaac cgccttgggc aaaacgtgct 21780 tcattccacg ctcaagggcg aggcgcgccg cgactacgtc cgcgactgcg tttacttatt 21840 tctgtgctac acctggcaaa cggccatggg cgtgtggcag cagtgcctgg aggagcgcaa 21900 cctgaaggag ctgcagaagc tgctaaagca aaacttgaag gacctatgga cggccttcaa 21960 cgagcgctcc gtggccgcgc acctggcgga cattatcttc cccgaacgcc tgcttaaaac 22020 cctgcaacag ggtctgccag acttcaccag tcaaagcatg ttgcaaaact ttaggaactt 22080 tatcctagag cgttcaggaa ttctgcccgc cacctgctgt gcgcttccta gcgactttgt 22140 gcccattaag tccgtgaat gccctccgcc gctttggggt cactgctacc ttntgcagct 22200 agccaactac cttgcctacc actccgacat catggaagac gtgagcggtg acggcctact 22260 ggagtgtcac tgtcgctgca acctatgcac cccgcaccgc tccctggtct gcaattcaca 22320 actgcttagc gaaagtcaaa ttatcggtac ctttgagctg cagggtccct cgcctgacga 22380 aaagtccgcg gctccggggt tgaaactcac tccggggctg tggacgtcgg cttaccttcg 22440 caaatttgta cctgaggact accacgccca cgagattagg ttctacgaag accaatcccg 22500 cccgccaaat gcggagctta ccgcctgcgt cattacccag ggccacatcc ttggccaatt 22560 gcaagccatt aacaaagccc gccaagagtt tctgctacga aagggacggg gggtttactt 22620 ggacccccag tccggcgagg agctcaaccc aatccccccg ccgccgcagc cctatcagca 22680 gccgcgggcc cttgcttccc aggatggcac ccaaaaagaa gctgcagctg ccgccgccgc 22740 cacccacgga cgaggaggaa tactgggaca gtcaggcaga ggaggttttg gacgaggagg 22800 aggagatgat ggaagactgg gacagcctag acgaggaagc ttccgaggcc gaagaggtgt 22860 cagacgaaac accgtcaccc tcggtcgcat tcccctcgcc ggcgccccag aaatcggcaa 22920 ccgttcccag cattgctaca acctccgctc ctcaggcgcc gccggcactg cccgttcgcc 22980 gacccaaccg tagatgggac accactggaa ccagggccgg taagtctaag cagccgccgc 23040 cgttagccca agagcaacaa cagcgccaag gctaccgctc gtggcgcgtg cacaagaacg 23100 ccatagttgc ttgcttgcaa gactgtgggg gcaacatctc cttcgcccgc cgctttcttc 23160 tctaccatca cggcgtggcc ttcccccgta acatcctgca ttactaccgt catctctaca 23220 gcccctactg caccggcggc agcggcagca acagcagcgg ccacgcagaa gcaaaggcga 23280 ccggatagca agactctgac aaagcccaag aaatccacag cggcggcagc agcaggagga 23340 ggagcactgc gtctggcgcc caacgaaccc gtatcgaccc gcgagcttag aaacaggatt 23400 tttcccactc tgtatgctat atttcaacag agcaggggcc aagaacaaga gctgaaaata 23460 aaaaacaggt ctctgcgctc cctcacccgc agctgcctgt atcacaaaag cgaagatcag 23520 cttcggcgca cgctggaaga cgcggaggct ctcttcagca aatactgcgc gctgactctt 23580 aaggactagt ttcgcgccct ttctcaaatt taagcgcgaa aactacgtca tctccagcgg 23640 ccacacccgg cgccagcacc tgtcgtcagc gccattatga gcaaggaaat tcccacgccc 23700 tacatgtgga gttaccagcc acaaatggga cttgcggctg gagctgccca agactactca 23760 acccgaataa actacatgag cgcgggaccc cacatgatat cccgggtcaa cggaatccgc 23820 gcccaccgaa accgaattct cctcgaacag gcggctatta ccaccacacc tcgtaataac 23880 cttaatcccc gtagttggcc cgctgccctg gtgtaccagg aaagtcccgc tcccaccact 23940 gtggtacttc ccagagacgc ccaggccgaa gttcagatga ctaactcagg ggcgcagctt 24000 gcgggcggct ttcgtcacag ggtgcggtcg cccgggcagg gtataactca cctgaaaatc 24060 agagggcgag gtattcagct caacgacgag tcggtgagct cctctcttgg tctccgtccg 24120 gacgggacat ttcagatcgg cggcgcgtgg ccgctcttca tttacgcccc gtcaggcgat 24180 cctaactctg cagacctcgt cctcggagcc gcgctccgga ggcattggaa ctctacaatt 24240 tattgaggag ttcgtgcctt cggtttactt caaccccttt tctggacctc ccggccacta 24300 cccggaccag tttattccca actttgacgc ggtaaaagac tcggcggacg gctacgactg 24360 aatgaccagt ggagaggcag agcaactgcg cctgacacac ctcgaccact gccgccgcca 24420 caagtgcttt gcccgcggct ccggtgagtt ttgttacttt gaattgcccg aagagcatat 24480 cgagggcccg gcgcacggcg tccggctcac cacccaggta gagcttacac gtagcctgat 24540 tcgggagttt accaagcgcc ccctgctagt ggagcgggag cggggtccct gtgttctgac 24600 cgtggtttgc aactgtccta accctggatt acatcaagat ctttgttgtc atctctgtgc 24660 tgagtataat aaatacagaa attagaatct actggggctc ctgtcgccat cctgtgaacg 24720 ccaccgtttt tacccaccca aagcagacca aagcaaacct cacctccggt ttgcacaagc 24780 gt; tccagcgaga cgaagtaagt ttgccacaca accttctcgg cttcaactac accgtcaaga 24900 aaaacaccac caccaccctc ctcacctgcc gggaacgtac gagtgcgtca ccggttgctg 24960 cgcccacacc tacagcctga gcgtaaccag acattactcc cattttccca aaacaggagg 25020 tgagctcaac tcccggaact caggtcaaaa aagcattttg cggggtgctg ggatttttta 25080 attaagtata tgagcaattc aagtaactct acaagcttgt ctaatttttc tggaattggg 25140 gtcggggtta tccttactct tgtaattctg tttattctta tactagcact tctgtgcctt 25200 agggttgccg cctgctgcac gcacgtttgt acctattgtc agctttttaa acgctggggg 25260 cgacatccaa gatgaggtac atgattttag gcttgctcgc ccttgcggca gtctgcagcg 25320 ctgccaaaaa ggttgagttt aaggaaccag cttgcaatgt tacatttaaa tcagaagcta 25380 atgaatgcac tactcttata aaatgcacca cagaacatga aaagcttatt attcgccaca 25440 aagacaaaat tggcaagtat gctgtatatg ctatttggca gccaggtgac actaacgact 25500 ataatgtcac agtcttccaa ggtgaaaatc gtaaaacttt tatgtataaa tttccatttt 25560 atgaaatgtg cgatattacc atgtacatga gcaaacagta caagttgtgg cccccacaaa 25620 agtgtttaga gaacactggc accttttgtt ccaccgctct gcttattaca gcgcttgctt 25680 tggtatgtac cttactttat ctcaaataca aaagcagacg cagttttatt gatgaaaaga 25740 aaatgccttg attttccgct tgcttgtatt cccctggaca atttactcta tgtgggatat 25800 gcgccaggcg ggaaagatta tacccacaac cttcaaatca aactttcctg gacgttagcg 25860 cctgacttct gccagcgcct gcactgcaaa tttgatcaaa cccagcttca gcttgcctgc 25920 tccagagatg accggctcaa ccatcgcgcc cacaacggac tatcgcaaca ccactgctac 25980 cggactaaaa tctgccctaa atttacccca agttcatgcc tttgtcaatg actgggcgag 26040 cttgggcatg tggtggtttt ccatagcgct tatgtttgtt tgccttatta ttatgtggct 26100 tatttgttgc ctaaagcgca gacgcgccag accccccatc tataggccta tcattgtgct 26160 caacccacac aatgaaaaaa ttcatagatt ggacggtctc aaaccatgtt ctcttctttt 26220 acagtatgat taaatgagac atgattcctc gagtccttat attattgacc cttgttgcgc 26280 ttttctgtgc gtgctctaca ttggctgcgg tcgctcacat cgaagtagat tgcatcccac 26340 ctttcacagt ttacctgctt tacggatttg tcacccttat cctcatctgc agcctcgtca 26400 ctgtagtcat cgccttcatt cagttcattg actggatttg tgtgcgcatt gcgtacctta 26460 ggcaccatcc gcaatacaga gacaggacta tagctgatct tctcagaatt ctttaattat 26520 gaaacggatt gtcacttttg ttttgctgat tttctgcgcc ctacctgtgc tttgctccca 26580 aacctcagcg cctcccaaaa gacatatttc ctgcagattc actcaaatat ggaacattcc 26640 cagctgctac aacaaacaga gcgatttgtc agaagcctgg ttatacgcca tcatctctgt 26700 catggttttt tgcagtacca tttttgccct agccatatac ccataccttg acattggttg 26760 gaatgccata gatgccatga accaccctac tttcccagcg cccaatgtca taccactgca 26820 acaggttatt gccccaatca atcagcctcg ccccccttct cccaccccca ctgagattag 26880 ctactttaat ttgacaggtg gagatgactg aatctctaga tctagaattg gatggaatta 26940 acaccgaaca gcgcctacta gaaaggcgca aggcggcgtc cgagcgagaa cgcctaaaac 27000 aagaagttga agacatggtt aacctgcacc agtgtaaaag aggtatcttt tgtgtggtca 27060 agcaggccaa acttacctac gaaaaaacca ctaccggcaa ccgccttagc tacaagctac 27120 ccacccagcg ccaaaaactg gtgcttatgg tgggagaaaa acctatcacc gtcacccagc 27180 actcggcaga aacagaaggc tgcctgcact tcccctatca gggtccagag gacctctgca 27240 ctcttattaa aaccatgtgt ggcattagag atcttattcc attcaactaa caataaacac 27300 acaataaatt acttacttaa aatcagtcag caaatctttg tccagcttat tcagcatcac 27360 ctcctttccc tcctcccaac tctggtattt cagcagcctt ttagctgcga actttctcca 27420 aagtctaaat gggatgtcaa attcctcatg ttcttgtccc tccgcaccca ctatcttcat 27480 attgttgcag atgaaacgcg ccagaccgtc tgaagacacc ttcaaccctg tgtacccata 27540 tgacacggaa accggccctc caactgtgcc tttccttacc cctccctttg tgtcgccaaa 27600 tgggttccaa gaaagtcccc ccggagtgct ttctttgcgt ctttcagaac ctttggttac 27660 ctcacacggc atgcttgcgc taaaaatggg cagcggcctg tccctggatc aggcaggcaa 27720 ccttacatca aatacaatca ctgtttctca accgctaaaa aaaacaaagt ccaatataac 27780 tttggaaaca tccgcgcccc ttacagtcag ctcaggcgcc ctaaccatgg ccacaacttc 27840 gcctttggtg gtctctgaca acactcttac catgcaatca caagcaccgc taaccgtgca 27900 agactcaaaa cttagcattg ctaccaaaga gccacttaca gtgttagatg gaaaactggc 27960 cctgcagaca tcagcccccc tctctgccac tgataacaac gccctcacta tcactgcctc 28020 acctcctctt actactgcaa atggtagtct ggctgttacc atggaaaacc cactttacaa 28080 caacaatgga aaacttgggc tcaaaattgg cggtcctttg caagtggcca ccgactcaca 28140 tgcactaaca ctaggtactg gtcagggggt tgcagttcat aacaatttgc tacatacaaa 28200 agttacaggc gcaatagggt ttgatacatc tggcaacatg gaacttaaaa ctggagatgg 28260 cctctatgtg gatagcgccg gtcctaacca aaaactacat attaatctaa ataccacaaa 28320 aggccttgct tttgacaaca ccgcaataac aattaacgct ggaaaagggt tggaatttga 28380 aacagactcc tcaaacggaa atcccataaa aacaaaaatt ggatcaggca tacaatataa 28440 taccaatgga gctatggttg caaaacttgg aacaggcctc agttttgaca gctccggagc 28500 cataacaatg ggcagcataa acaatgacag acttactctt tggacaacac cagacccatc 28560 cccaaattgc agaattgctt cagataaaga ctgcaagcta actctggcgc taacaaaatg 28620 tggcagtcaa attttgggca ctgtttcagc tttggcagta tcaggtaata tggcctccat 28680 caatggaact ctaagcagtg taaacttggt tcttagattt gatgacaacg gagtgcttat 28740 gtcaaattca tcactggaca aacagtattg gaactttaga aacggggact ccactaacgg 28800 tcaaccatac acttatgctg ttgggtttat gccaaaccta aaagcttacc caaaaactca 28860 aagtaaaact gcaaaaagta atattgttag ccaggtgtat cttaatggtg acaagtctaa 28920 accattgcat tttactatta cgctaaatgg aacagatgaa accaaccaag taagcaaata 28980 ctcaatatca ttcagttggt cctggaacag tggacaatac actaatgaca aatttgccac 29040 caattcctat accttctcct acattgccca ggaataaaga atcgtgaacc tgttgcatgt 29100 tatgtttcaa cgtgtttatt tttcaattgc agaaaatttc aagtcatttt tcattcagta 29160 gtatagcccc accaccacat agcttatact aatcaccgta ccttaatcaa actcacagaa 29220 ccctagtatt caacctgcca cctccctccc aacacacaga gtacacagtc ctttctcccc 29280 ggctggcctt aaacagcatc atatcatggg taacagacat attcttaggt gttatattcc 29340 acacggtctc ctgtcgagcc aaacgctcat cagtgatgtt aataaactcc ccgggcagct 29400 cgcttaagtt catgtcgctg tccagctgct gagccacagg ctgctgtcca acttgcggtt 29460 gctcaacggg cggcgaagga gaagtccacg cctacatggg ggtagagtca taatcgtgca 29520 tcaggatagg gcggtggtgc tgcagcagcg cgcgaataaa ctgctgccgc cgccgctccg 29580 tcctgcagga atacaacatg gcagtggtct cctcagcgat gattcgcacc gcccgcagca 29640 taaggcgcct tgtcctccgg gcacagcagc gcaccctgat ctcacttaag tcagcacagt 29700 aactgcagca cagtaccaca atattgttta aaatcccaca gtgcaaggcg ctgtatccaa 29760 agctcatggc ggggaccaca gaacccacgt ggccatcata ccacaagcgc aggtagatta 29820 agtggcgacc cctcataaac acgctggaca taaacattac ctcttttggc atgttgtaat 29880 tcaccacctc ccggtaccat ataaacctct gattaaacat ggcgccatcc accaccatcc 29940 taaaccagct ggccaaaacc tgcccgccgg ctatgcactg cagggaaccg ggactggaac 30000 aatgacagtg gagagcccag gactcgtaac catggatcat catgctcgtc atgatatcaa 30060 tgttggcaca acacaggcac acgtgcatac acttcctcag gattacaagc tcctcccgcg 30120 tcagaaccat atcccaggga acaacccatt cctgaatcag cgtaaatccc acactgcagg 30180 gaagacctcg cacgtaactc acgttgtgca ttgtcaaagt gttacattcg ggcagcagcg 30240 gatgatcctc cagtatggta gcgcgtgtct ctgtctcaaa aggaggtagg cgatccctac 30300 tgtacggagt gcgccgagac aaccgagatc gtgttggtcg tagtgtcatg ccaaatggaa 30360 cgccggacgt agtcatattt cctgaagcaa aaccaggtgc gggcgtgaca aacagatctg 30420 cgtctccggt ctcgtcgctt agctcgctct gtgtagtagt tgtagtatat ccactctctc 30480 aaagcatcca ggcgccccct ggcttcgggt tctatgtaaa ctccttcatg cgccgctgcc 30540 ctgataacat ccaccaccgc agaataagcc acacccagcc aacctacaca ttcgttctgc 30600 gagtcacaca cgggaggagc gggaagagct ggaagaacca tgtttttttt ttttattcca 30660 aaagattatc caaaacctca aaatgaagat ctattaagtg aacgcgctcc cctccggtgg 30720 cgtggtcaaa ctctacagcc aaagaacaga taatggcatt tgtaagatgt tgcacaatgg 30780 cttccaaaag gcaaactgcc ctcacgtcca agtggacgta aaggctaaac ccttcanggt 30840 gaatctcctc tataaacatt ccagcacctt caaccatgcc caaataattt tcatctcgcc 30900 accttatcaa tatgtctcta agcaaatccc gaatattaag tccggccatt gtaaaaatct 30960 gctccagagc gccctccacc ttcagcctca agcagcgaat catgattgca aaaattcagg 31020 ttcctcacag acctgtataa gattcaaaag cggaacatta acaaaaatac cgcgatcccg 31080 taggtccctt cgcagggcca gctgaacata atcgtgcagg tctgcacgga ccagcgcggc 31140 cacttccccg ccaggaacca tgacaaaaga acccacactg attatgacac gcatactcgg 31200 agctatgcta accagcgtag ccccgatgta agcttgttgc atgggcggcg atataaaatg 31260 caaggtactg ctcaaaaaat caggcaaagc ctcgcgcaaa aaagcaagca catcgtagtc 31320 atgctcatgc agataaaggc aggtaagttc cggaaccacc acagaaaaag acaccatttt 31380 tctctcaaac atgtctgcgg gttcctgcat aaacacaaaa taaaataaca aaaaaaaaaa 31440 aacatttaaa cattagaagc ctgtcttaca acaggaaaaa caacccttat aagcataaga 31500 cggactacgg ccatgccggc gtgaccgtaa aaaaactggt caccgtgatt aaaaagcacc 31560 accgacagtt cctcggtcat gtccggagtc ataatgtaag actcggtaaa cacatcaggt 31620 tggttaacat cggtcagtgc taaaaagcga ccgaaatagc ccgggggaat acatacccgc 31680 aggcgtagag acaacattac agcccccata ggaggtataa caaaattaat aggagagaaa 31740 aacacataaa cacctgaaaa accctcctgc ctaggcaaaa tagcaccctc ccgctccaga 31800 acaacataca gcgcttccac agcggcagcc ataacagtca gccttaccag taaaaaaacc 31860 tattaaaaaa caccactcga cacggcacca gctcaatcag tcacagtgta aaaagggcca 31920 agtacagagc gagtatatat aggactaaaa aatgacgtaa cggttaaagt ccacaaaaac 31980 cacccagaaa accgcacgcg aacctacgcc cagaaacgaa agccaaaaaa cccacaactt 32040 cctcaaatct tcacttccgt tttcccacga tacgtcactt cccattttaa aaaaaaacta 32100 caattcccaa tacatgcaag ttactccgcc ctaaaaccta cgtcacccgc cccgttccca 32160 cgccccgcgc cacgtcacaa actccacccc ctcattatca tattggcttc aatccaaaat 32220 aaggtatatt attgatgatg aaattctaga aatcgataag cttgagtatt ctatagtgtc 32280 acctaaatag cttggcgtaa tcatggtcat agctgtttcc tgtgtgaaat tgttatccgc 32340 tcacaattcc acacaacata cgagccggaa gcataaagtg taaagcctgg ggtgcctaat 32400 gagtgagcta actcacatta attgcgttgc gctcactgcc cgctttccag tcgggaaacc 32460 tgtcgtgcca gctgcattaa tgaatcggcc aacgcgcggg gagaggcggt ttgcgtattg 32520 ggcgctcttc cgcttcctcg ctcactgact cgctgcgctc ggtcgttcgg ctgcggcgag 32580 cggtatcagc tcactcaaag gcggtaatac ggttatccac agaatcaggg gataacgcag 32640 gaaagaacat gtgagcaaaa ggccagcaaa aggccaggaa ccgtaaaaag gccgcgttgc 32700 tggcgttttt ccataggctc cgcccccctg acgagcatca caaaaatcga cgctcaagtc 32760 agaggtggcg aaacccgaca ggactataaa gataccaggc gtttccccct ggaagctccc 32820 tcgtgcgctc tcctgttccg accctgccgc ttaccggata cctgtccgcc tttctccctt 32880 cgggaagcgt ggcgctttct catagctcac gctgtaggta tctcagttcg gtgtaggtcg 32940 ttcgctccaa gctgggctgt gtgcacgaac cccccgttca gcccgaccgc tgcgccttat 33000 ccggtaacta tcgtcttgag tccaacccgg taagacacga cttatcgcca ctggcagcag 33060 ccactggtaa caggattagc agagcgaggt atgtaggcgg tgctacagag ttcttgaagt 33120 ggtggcctaa ctacggctac actagaagaa cagtatttgg tatctgcgct ctgctgaagc 33180 cagttacctt cggaaaaaga gttggtagct cttgatccgg caaacaaacc accgctggta 33240 gcggtggttt ttttgtttgc aagcagcaga ttacgcgcag aaaaaaagga tctcaagaag 33300 atcctttgat cttttctacg gggtctgacg ctcagtggaa cgaaaactca cgttaaggga 33360 ttttggtcat gagattatca aaaaggatct tcacctagat ccttttaaat taaaaatgaa 33420 gttttaaatc aatctaaagt atatatgagt aaacttggtc tgacagttac caatgcttaa 33480 tcagtgaggc acctatctca gcgatctgtc tatttcgttc atccatagtt gcctgactcc 33540 ccgtcgtgta gataactacg atacgggagg gcttaccatc tggccccagt gctgcaatga 33600 taccgcgaga cccacgctca ccggctccag atttatcagc aataaaccag ccagccggaa 33660 gggccgagcg cagaagtggt cctgcaactt tatccgcctc catccagtct attaattgtt 33720 gccgggaagc tagagtaagt agttcgccag ttaatagttt gcgcaacgtt gttgccattg 33780 ctacaggcat cgtggtgtca cgctcgtcgt ttggtatggc ttcattcagc tccggttccc 33840 aacgatcaag gcgagttaca tgatccccca tgttgtgcaa aaaagcggtt agctccttcg 33900 gtcctccgat cgttgtcaga agtaagttgg ccgcagtgtt atcactcatg gttatggcag 33960 cactgcataa ttctcttact gtcatgccat ccgtaagatg cttttctgtg actggtgagt 34020 actcaaccaa gtcattctga gaatagtgta tgcggcgacc gagttgctct tgcccggcgt 34080 caatacggga taataccgcg ccacatagca gaactttaaa agtgctcatc attggaaaac 34140 gttcttcggg gcgaaaactc tcaaggatct taccgctgtt gagatccagt tcgatgtaac 34200 ccactcgtgc acccaactga tcttcagcat cttttacttt caccagcgtt tctgggtgag 34260 caaaaacagg aaggcaaaat gccgcaaaaa agggaataag ggcgacacgg aaatgttgaa 34320 tactcatact cttccttttt caatattatt gaagcattta tcagggttat tgtctcatga 34380 gcggatacat atttgaatgt atttagaaaa ataaacaaat aggggttccg cgcacatttc 34440 cccgaaaagt gccacctgac gtctaagaaa ccattattat catgacatta acctataaaa 34500 ataggcgtat cacgaggccc tttcgtctcg cgcgtttcgg tgatgacggt gaaaacctct 34560 gacacatgca gctcccggag acggtcacag cttgtctgta agcggatgcc gggagcagac 34620 aagcccgtca gggcgcgtca gcgggtgttg gcgggtgtcg gggctggctt aactatgcgg 34680 catcagagca gattgtactg agagtgcacc atatgcggtg tgaaataccg cacagatgcg 34740 taaggagaaa ataccgcatc aggaaattgt aagcgttaat attttgttaa aattcgcgtt 34800 aaatttttgt taaatcagct cattttttaa ccaataggcc gaaatcggca aaatccctta 34860 taaatcaaaa gaatagaccg agatagggtt gagtgttgtt ccagtttgga acaagagtcc 34920 actattaaag aacgtggact ccaacgtcaa agggcgaaaa accgtctatc agggcgatgg 34980 cccactacgt gaaccatcac cctaatcaag ttttttgggg tcgaggtgcc gtaaagcact 35040 aaatcggaac cctaaaggga gcccccgatt tagagcttga cggggaaagc cggcgaacgt 35100 ggcgagaaag gaagggaaga aagcgaaagg agcgggcgct agggcgctgg caagtgtagc 35160 ggtcacgctg cgcgtaacca ccacacccgc cgcgcttaat gcgccgctac agggcgcgtc 35220 cattcgccat tcaggctgcg caactgttgg gaagggcgat cggtgcgggc ctcttcgcta 35280 ttacgccagc tggcgaaagg gggatgtgct gcaaggcgat taagttgggt aacgccaggg 35340 ttttcccagt cacgacgttg taaaacgacg gccagtgaat tgtaatacga ctcactata 35399 <210> 3 <211> 73 <212> DNA <213> Artificial Sequence <220> <223> Restriction enzyme site <400> 3 ggccaagtcg gccttaatta acttaaggtt taaacgatat catttaaatt acgtactcga 60 gggatccaag ctt 73 <210> 4 <211> 42 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 4 atgcttaatt aaatcatcaa taatatacct tattttggat tg 42 <210> 5 <211> 40 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 5 atgccttaag tttcagtccc ggtgtcggag cggctcggag 40 <210> 6 <211> 48 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 6 atttaattaa gcgatcgcat catcaataat ataccttatt ttggattg 48 <210> 7 <211> 24 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 7 atgcttccat caaacgagtt ggcg 24 <210> 8 <211> 24 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 8 tcttacctct ggtttccatg agcc 24 <210> 9 <211> 45 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 9 atttaattaa gcgatcgcca tcatcaataa tataccttat tttgg 45 <210> 10 <211> 78 <212> DNA <213> Artificial Sequence <220> <223> Restriction enzyme site <400> 10 cttaaggagc tcttcgaact cgaggtttaa acgatatctt aattaaggat ccatttaaat 60 tctagaatcg ataagctt 78 <210> 11 <211> 26 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 11 atcatcaata atatacctta ttttgg 26 <210> 12 <211> 26 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 12 tccggctcgt atgttgtgtg gaattg 26 <210> 13 <211> 25 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 13 tagaatcgat aagcttgagt attct 25 <210> 14 <211> 34 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 14 atgccttaag aattcgccct atagtgagtc gtat 34 <210> 15 <211> 27 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 15 ctgggatttt ttaattaagt atatgag 27 <210> 16 <211> 41 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 16 tactcaagct tatcgcatca tcaataatat accttatttt g 41

Claims (20)

혈청형 6 아데노바이러스 게놈에서, 서열번호 1의 염기서열 중 2,939 ~ 2,998의 서열을 가지는 LITR(left Ad6 inverted terminal repeat), 핵산외각생성신호 (encapsidation signal), RITR(right Ad6 inverted terminal repeat), right arm homology 및 상기 right arm homology와 인접하는 left arm homology를 포함하고, 혈청형 6 아데노바이러스 게놈의 E1 영역은 포함하지 않으며, 복제기점 및 항생제 저항성 유전자를 포함하는 혈청형 6 재조합 아데노바이러스 제조용 셔틀벡터.
In the serotype 6 adenovirus genome, a LITR (left Ad6 inverted terminal repeat), a nucleic acid encapsidation signal, a right Ad6 inverted terminal repeat (RITR) having a sequence of 2,939 to 2,998 in the nucleotide sequence of SEQ ID NO: 1, a right a shuttle vector for serotype 6 recombinant adenovirus comprising the arm homology and the left arm homology adjacent to the right arm homology, but not including the E1 region of the serotype 6 adenovirus genome, and a replication origin and an antibiotic resistance gene.
제1항에 있어서, right arm homology와 left arm homology 연결 부위에 단일 제한효소 절단부위를 가지는 것을 특징으로 하는 셔틀벡터.
2. The shuttle vector according to claim 1, wherein the shuttle vector has a single restriction enzyme cleavage site at a right arm homology and a left arm homology junction.
제1항에 있어서, 다중클로닝부위를 추가로 함유하는 것을 특징으로 하는 셔틀벡터.
2. The shuttle vector of claim 1, further comprising a multiple cloning site.
제1항에 있어서, 목적 단백질을 코딩하는 유전자를 추가로 함유하는 것을 특징으로하는 셔틀벡터.
The shuttle vector according to claim 1, further comprising a gene encoding a target protein.
제1항에 있어서, 상기 복제기점과 상기 항생제 저항성 유전자가 제한효소에 의해 제거될 수 있는 구조를 가지는 것을 특징으로 하는 셔틀벡터.
The shuttle vector according to claim 1, wherein the origin of replication and the antibiotic resistance gene are capable of being removed by restriction enzymes.
삭제delete 제1항에 있어서, 상기 RITR(right Ad6 inverted termial repeat)은 서열번호 1의 염기서열 중 6,946 ~ 7,005의 서열을 가지는 것을 특징으로 하는 셔틀벡터.
2. The shuttle vector according to claim 1, wherein the RITR (right Ad6 inverted terminal repeat) has a sequence of 6,946 to 7,005 of the nucleotide sequence of SEQ ID NO: 1.
제1항에 있어서, 상기 핵산외각생성신호 (encapsidation signal)는 서열번호 1의 염기서열 중 3,120 ~ 3,269의 서열을 가지는 것을 특징으로 하는 셔틀벡터.
The shuttle vector according to claim 1, wherein the nucleic acid encapsidation signal has a sequence of 3,120 to 3,269 of the nucleotide sequence of SEQ ID NO: 1.
제1항에 있어서, 상기 right arm homology는 서열번호 1의 염기서열 중3,604 ~ 5,848의 서열을 가지고, 상기 left arm homology는 서열번호 1의 염기서열 중 5,855 ~ 7,006의 서열을 가지는 것을 특징으로 하는 셔틀벡터.
2. The method according to claim 1, wherein the right arm homology has a sequence of 3,604 to 5,848 of the nucleotide sequence of SEQ ID NO: 1 and the left arm homology has a sequence of 5,855 to 7,006 of the nucleotide sequence of SEQ ID NO: vector.
E1 영역이 제거된 혈청형 6 아데노바이러스 게놈, 서열번호 1의 염기서열 중 3,604 ~ 5,848의 서열을 가지는 right arm homology 및 상기 right arm homology와 인접하고, 서열번호 1의 염기서열 중 5,855 ~ 7,006의 서열을 가지는 left arm homology, 복제기점, 항생제 저항성 유전자를 포함하는 혈청형 6 재조합 아데노바이러스 제조용 레스큐벡터 (rescue vector).
The serotype 6 adenovirus genome from which the E1 region has been deleted, having a sequence of 3,604 to 5,848 of the nucleotide sequence of SEQ ID NO: 1 right arm homology and the right arm homology, and a left arm homology having a sequence of 5,855 to 7,006 in the nucleotide sequence of SEQ ID NO: 1, a replication origin, and a rescue vector for producing serotype 6 recombinant adenovirus comprising an antibiotic resistance gene vector).
제10항에 있어서, 상기 제거된 E1 영역은 LITR~AFlll 영역인 것을 특징으로 하는 혈청형 6 재조합 아데노바이러스 제조용 레스큐벡터 (rescue vector).
[Claim 11] The rescue vector for preparing serotype 6 recombinant adenovirus according to claim 10, wherein the deleted El region is a LITR to AF11 region.
제10항에 있어서, 상기 E1 영역이 제거된 혈청형 6 아데노바이러스 게놈은 서열번호 2의 염기서열 중 10~32,251의 염기서열을 가지는 것을 특징으로 하는 혈청형 6 재조합 아데노바이러스 제조용 레스큐벡터 (rescue vector).
The recombinant adenoviral vector according to claim 10, wherein the serotype 6 adenovirus genome from which the E1 region has been deleted has a nucleotide sequence of 10 to 32,251 of the nucleotide sequence of SEQ ID NO: 2. ).
삭제delete 다음 단계를 포함하는 재조합 혈청형 6 아데노바이러스 벡터의 제조방법:
(a) 제1항 내지 제5항 및 제7항 내지 제9항 중 어느 한 항의 셔틀벡터와 제10항 내지 제12항 중 어느 하나의 레스큐벡터를 리콤비네이즈 활성을 가지는 미생물에 동시에 형질전환시켜 상동성 재조합시키는 단계;
(b) 상기 형질전환된 미생물을 배양하는 단계; 및
(c) 상기 배양된 미생물에서 재조합 혈청형 6 아데노바이러스 벡터를 수득하는 단계.
A method for preparing a recombinant serotype 6 adenovirus vector comprising the steps of:
(a) transfecting the shuttle vector of any one of claims 1 to 5 and 7 to 9 and the rescue vector of any one of claims 10 to 12 into a microorganism having recombinase activity Homologous recombination;
(b) culturing the transformed microorganism; And
(c) obtaining a recombinant serotype 6 adenovirus vector from the cultured microorganism.
제14항에 있어서, 상기 셔틀벡터는 형질전환 이전에 right arm homology와 left arm homology 연결부위를 제한효소로 절단하여 선형화시킨 것임을 특징으로 하는 재조합 혈청형 6 아데노바이러스 벡터의 제조방법.
15. The method according to claim 14, wherein the shuttle vector is linearized by digesting a right arm homology and a left arm homology linkage region with restriction enzymes before transformation.
제14항에 있어서, 리콤비네이즈 활성을 가지는 미생물은 대장균 또는 아데노바이러스 생산세포주인 것을 특징으로 하는 재조합 혈청형 6 아데노바이러스 벡터의 제조방법.
15. The method for producing a recombinant serotype 6 adenoviral vector according to claim 14, wherein the microorganism having recombinase activity is an E. coli or adenovirus producing cell line.
제14항의 방법에 의해 제조되고, E1 유전자를 포함하지 않는 혈청형 6 아데노바이러스 유전체, 프로모터, 복제기점 및 항생제 저항성 유전자를 함유하는 것을 특징으로 하는 재조합 혈청형 6 아데노바이러스 벡터.
A recombinant serotype 6 adenovirus vector, produced by the method of claim 14, which contains serotype 6 adenovirus genome, promoter, origin of replication and antibiotic resistance gene which does not contain the E1 gene.
제17항에 있어서, 목적단백질을 코딩하는 유전자를 추가로 함유하는 것을 특징으로 하는 재조합 혈청형 6 아데노바이러스 벡터.
The recombinant serotype 6 adenovirus vector according to claim 17, further comprising a gene encoding a target protein.
제18항에 있어서, 목적단백질은 치료용 단백질인 것을 특징으로 하는 재조합 혈청형 6 아데노바이러스 벡터.
19. The recombinant serotype 6 adenovirus vector according to claim 18, wherein the target protein is a therapeutic protein.
삭제delete
KR1020130034585A 2013-03-29 2013-03-29 Vectors for Preparing Serotype 6 Recombinant Adenovirus KR101557974B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020130034585A KR101557974B1 (en) 2013-03-29 2013-03-29 Vectors for Preparing Serotype 6 Recombinant Adenovirus
PCT/KR2013/006602 WO2014157778A1 (en) 2013-03-29 2013-07-24 Vector for producing serotype 6 recombinant adenovirus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020130034585A KR101557974B1 (en) 2013-03-29 2013-03-29 Vectors for Preparing Serotype 6 Recombinant Adenovirus

Publications (2)

Publication Number Publication Date
KR20140118510A KR20140118510A (en) 2014-10-08
KR101557974B1 true KR101557974B1 (en) 2015-10-08

Family

ID=51624720

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020130034585A KR101557974B1 (en) 2013-03-29 2013-03-29 Vectors for Preparing Serotype 6 Recombinant Adenovirus

Country Status (2)

Country Link
KR (1) KR101557974B1 (en)
WO (1) WO2014157778A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100389526B1 (en) * 1993-10-25 2004-04-03 캔지, 인크. Recombinant Adenovirus Vectors and Methods of Use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100250837B1 (en) * 1997-10-21 2000-04-01 박호군 Recombinant adenovirus producing thymidine kinase of herpes simplex virus-1 and its usage
AU2006249877A1 (en) * 2005-05-23 2006-11-30 Vaxin, Inc. Rapid production of adenovirus-free recombinant adenovirus vectors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100389526B1 (en) * 1993-10-25 2004-04-03 캔지, 인크. Recombinant Adenovirus Vectors and Methods of Use

Also Published As

Publication number Publication date
KR20140118510A (en) 2014-10-08
WO2014157778A1 (en) 2014-10-02

Similar Documents

Publication Publication Date Title
AU2018229561B2 (en) Recombinant adenoviruses and use thereof
CN108138154B (en) Adeno-associated virus vectors for the treatment of mucopolysaccharidosis
AU2013221187B9 (en) Virus like particle composition
US6451769B1 (en) Compositions and methods for administering Borrelia DNA
CN1913919A (en) HIV vaccines based on env of multiple clades of hiv
CN106544361B (en) Mammalian cell expression vector, expression system, preparation method and application
US20230149566A1 (en) Compositions and methods for treating macular dystrophy
KR20110039258A (en) Improved protein expression system
KR20140034150A (en) Methods and compositions for increasing sialic acid production and treating sialic related disease conditions
CN109652381A (en) The CAR-T cell preparation method and application of CD133 is targeted based on base editor
US20220017594A1 (en) Il-2 dependent nk-92 cells with stable fc receptor expression
CN109207491A (en) A kind of M1 virus full length infection clones and preparation method and its preparing the application in M1 virus
KR101557974B1 (en) Vectors for Preparing Serotype 6 Recombinant Adenovirus
CN114874332B (en) Use of modified RNF112 as a medicament for the treatment of ALS
CN109022363A (en) A kind of CD-133-CAR-T system constituting method based on PiggyBac carrier
KR20150030951A (en) Recombinant foot and mouth disease virus expressing protective antigen of Asia1 type standard vaccine strain and producing method thereof
KR101153845B1 (en) trans splicing group I ribozyme specific for Kras G12V RNA
KR102341583B1 (en) Preparation and purification method of recombinant human fibrost growth factor receptor by using solubility-enhancing bifunctional fusion tag combined with split intein and use thereof
CN111100874B (en) Targeting vector, method for integrating exogenous gene into mouse DC-SIGN exon 7 locus to construct BAC clone and application
CN111484979A (en) Liver tumor cell strain capable of tracing in vivo and construction method thereof
CN114395020A (en) Application of GmRALF1 protein in promoting absorption of phosphorus element by plants
CN106399373B (en) A kind of Cas9 expression vector
CN109321602B (en) PKD2 recombinant overexpression vector and construction method and application thereof
KR102065917B1 (en) Transformed stem cell expressing glb1 gene and pharmaceutical composition for treating gm1 gangliosidosis comprising same
CN115093482A (en) High-precision gonad purine base editor and application thereof

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
FPAY Annual fee payment

Payment date: 20180921

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20190925

Year of fee payment: 5